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ABSTRACT 
This dissertation presents the development of new catalysts for enantioselective, 
rhodium-catalyzed alkene hydroacylation to form polycyclic heterocyclic ketones, the first 
examples of nickel-catalyzed alkene carboacylation via amide C−N bond activation, and 
the first examples of enantioselective, intermolecular palladium-catalyzed alkene 
carboacylation via ester C−O bond activation. 
Chapter II describes the enantioselective synthesis of polycyclic nitrogen, oxygen, 
and sulfur heterocycles by rhodium-catalyzed intramolecular alkene hydroacylation. The 
intramolecular hydroacylation reactions generate 1,4-dihydrocyclopenta[b]indol-3(2H)-
ones and 3,4-dihydrocyclopenta[b]indol-1(2H)-one in moderate-to-high yields (65-99%) 
with good-to-excellent enantioselectivities (84-99% ee). The catalyst system also promotes 
alkene hydroacylation of 3-vinylfuran-, 3-vinylbenzothiophene-, and 3-vinylthiophene-2-
carboxaldehydes to generate the corresponding ketone products in moderate-to-high yields 
(71-91% yield) with excellent enantioselectivities (97-99% ee). 
Chapter III discusses nickel-catalyzed formal carboacylation of ortho-
allylbenzamides with arylboronic acid pinacol esters. The reaction is triggered by oxidative 
addition of an activated amide C−N bond to a Ni(0) catalyst and proceeds via alkene 
insertion into a Ni(II)-acyl bond. The exo-selective carboacylation reaction generates 2-
benzyl-2,3-dihydro-1H-inden-1-ones in moderate to high yields (46−99%) from a variety 
of arylboronic acid pinacol esters and substituted ortho-allylbenzamides. These results 
show that amides are practical substrates for alkene carboacylation via amide C−N bond 
activation, and this approach bypasses challenges associated with alkene carboacylation 
triggered by C−C bond activation. 
ix 
Chapter IV describes palladium-catalyzed formal intermolecular carboacylation of 
aryl benzoate esters with sodium tetraarylborates and norbornene. The reaction is triggered 
by oxidative addition of an activated amide C−O bond to a Pd(0) catalyst and proceeds via 
alkene insertion into a Pd(II)-acyl bond. The three-component intermolecular 
carboacylation reaction generates phenyl(3-phenylbicyclo[2.2.1]heptan-2-yl)methanones 
in up to 99% yield with 1:1 diastereomeric ratio and in moderate to high enantiomeric 
excess from a variety of aryl benzoate esters and sodium tetraarylborates. These results 
show that esters are practical substrates for enantioselective, intermolecular alkene 
carboacylation via ester C−O bond activation. This approach bypasses challenges 
associated with alkene carboacylation triggered by C−C bond activation and expands 
alkene carboacylation via carbon-heteroatom bond activation beyond twisted amides. 
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CHAPTER 1.    INTRODUCTION: THESIS FORMATTING 
General Introduction 
Transition-metal catalysis has been established as an essential component of modern 
synthetic organic chemistry.1 This broad research area encompasses reactions such as cross-
coupling, C−H activation chemistry, hydrofunctionalization, and metathesis, among many 
others.1 Vast amounts of insight have been gained through advances in transition metal-
catalyzed processes and enabled both identification of novel and improved catalysts for a 
variety of chemical transformations.  In this dissertation, fundamental principles of transition-
metal catalysis is applied to the development of new catalysts for alkene difunctionalization 
reactions including an enantioselective, rhodium catalyst for the synthesis of polycyclic 
heterocycles, a nickel-NHC (N-heterocyclic carbene) catalyst for the formal alkene 
carboacylation of ortho-allylbenzamides via amide C−N bond activation, and a palladium 
catalyst for enantioselective, intermolecular formal alkene carboacylation of aryl benzoates via 
ester C−O bond activation. 
Nitrogen- and oxygen-containing polycyclic heterocycles are common scaffolds 
present in many biologically active small molecules and natural products. The chiral 
cyclopenta[b]indole scaffold is present in a number of these biologically active compounds.5-
10 Therefore, the development of enantioselective methods to access this scaffold and its 
derivatives remains important.11-17 However, limited enantioselective methods to access this 
scaffold have been reported. Rueping et al. developed a direct method to generate the 
cyclopenta[b]indole scaffold via enantioselective copper-catalyzed Nazarov Cyclizations 
(Scheme 1a).12 Enantioselective intramolecular alkene hydroacylations in the presence of 
transition-metal catalysts are established processes to generate cyclic five-membered 
11 
ketones.18 The ability to generate heteroatom containing cycle five-membered ketones has 
been previously developed in our group (Scheme 1b).19 This dissertation presents an 
enantioselective, catalytic method for the direct synthesis of the cyclopenta[b]indole scaffold 
in addition to oxygen- and sulfur-containing heterocyclic scaffolds (Scheme 1c).20 The 
rhodium-catalyzed alkene hydroacylation reaction bypasses the requirement of activated 
alkenes in Nazarov cyclizations and enables rapid access into a library of enantioenriched 
polycyclic heterocycles.  
 
Scheme 1: Catalytic, Enantioselective Synthesis of Nitrogen-Containing Heterocyclic 
Scaffolds 
Similar to hydroacylation, alkene carboacylation enables the difunctionalization of an 
alkene. Carboacylation of alkenes in the presence of a transition-metal catalyst is an emerging 
reaction that enables the formation of two C−C σ bonds.21-36 The most studied and developed 
approaches to alkene carboacylation are reactions triggered by the initial activation of a C−C  
X O X
R1
O
23 examples 
up to 99% yield 
up to 99% ee
X = NR3, O, S
R2 R2
H R
1
N
R2
O
R3
chiral
Rh catalyst
N
R2
R3
R1
O
R1
14 examples
up to 99% yield
up to 99% ee
N
H
O
CO2Me
R
N
H
O
R
CO2Mechiral
Cu catalyst
(a) Nazarov cyclization to generate cyclopenta[b]indole scaffold
(Rueping, 2015)
19 examples
up to 93% yield
up to 98% ee
(Stanley, 2014)
(b) Alkene hydroacylation to generate nitrogen containing cyclic 5-membered ketones
(c) Alkene hydroacylation to generate cyclopenta[b]indole scaffold and derivatives
chiral
Rh catalyst
this work
12 
bond of a ketone (Scheme 2). Although much progress has been made to understand 
mechanistic pathways, the development and utility of alkene carboacylation is limited to 
substrates containing either a quinoline direction group21-25 or a strained cyclic ketone.26-32 The 
ability to bypass these limitations and perform alkene carboacylation reactions simple 
substrates has the potential to expand the utility of these reactions.33-36,37-41   
 
Scheme 2. Alkene Carboacylation via C−C σ Bond Activation 
Recently, studies by a number of groups have demonstrated Suzuki-Miyaura coupling 
of benzamides with arylboron compounds to generate a variety of ketones.42-53 The Suzuki-
Miyaura coupling reactions are initiated by C−N bond activation of an activated twisted 
benzamide. The oxidative addition into the amide C−N bond and transmetalation with an 
arylboron compound generates a key acyl-metal-aryl intermediate A, and subsequent reductive 
elimination forms a diaryl ketone (Scheme 1a). The ability to intercept the key acy-metal-aryl 
intermediate A with alkenes offers the potential to develop a new class of alkene 
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functionalization reactions. During the course of our studies, Garg et al. developed Mizoroki-
Heck cyclization of ortho-allylbenzamides that involved the insertion of the pendant alkene 
into acyl-Ni(II)-amido intermediate B (Scheme 1b).54 Subsequent β-hydride elimination of 
intermeidate B forms 2-vinylindanones. This dissertation presents the first example of nickel-
catalyzed formal alkene carboacylation reactions via activation of amide C−N bonds. The 
alkene carboacylation reaction is triggered by oxidative addition of the twisted amide C−N 
bond with a nickel(0) catalyst and subsequent transmetalation with an organoboron nucleophile 
forms the key acyl-Ni(II)-aryl intermediate. We envisioned intercepting the key intermediate 
generated from the readily accessible ortho-allylbenzamides with the pendant alkene to obtain 
exo-selective formal alkene carboacylation. The alkene carboacylation reactions demonstrate 
that amides are practical substrates for alkene carboacylation and this approach bypasses the 
challenges associated with carboacylation via C−C σ bond activation (Scheme 1c).55 
 
Scheme 3. Ketone Synthesis via Transition Metal-Catalyzed Activation of Amide C−N Bonds 
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Scheme 4. Transition Metal-Catalyzed Alkene Carboacylation via Ester C−O Bond Activation 
Transition metal-catalyzed oxidative addition into activated twisted amide C−N bonds 
is relatively well established.42-53,56-61 Although there are a fewer examples, similar cross-
coupling reactions have been developed with aryl benzoates and organometallic nucleophiles 
via ester C−O bond activation.62-68 Our group previously reported one example of alkene 
carboacylation via ester C−O bond activation to generate an indanone in 50% yield (Scheme 
4a).55 To extend formal alkene carboacylation beyond activated amides we envisioned utilizing 
esters for the synthesis of ketones from esters, alkenes, and organoboron nucleophiles (Scheme 
4b). This dissertation presents the first examples of enantioselective, intermolecular alkene 
carboacylation of esters via C−O bond activation. This palladium-catalyzed process generates 
phenyl(3-phenylbicyclo[2.2.1]heptan-2-yl)methanones products with high 
enantioselectivities. Continued efforts to mitigate epimerization and improve the 
diastereomeric ratios through catalyst design are ongoing in our lab. 
Dissertation Organization 
This dissertation is comprised of five chapters that contain work that has been published 
in peer-reviewed journals and research results that are in preparation for publication. Chapter 
I serves to introduce transition-metal catalysis and catalytic methods development in the 
O
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(a) Intramolecular Alkene Carboacylation of Esters
(b) Intermolecular, Three Component Alkene Carboacylation of Esters
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context of alkene hydroacylation and carboacylation reactions. Chapter II is adapted from a 
paper published in Organic Letters. Chapter III is adapated from a paper published in Journal 
of the American Chemical Society. Chapter IV discusses research results that are currently in 
preparation for submission. Chapter V serves as a general summary and conclusion of the 
presented research and provides a future outlook that proposes strategies to address the 
limitations that remain. 
Chapter II describes the rhodium-catalyzed synthesis of cyclopenta[b]indoles and is a 
modified version from a paper published in Organic Letters in 2017. The work included in this 
chapter encompasses the development of an enantioselective, catalytic method for the 
synthesis of nitrogen-, oxygen-, and sulfur-containing polycyclic heterocycles. The catalytic 
method facilitates the synthesis of heterocycles with a range of electronic character and 
substitution. The author of this dissertation is responsible for all work reported in this chapter. 
Chapter III describes the development of nickel-catalyzed formal alkene 
carboacylation of ortho-allylbenzamides via amide C−N bond activation. The chapter is a 
modified version from a published paper in Journal of the American Chemical Society in 2017. 
This chapter demonstrates new synthetic utility of amides in organic chemistry for their use in 
formal carboacylation reactions. The developed method also bypasses the current limitations 
of traditional alkene carboacylation via C−C σ bond activation. Mechanistic studies were 
conducted and a catalytic cycle was proposed for the new reaction. This work was 
accomplished in collaboration with James Walker who completed his PhD as a student of the 
Stanley group in 2017, and Jenna Humke, an undergraduate researcher. James Walker was 
responsible for the synthesis and characterization of ortho-allylbenzamides and the scope of 
ortho-allylbenzamides. Jenna Humke was responsible for assisting in the synthesis of ortho-
16 
allylbenzamides. The author of this dissertation is responsible for the synthesis of the 
arylboronate esters, carboacylation scope involving the arylboron compounds, characterization 
of the products, and the competition experiments to gain mechanistic insight. The author of 
this dissertation and James Walker contributed equally to this publication. 
Chapter IV describes the development of palladium-catalyzed formal carboacylation 
of aryl benzoates with alkenes via ester C−O bond activation. The chapter contains research 
results that will be utilized for a manuscript currently in preparation. This chapter discusses 
efforts towards the development of a palladium catalyst for enantioselective, intermolecular 
three component alkene hydroacylation of aryl benzoates with alkenes and organoboron 
nucleophiles. The catalyst system is able to generate highly enantioenriched ketone products 
and efforts are ongoing to improve the diastereomeric ratios in addition to simple alkenes. This 
work was accomplished in collaboration with Haley Banovetz, a graduate student of the 
Stanley group. Haley Banovetz was responsible for assisting in the development of reactions 
conditions. The author of this dissertation is responsible for the synthesis and characterization 
of aryl benzoates, development of reaction conditions, and control experiments to gain 
mechanistic insight.  
Chapter V discusses general conclusions from the work presented and proposes future 
directions for the continuation of this research in the Stanley lab.  
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CHAPTER 2.     
CATALYTIC, ENANTIOSELECTIVE SYNTHESIS OF POLYCYCLIC NITROGEN, 
OXYGEN, AND SULFUR HETEROCYCLES VIA RHODIUM-CATALYZED 
ALKENE HYDROACYLATION 
Modified from a paper published in Organic Letters 
Kevin L. Vickerman, Levi M. Stanley 
Department of Chemistry, Iowa State University, Ames, Iowa 50011-3111, United States 
 
Abstract 
We report enantioselective synthesis of polycyclic nitrogen, oxygen, and sulfur 
heterocycles by rhodium-catalyzed intramolecular alkene hydroacylation. The intramolecular 
hydroacylation reactions generate 1,4-dihydrocyclopenta[b]indol-3(2H)-ones and 3,4-
dihydrocyclopenta[b]indol-1(2H)-one in moderate-to-high yields (65-99%) with good-to-
excellent enantioselectivities (84-99% ee). The catalyst system also promotes alkene 
hydroacylation of 3-vinylfuran-, 3-vinylbenzothiophene-, and 3-vinylthiophene-2-
carboxaldehydes to generate the corresponding ketone products in moderate-to-high yields 
(71-91% yield) with excellent enantioselectivities (97-99% ee). 
Introduction 
Polycyclic nitrogen-containing heterocycles are common structural motifs present in 
many biologically active natural products and small molecules.1-3 Chiral cyclopenta[b]indoles 
are core architectures in a number of these biologically active compounds (Figure 1).4-9 Thus, 
the development of new catalytic, enantioselective methods to generate chiral 
cyclopenta[b]indoles and derivatives remains important.10-16 
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Figure 1. Biologically Active Cyclopenta[b]indoles 
Recently, Rueping et al. reported a direct method to generate cyclopenta[b]indole 
derivatives via enantioselective copper-catalyzed Nazarov cyclizations involving activated 
alkenes (Scheme 1a).11-14 Enantioselective, intramolecular alkene hydroacylations in the 
presence of transition-metal catalysts are established processes to generate cyclic five-
membered ketones17-35, including previous studies from our group on enantioselective, Rh-
catalyzed hydroacylation of N-vinylindole-2-carboxaldehydes to generate 2,3-dihydro-1H-
pyrrolo[1,2-a]indolones.36 We envisioned that a related rhodium catalyst would promote 
intramolecular hydroacylation of 3-vinylindole-2-carboxaldehydes to allow rapid access to the 
cyclopenta[b]indole core and related polycyclic heterocycles (Scheme 1b). Herein, we report 
catalytic, enantioselective synthesis of a variety of polycyclic heterocycles through rhodium-
catalyzed intramolecular alkene hydroacylation reactions. 
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Scheme 1.  Catalytic, Enantioselective Synthesis of Dihydrocyclo-penta[b]indolones 
Results and Discussion 
To assess the feasibility of Rh-catalyzed alkene hydroacylation to generate 
dihydrocyclopenta[b]indolones, we evaluated the reaction of 1-methyl-3-(prop-1-en-2-yl)-1H-
indole-2-carboxaldehyde 1a as a model substrate (Table 1). The hydroacylation of 1a in the 
presence of a catalyst generated from [Rh(cod)Cl]2, (R)-BINAP, and AgBF4 formed the ketone 
product 2a in 24-42% yield at temperatures ranging from rt to 100 °C (entries 1-4). When the 
active catalyst was generated from [Rh(cod)2]BF4 and (R)-BINAP in the absence of a silver 
salt, the hydroacylation of 1a formed 2a in 78% yield and 98% ee (entry 5). We observed an 
increase in the yield of ketone 2a to 87% when the catalyst was generated from [Rh(cod)Cl]2, 
(R)-BINAP, and sodium tetrakis[3,5-bis(trifluoromethyl)phenyl]borate (NaBARF) (entry 6).  
To evaluate the impact of steric and electronic properties of the ligand, we evaluated reactions 
in the presence of catalysts prepared from a series of chiral bisphosphines, [Rh(cod)Cl]2 and 
NaBARF in THF at 60 °C (entries 6-10).  A catalyst generated from [Rh(cod)Cl]2, (R)-MeO-
Biphep, and NaBARF provided the best combination of yield and enantioselectivity with the 
desired dihydrocyclopenta[b]indolone derivative formed in 94% yield and 99% ee (entry 9). 
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Table 1. Identification of Catalysts for Rh-Catalyzed Hydroacylation of 1aa 
 
entry temp (°C) ligand additive yield 2 (%)b ee (%)c 
1 rt (R)-BINAP AgBF4 24 - 
2 40 (R)-BINAP AgBF4 28 - 
3 60 (R)-BINAP AgBF4 42 - 
4d 100 (R)-BINAP AgBF4 39 - 
5e 60 (R)-BINAP - 78 98 
6 60 (R)-BINAP NaBARF 87 98 
7 60 (R)-Tol-BINAP NaBARF 80 99 
8 60 (R)-Xyl-BINAP NaBARF 91 99 
9 60 (R)-MeO-Biphep NaBARF 94 99 
10 60 (R)-Segphos NaBARF 84 99 
aReaction conditions: 1 (0.10 mmol), [Rh(cod)Cl]2 (0.0025 mmol), ligand (0.0050 mmol), 
additive (0.0050 mmol), THF (0.25 mL), 16 h. bIsolated yield of 2. cDetermined by chiral 
HPLC analysis. d1,4-dioxane (0.25 mL) used as solvent, e[Rh(cod)2]BF4 (0.0050 mmol) used 
as rhodium precatalyst. 
 
With a practical catalyst system identified, we evaluated alkene hydroacylations of a 
variety of 1-methyl-3-vinyl-1H-indole-2-carboxaldehydes containing alkyl- and aryl-
substituted vinyl units (Table 2). The hydroacylations of alkyl-substituted 1-methyl-3-vinyl-
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1H-indole-2-carboxaldehydes 1a (R = Me) and 1b (R = cyclohexyl) occur to form polycyclic 
heterocyclic ketones 2a and 2b in 94% and 88% yields with 99% ee (entries 1 and 2). 
Hydroacylation of 1c (R = Ph) generated the ketone 2c in 99% yield and 99% ee (entry 3), and 
this reaction can be conducted on a 1.32 mmol scale without loss of enantioselectivity (entry 
4). 
Table 2. Rh-Catalyzed, Enantioselective Hydroacylation of 1a-1oa 
 
entry 1 R 2 yield 2 (%)b ee (%)c 
1 1a Me 2a 94 99 
2 1b Cy 2b 88 99 
3 1c Ph 2c 99 99 
4d 1c Ph 2c 83 99 
5 1d 4-MeO-C6H4 2d 77 97 
6 1e 4-F-C6H4 2e 72 98 
7 1f 4-Cl-C6H4 2f 87 99 
8 1g 3-MeO-C6H4 2g 91 99 
9 1h 3-F-C6H4 2h 96 99 
10 1i 3-CF3-C6H4 2i 87 99 
11 1j 2-F-C6H4 2j 77 98 
12e 1k 2-Me-C6H4 2k 95 84 
13e 1l 2-Cl-C6H4 2l 94 87 
14 1m 2-furyl 2m 65 98 
15 1n 2-thienyl 2n 71 99 
16 1o CO2Me 2o 88 99 
aReaction conditions: 1 (0.10 mmol), [Rh(cod)Cl]2 (0.0025 mmol), (R)-MeO-Biphep (0.0050 
mmol), NaBARF (0.0050 mmol), THF (0.25 mL), 60 °C, 16 h. bIsolated yield of 2. 
cDetermined by chiral HPLC analysis. d1.32 mmol scale based on 1c. eReaction performed 
with 1,4-dioxane as solvent at 100 °C. 
 
Substrates containing electron-rich or electron-poor para-, meta-, and ortho-substituted 
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hydroacylations to form dihydrocyclopenta[b]indolone products. The hydroacylation reactions 
of 1d−1j occur to form 4-methyl-1-aryl-1,4-dihydrocyclopenta[b]indol-3-(2H)-ones 2d−2j in 
72−96% yield with excellent enantioselectivities (97−99%) (entries 5− 11). Substrates 
containing aryl groups with larger ortho-substituted aryl units (1k and 1l) require reactions to 
be carried out at 100 °C in 1,4-dioxane to generate the corresponding heterocyclic ketones 2k 
and 2l in 95% and 94% yield with 84% and 87% ee (entries 12 and 13). Additionally, 1-methyl-
3-vinyl-1H-indole-2-carboxaldehydes (1m and 1n) with oxygen- and sulfur-containing 
heteroarene substitution on the vinyl moiety are tolerated. Hydroacylations of 1m and 1n 
generate the corresponding ketones 2m and 2n in 65% and 71% yield with 98% and 99% ee 
(entries 14 and 15). The hydroacylation of 1o (R = CO2Me), a substrate containing an electron-
withdrawing group at the internal carbon of the vinyl unit, forms the corresponding 
heterocyclic ketone 2o in 88% yield and 99% ee (entry 16). 
The alkene hydroacylation reactions are not limited to 1-methyl-3-vinyl-1H-indole-2-
carboxaldehydes. The hydroacylation of 1-benzyl-3-(1-phenylvinyl)-1H-indole-2-
carboxaldehyde 1p occurs to form 4-benzyl-1-phenyl-1,4-dihydrocyclopenta-[b]indol-3(2H)-
one 2p in 91% yield and 99% ee (Scheme 2a). The hydroacylation of 1-allyl-3-(1-
phenylvinyl)-1H-indole-2- carboxaldehyde 1q occurs to form ketones 2q and 3q in 69% and 
20% yield with 99% ee (Scheme 2b). Ketone 3q is generated through alkene hydroacylation 
of the vinyl group and alkene isomerization of the N-allyl unit to the internal alkene. We 
observed the hydroacylation of N-allyl substituted 1q to be completely selective for the vinyl 
alkene to generate a five-membered ring over the allyl alkene, which would generate a six-
membered ring. 
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aIsolated yield of 2.  Enantiomeric excesses were determined by chiral HPLC analysis. 
Scheme 2. Rh-Catalyzed Hydroacylation of N-Substituted 3-Vinyl-1H-indole-2-
carboxaldehydes 1p−1qa 
The alkene hydroacylation also occurs to generate polycyclic heterocycles containing 
oxygen, sulfur, and additional substituted indole derivatives (Scheme 3). The hydroacylations 
of 1-methyl-3-vinyl-1H-indole-2-carboxaldehydes with electron-withdrawing substituents on 
the indole backbone are promoted by our catalyst system. Hydroacylation of 5-fluoro-1-
methyl-3-(1-phenylvinyl)-1H-indole-2-carboxaldehyde 1r and 1-methyl-3-(1-phenylvinyl)-5-
(trifluoromethyl)-1H-indole-2-carboxaldehyde 1s generated the corresponding ketones 2r and 
2s in high yields (93% and 95%) with excellent enantioselectivities (99% ee). The 
hydroacylation of an oxygen containing heterocycle, 3-(1-phenylvinyl)furan-2-
carboxaldehyde 1t, required the reaction to be carried out at 100 °C in 1,4-dioxane to form 4- 
phenyl-4,5-dihydro-6H-cyclopenta[b]furan-6-one 2t in 71% yield with 97% ee. The absolute 
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configuration of 2t was determined to be (R)-4-phenyl-4,5-dihydro-6H-cyclopenta[b]-furan-6-
one by comparing the sign of the optical rotation with a literature value.36 In addition, the 
hydroacylations of sulfur-containing heterocycles 3-(1-phenylvinyl)thiophene-2-carbaldehyde 
1u and 3-(1-phenylvinyl)benzo[b]thiophene-2-carbaldehyde 1v generated the corresponding 
sulfur-containing polycyclic ketones 2u and 2v in 90% and 91% yield with 99% ee. 
 
aIsolated yield of 2. Enantiomeric excesses were determined by chiral HPLC analysis. 
bReaction performed with 1,4-dioxane at 100 °C. 
 
Scheme 3. Rh-Catalyzed Hydroacylation of Nitrogen, Oxygen, and Sulfur Containing 
Heterocyclesa 
 
X
[Rh(cod)Cl]2 (2.5 mol %)
(R)-MeO-Biphep (5 mol %)
NaBARF (5 mol %)
THF, 60 °C X
Ph
O
Ph
1r-1v
X = NMe O, S
R R
O
O
Ph
S
O
Ph
2v
91% yield, 99% ee
S
O
Ph
N
Me
O
Ph
F
N
Me
O
Ph
F3C
2r
93% yield, 99% ee
2s
95% yield, 99% ee
2u
90% yield, 99% ee
2t
71% yield, 97% ee
(1,4-dioxane, 100 °C)
O
2r-2v
N
Me
O
Ph
2w
77% yield, 97% ee
[Rh(cod)Cl]2 (2.5 mol %)
(R)-MeO-Biphep (5.0 mol %)
NaBARF (5.0 mol %)
THF, 60 °CN
Me
Ph
O
(1)
1w
28 
To further evaluate the utility of the catalyst system for intramolecular alkene 
hydroacylation to form polycyclic heterocycles, we investigated exchanging the positions of 
the aldehyde and vinyl moieties on the indole core. The hydroacylation of 1-methyl-2-(1-
phenylvinyl)-1H-indole-3-carboxaldehyde 1w occurs to form 4-methyl-3-phenyl-3,4-dihydro- 
cyclopenta[b]indol-1(2H)-one 2w in 77% yield and 97% ee (eq 1). The hydroacylation of 1w 
allows access to a dihydrocyclopenta[b]indolone with the stereogenic carbon center and 
functional group handle in different positions relative to the indole core.37 
 
 
Scheme 4. Synthetic Transformations of Dihydrocyclopenta[b]indolones 
To demonstrate the utility of the ketone products generated from these hydroacylation 
reactions, we carried out select addition reactions to the carbonyl of 
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dihydrocyclopenta[b]indolone 2c and a straightforward deprotection of dihydro- 
cyclopenta[b]indolone 2p (Scheme 4). The addition of vinyl and allyl Grignard reagents to 2c 
generated the corresponding alcohol products 4a and 4b in 84% and 79% yield with 10:1 and 
3:1 diastereomeric ratios. Reduction of 2c with lithium aluminum hydride formed the 
secondary alcohol product 4c in 95% yield with 10:1 dr. Debenzylation of 2p occurs in the 
presence of AlCl3 to form 4d in 83% yield without significant degradation of the optical purity. 
Conclusion 
In summary, we have developed a catalyst system for intramolecular hydroacylation of 
nitrogen, oxygen, and sulfur heterocycles to generate structurally complex polycyclic 
heterocycles in moderate-to-high yields and with excellent enantioselectivities. The rhodium-
catalyzed alkene hydroacylation encompasses reactions of a range of nitrogen, oxygen, and 
sulfur heterocycles with a variety of alkyl, electron-rich and electron-poor aryl, and heteroaryl 
substitution on the alkene unit. Indoles with varied substitution at the nitrogen are also 
tolerated, and we observed complete selectivity for five-membered ring formation over the 
potential six-membered ring formation in the reaction of 1-allyl-3-(1-phenylvinyl)-1H- indole-
2-carboxaldehyde. In addition, the catalyst system is active for intramolecular hydroacylation 
of 1-methyl-2-vinyl-1H-indole-3-carboxaldehydes to generate an additional 
dihydrocyclopenta[b]indolone scaffold. Further studies are ongoing in our laboratory to 
expand the breadth of enantioselective alkene hydroacylation reactions to access heterocyclic 
compounds. 
Experimental 
General synthetic details. All air-sensitive procedures were conducted under inert 
atmosphere in a nitrogen-filled dry box or by standard Schlenk techniques. All reactions were 
performed under nitrogen unless otherwise stated. All glassware for moisture sensitive 
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reactions was dried in an oven at 140 ºC for at least two hours before use. THF, Et2O, and 
DCM were degassed by purging with argon for 45 minutes and dried with a solvent purification 
system by passing through a one-meter column of activated alumina. Anhydrous 1,4-dioxane 
and DMF were purchased from Sigma-Aldrich and used as received. Flash column 
chromatography was performed on SiliFlash® P60 silica gel (40-63µm, 60 Å) using hexanes, 
hexanes/ethyl acetate or hexanes/diethyl ether mixtures. Products were visualized on TLC by 
UV light or by staining with KMnO4. 
Instrumentation. HRMS (ESI) analysis was performed at the Iowa State University 
Chemical Instrumentation Facility on an Agilent 6540 QTOF spectrometer. HPLC analyses 
were carried out on a Waters Alliance HPLC system with an e2695 separations module and a 
2489 dual wavelength detector. Optical rotations were measured on an Atago AP-300 
automatic polarimeter using a 0.5 dm cell. NMR spectra were acquired on Varian MR-400 and 
Bruker Avance III 600 spectrometers at the Iowa State University Chemical Instrumentation 
Facility. Chemicals shifts are reported in ppm relative to residual solvent peaks (CDCl3 = 7.26 
ppm for 1H and 77.16 ppm for 13C). Coupling constants are reported in hertz. 19F NMR shifts 
are reported based on indirect reference to CDCl3.38 
Materials. Tributyltin hydride, tributyltin chloride, diisopropylamine, bromine, 
sodium hydride, lithium aluminum hydride, manganese(IV) oxide, cesium fluoride, copper(I) 
iodide, magnesium, sodium sulfate, magnesium sulfate, 2-bromopropene, 2-furyl methyl 
ketone, 4'-methoxyacetophenone, 2'-methoxyacetophenone, and 2-acetylthiophene were 
purchased from Sigma-Aldrich and used without further purification. n-Butyllithium (2.5M in 
hexanes) was purchased from Sigma-Aldrich and titrated with recrystallized diphenylacetic 
acid prior to use. 3-Bromothiophene-2-carbaldehyde was purchased from Maybridge and used 
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without further purification. Acetophenone, triethylamine and p-toluenesulfonic acid were 
purchased from Fisher Scientific and used without further purification. 3'-
Methoxyacetophenone, 2'-chloroacetophenone, 3'-chloroacetophenone, and 3'-
(trifluoromethyl)acetophenone were purchased from AK Scientific and used without further 
purification. Cyclohexyl methyl ketone was purchased from Alfa Aesar and used without 
further purification. Methyl iodide was purchased from Acros Organics and used without 
further purification. 
Pd(PPh3)4, [Rh(cod)Cl]2, [Rh(cod)2]BF4, rac-BINAP ((rac)-2,2'-
bis(diphenylphosphino)-1,1'-binaphthalene), (R)-BINAP ((R)-2,2'-bis(diphenylphosphino)-
1,1'-binaphthalene), (R)-Tol-BINAP ((R)-2,2'-bis(di-p-tolylphosphino)-1,1'-binaphthalene), 
(R)-Xyl-BINAP ((R)-2,2'-bis(di-3,5-dimethylphenylphosphino)-1,1'-binaphthalene), (R)-
MeO-Biphep ((R)-2,2'-bis(diphenylphosphino)-1,1'-biphenyl), and (R)-Segphos ((R)-2,2'-
bis(diphenylphosphino)-4,4'-bi-1,3-benzodioxole), and  were purchased from Strem 
Chemicals and used without further purification.  
NaBARF (sodium tetrakis[3,5-bis(trifluoromethyl)phenyl]borate) was prepared 
according to a literature procedure.39 1H-Indole-2-methanol was prepared according to a 
literature procedure from ethyl 1H-indole-2-carboxylate.30 1H-Indole-2-carbaldehyde was 
prepared according to a literature procedure from 1H-indole-2-methanol.30 1-Methyl-1H-
indole-2-carbaldehyde was prepared according to a literature procedure from 1H-indole-2-
carbaldehyde.40 3-Bromo-1-methyl-1H-indole-2-carbaldehyde was prepared according to a 
literature procedure from 1-methyl-1H-indole-2-carbaldehyde.41 Ethyl 5-fluoro-1H-indole-2-
carboxylate was prepared according to a literature procedure from 2-bromo-5-
fluorobenzaldehyde.42 Organostannanes were prepared according to a literature procedure 
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from corresponding ketones and used as crude mixtures after filtration through a short plug of 
silica eluting with hexane.43 Methyl 2-(tributylstannyl)acrylate was prepared according to a 
literature procedure from methyl propiolate.44 
 
Synthesis of 1-Methyl-6-(trifluoromethyl)-1H-indole-2-carbaldehyde S1 
 
 1-Methyl-6-(trifluoromethyl)-1H-indole-2-carbaldehyde (S1): In an oven dried 
round-bottom-flask, 6-(trifluoromethyl)-1H-indole-2-carbaldehyde (0.851 g, 4.00 mmol) was 
dissolved in DMF (20 mL, 0.20 M). The solution was then cooled to 0 °C and sodium hydride 
(0.239 g, 6.00 mmol) was added and stirred for 1 hour. Methyl iodide (0.37 mL, 6.0 mmol) 
was then added dropwise and the reaction was warmed to rt and stirred for 3 hours. After 
completion of the reaction, water was added to quench the reaction, and ether was added to the 
solution. The solution was washed three times with water and once with aq. NH4Cl (sat.), and 
then the organic layer was then dried with MgSO4. The dried organic layer was concentrated 
under reduced pressure to yield the crude product. The crude product was purified by flash 
column chromatography (90:10 hexanes:EtOAc) to yield S1 (470 mg, 2.07 mmol, 52% yield) 
as a white solid. 1H NMR (CDCl3, 400 MHz): δ 4.15 (s, 3H), 7.31 (s, 1H), 7.40 (d, J = 8.0 Hz, 
1H), 7.71 (s, 1H), 7.85 (d, J = 8.0 Hz, 1H), 9.96 (s, 1H). 13C NMR (CDCl3, 100 MHz): δ 31.9, 
108.4 (q, J = 4.2 Hz, 1C), 116.7, 117.4 (q, J = 3.3 Hz, 1C), 124.2, 124.7 (q, J = 271 Hz, 1C), 
128.4, 128.6 (q, J = 31.9 Hz, 1C), 137.6, 139.6, 183.2. 19F NMR (CDCl3, 376 MHz) δ -61.6 
(s, 3F). HRMS (ESI) calcd. for C11H9F3NO+ (M+H+) 228.0631, found 228.0633. 
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General Procedure A: Synthesis of S2a-S2b 
 
In an oven dried round-bottom-flask, the corresponding indole (1.00 equiv) was dissolved in 
DMF (0.10 M). N-Bromosuccinimide (1.20 equiv) was then added to the solution and stirred 
at rt for 16 hours. After completion of the reaction, aqueous saturated NH4Cl solution was 
added to quench the reaction, and EtOAc was added to the solution. The solution was washed 
three times with water and once with aq. NH4Cl (sat.), and then the organic layer was then 
dried with MgSO4. The dried organic layer was concentrated under reduced pressure to yield 
the crude product. The crude reaction mixtures were purified by flash column chromatography 
(90:10 hexanes:EtOAc) to yield S2a-S2b. 
 
3-Bromo-1-methyl-6-(trifluoromethyl)-1H-indole-2-carbaldehyde 
(S2a): Prepared according to general procedure A from 1-methyl-6-
(trifluoromethyl)-1H-indole-2-carbaldehyde (0.439 g, 1.93 mmol) (S1) 
and NBS (0.412 g, 2.32 mmol). The crude product was purified by flash column 
chromatography (90:10 hexanes:EtOAc) to yield S2a (556 mg, 1.82 mmol, 94% yield) as a 
white solid. 1H NMR (CDCl3, 400 MHz): δ 4.14 (s, 3H), 7.47 (d, J = 8.0 Hz, 1H), 7.70 (s, 1H), 
7.82 (d, J = 8.0 Hz, 1H), 10.18 (s, 1H). 13C NMR (CDCl3, 100 MHz): δ 32.3, 105.3, 108.7 (q, 
J = 4.8 Hz, 1C), 118.1 (q, J = 3.0 Hz, 1C), 122.6, 124.4 (q, J = 271 Hz, 1C), 128.1, 129.8 (q, J 
= 32.3 Hz, 1C), 131.9, 138.2, 182.8. 19F NMR (CDCl3, 376 MHz) δ -61.7 (s, 3F). HRMS 
(ESI) calcd. for C11H8BrF3NO+ (M+H+) 305.9736, found 305.9735. 
N
Me
O
NBS
DMF
R
N
Me
O
R
Br
S2a-B
S2a: R = 6-CF3S2b: R = 5-F
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3-Bromo-5-fluoro-1-methyl-1H-indole-2-carbaldehyde (S2b): 
Prepared according to general procedure A from 5-fluoro-1-methyl-1H-
indole-2-carbaldehyde (0.470 g, 2.65 mmol) and NBS (0.519 g, 2.92 
mmol). The crude product was purified by flash column chromatography (90:10 
hexanes:EtOAc) to yield S2b (576 mg, 2.25 mmol, 85% yield) as a white solid. 1H NMR 
(CDCl3, 400 MHz): δ 4.06 (s, 3H), 7.22 (td, J = 8.0, 2.6 Hz, 1H), 7.30-7.33 (m, 2H), 10.10 (s, 
1H). 13C NMR (CDCl3, 100 MHz): δ 32.0, 104.8 (d, J = 6.0 Hz, 1C), 105.7 (d, J = 24.6 Hz, 
1C), 111.9 (d, J = 9.2 Hz, 1C), 117.5 (d, J = 27.3, 1C), 126.3 (d, J = 10.3 Hz, 1C), 131.0, 136.0, 
158.5 (d, J = 239 Hz, 1C), 182.5. 19F NMR (CDCl3, 376 MHz) δ -120.6 (m, 1F). HRMS (ESI) 
calcd. for C10H8BrFNO+ (M+H+) 255.9768, found 255.9770. 
 
General Procedure B: Synthesis of Indoles 1a-1u 
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In a nitrogen-filled dry box, the appropriate arylbromide (1.00 equiv) was added to an 
oven dried round-bottom-flask and dissolved in DMF (0.20 M). The appropriate 
organostannane (1.10-1.50 equiv), CsF (2.00 equiv), tetrakis(triphenylphosphine)palladium(0) 
(10 mol %), and copper(I) iodide (8.0 mol %) were then added to the flask in the indicated 
order, and the flask was capped with a septum. The flask was removed from the dry box and 
stirred at 60 °C for 16 hours. The reaction mixture was cooled to room temperature, and EtOAc 
was added. This solution was then washed 3 times with water and once with aq. NH4Cl (sat.). 
The organic layer was dried over MgSO4. The dried organic layer was filtered through a plug 
of celite, eluting with EtOAc, and concentrated under reduced pressure. The crude reaction 
mixtures were purified by flash column silica gel chromatography (100:0 to 90:10 gradient of 
hexanes:EtOAc) to yield 1a-1u.  
N
Me
Br
Pd(PPh3) (10 mol %)
CuI (8 mol %)
CsF (2 equiv)
DMF, 60 °C, 16 h
+
Ph
SnBu3
N
Me
O
Ph
O
1w
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1-Methyl-3-(prop-1-en-2-yl)-1H-indole-2-carbaldehyde (1a): Prepared 
according to general procedure B starting from 3-bromo-1-methyl-1H-
indole-2-carbaldehyde (0.357 g, 1.50 mmol), tributyl(prop-1-en-2-
yl)stannane (0.546 g, 1.65 mmol), Pd(PPh3)4 (0.173 g, 0.150 mmol), CuI 
(22.9 mg, 0.120 mmol), and CsF (0.466 g, 3.00 mmol). The crude product was purified by 
flash column chromatography (100% hexanes then gradient to 90:10 hexanes:EtOAc) to yield 
1a (0.162 g, 0.811 mmol, 54% yield) as a white solid. 1H NMR (CDCl3, 400 MHz): δ 2.3 (dd, 
J = 1.4, 0.9 Hz, 3H), 4.09 (s, 3H), 5.11 (m, 1H), 5.49 (m, 1H), 7.18 (ddd, J = 8.0, 6.8, 1.1 Hz, 
1H), 7.37 (d, J = 8.5 Hz, 1H), 7.43 (m, 1H), 7.75 (dt, J = 8.2, 0.9 Hz, 1H), 10.02 (s, 1H). 13C 
NMR (CDCl3, 100 MHz): δ 25.1, 31.8, 110.4, 119.7, 120.8, 122.6, 125.3, 127.2, 131.0, 133.7, 
136.5, 139.6, 183.7. HRMS (ESI) calcd. for C13H14NO+ (M+H+) 200.1070, found 200.1068. 
 
3-(1-Cyclohexylvinyl)-1-methyl-1H-indole-2-carbaldehyde (1b): 
Prepared according to general procedure B starting from 3-bromo-1-methyl-
1H-indole-2-carbaldehyde (0.262 g, 1.10 mmol), tributyl(1-
cyclohexylvinyl)stannane (0.879 g, 2.20 mmol), Pd(PPh3)4 (0.129 g, 0.110 
mmol), CuI (16.8 mg, 0.088 mmol), and CsF (0.334 g, 2.20 mmol). The crude 
product was purified by flash column chromatography (100% hexanes then gradient to 90:10 
hexanes:EtOAc) to yield 1b (0.177 g, 0.663 mmol, 60% yield) as a pale yellow solid. 1H NMR 
(CDCl3, 400 MHz): δ 1.1 – 1.3 (m, 5H), 1.65 – 1.7 (m, 1H), 1.75 – 1.8 (m, 2H), 1.88 – 1.91 
(m, 2H), 2.41 (m, 1H), 4.10 (s, 3H), 5.10 (m, 1H), 5.44 (m, 1H), 7.15 (ddd, J = 8.0, 6.8, 1.1 
Hz, 1H), 7.37 (dt, J = 8.5, 0.9 Hz, 1H), 7.43 (m, 1H), 7.75 (dt, J = 8.1, 1.0 Hz, 1H), 9.90 (s, 
1H). 13C NMR (CDCl3, 100 MHz): δ 26.3, 26.7, 31.7, 32.5, 45.5, 110.3, 116.6, 120.7, 122.6, 
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126.0, 127.2, 131.7, 133.8, 139.5, 146.3, 183.9. HRMS (ESI) calcd. for C18H22NO+ (M+H+) 
268.1696, found 268.1694.  
 
1-Methyl-3-(1-phenylvinyl)-1H-indole-2-carbaldehyde (1c): Prepared 
according to general procedure B starting from 3-bromo-1-methyl-1H-
indole-2-carbaldehyde (0.478 g, 2.00 mmol), tributyl(1-
phenylvinyl)stannane (0.881 g, 2.20 mmol), Pd(PPh3)4 (0.234 g, 0.200 
mmol), CuI (51.9 mg, 0.160 mmol), and CsF (0.632 g, 4.00 mmol). The crude 
product was purified by flash column chromatography (100% hexanes then gradient to 90:10 
hexanes:EtOAc) to yield 1c (0.361 g, 1.38 mmol, 69% yield) as a pale yellow solid. 1H NMR 
(CDCl3, 400 MHz): δ 4.15 (s, 3H), 5.42 (d, J = 0.9 Hz, 1H), 6.00 (d, J = 0.9 Hz, 1H), 7.05 
(ddd, J = 5.3, 3.4, 1.8 Hz, 1H), 7.30 – 7.33 (m, 4H), 7.39 – 7.41 (m, 4H), 9.93 (s, 1H). 13C 
NMR (CDCl3, 100 MHz): δ 31.9, 110.4, 119.4, 121.0, 122.9, 126.1, 127.3, 127.3, 128.3, 128.6, 
131.1, 132.5, 139.6, 140.1, 141.2, 183.9. HRMS (ESI) calcd. for C18H16NO+ (M+H+) 
262.1226, found 262.1224.  
 
3-(1-(4-Methoxyphenyl)vinyl)-1-methyl-1H-indole-2-carbaldehyde 
(1d): Prepared according to general procedure B starting from 3-bromo-
1-methyl-1H-indole-2-carbaldehyde (0.179 g, 0.750 mmol), tributyl(1-(4-
methoxyphenyl)vinyl)stannane (0.351 g, 0.830 mmol), Pd(PPh3)4 (89.1 
mg, 0.075 mmol), CuI (12.7 mg, 0.060 mmol), and CsF (0.270 g, 1.50 
mmol). The crude product was purified by flash column chromatography (100% hexanes then 
gradient to 90:10 hexanes:EtOAc) to yield 1d (45.1 mg, 0.155 mmol, 21% yield) as a white 
38 
solid. 1H NMR (CDCl3, 400 MHz): δ 3.82 (s, 3H), 4.15 (s, 3H), 5.31 (d, J = 1.4 Hz, 1H), 5.90 
(d, J = 1.4 Hz, 1H), 6.85 (m, 2H), 7.05 (ddd, J = 8.0, 5.0, 2.8 Hz, 1H), 7.31 – 7.35 (m, 3H), 
7.39 – 7.44 (m, 2H), 9.94 (s, 1H). 13C NMR (CDCl3, 100 MHz): δ 31.9, 55.4, 110.3, 113.9, 
117.6, 120.9, 123.0, 126.1, 127.2, 128.6, 131.4, 132.5, 133.8, 139.3, 139.6, 159.8, 184.0. 
HRMS (ESI) calcd. for C19H18NO2+ (M+H+) 292.1332, found 292.1333.  
 
3-(1-(4-Fluorophenyl)vinyl)-1-methyl-1H-indole-2-carbaldehyde (1e): 
Prepared according to general procedure B starting from 3-bromo-1-methyl-
1H-indole-2-carbaldehyde (0.448 g, 2.00 mmol), tributyl(1-(4-
fluorophenyl)vinyl)stannane (1.23 g, 3.00 mmol), Pd(PPh3)4 (0.231 g, 0.200 
mmol), CuI (30.5 mg, 0.160 mmol), and CsF (0.608 g, 4.00 mmol). The crude 
product was purified by flash column chromatography (100% hexanes then gradient to 90:10 
hexanes:EtOAc) to yield 1e (0.221 g, 0.789 mmol, 39% yield) as a pale orange solid. 1H NMR 
(CDCl3, 400 MHz): δ 4.13 (s, 3H), 5.31 (d, J = 0.8 Hz, 1H), 5.91 (d, J = 0.8 Hz, 1H), 6.98 (m, 
2H), 7.03 (ddd, J = 7.9, 5.0, 2.8 Hz, 1H), 7.24 (bs, 1H), 7.33 – 7.42 (m, 4H), 9.91 (s, 1H). 13C 
NMR (CDCl3, 100 MHz): δ 32.0, 110.5, 115.5, 115.6 (d, J = 22.0 Hz, 1C), 121.1, 122.8, 126.0, 
127.4, 129.1 (d, J = 8.1 Hz, 1C), 130.8, 132.5, 137.3 (d, J = 3.3 Hz, 1C), 139.1, 139.6, 162.9 
(d, J = 247 Hz, 1C), 183.7. 19F NMR (CDCl3, 376 MHz) δ -113.8 (m, 1F). HRMS (ESI) calcd. 
for C18H15FNO+ (M+H+) 280.1132, found 280.1130.  
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3-(1-(4-Chlorophenyl)vinyl)-1-methyl-1H-indole-2-carbaldehyde (1f): 
Prepared according to general procedure B starting from 3-bromo-1-methyl-
1H-indole-2-carbaldehyde (0.417 g, 1.75 mmol), tributyl(1-(4-
chlorophenyl)vinyl)stannane (0.973 g, 2.28 mmol), Pd(PPh3)4 (0.202 g, 
0.175 mmol), CuI (26.7 mg, 0.140 mmol), and CsF (0.532 g, 3.50 mmol). 
The crude product was purified by flash column chromatography (100% hexanes then gradient 
to 90:10 hexanes:EtOAc) to yield 1f (0.139 g, 0.471 mmol, 27% yield) as a yellow solid. 1H 
NMR (CDCl3, 400 MHz): δ 4.15 (s, 3H), 5.42 (d, J = 1.2 Hz, 1H), 5.98 (d, J = 1.2 Hz, 1H), 
7.06 (ddd, J = 8.0, 5.1, 2.7 Hz, 1H), 7.25 – 7.30 (m, 3H), 7.32 – 7.35 (m, 2H), 7.39 – 7.44 (m, 
2H), 9.92 (s, 1H). 13C NMR (CDCl3, 100 MHz): δ 31.9, 110.5, 119.7, 121.1, 122.8, 125.9, 
127.4, 128.6, 128.8, 130.4, 132.5, 134.3, 139.0, 139.59, 139.60, 183.6. HRMS (ESI) calcd. for 
C18H15ClNO+ (M+H+) 296.0837, found 296.0836.  
 
3-(1-(3-Methoxyphenyl)vinyl)-1-methyl-1H-indole-2-carbaldehyde 
(1g): Prepared according to general procedure B starting from 3-bromo-
1-methyl-1H-indole-2-carbaldehyde (0.476 g, 2.00 mmol), tributyl(1-
(3-methoxyphenyl)vinyl)stannane (1.69 g, 4.00 mmol), Pd(PPh3)4 
(0.231 g, 0.200 mmol), CuI (30.5 mg, 0.160 mmol), and CsF (0.608 g, 
4.00 mmol). The crude product was purified by flash column chromatography (100% hexanes 
then gradient to 90:10 hexanes:EtOAc) to yield 1g (0.259 g, 0.890 mmol, 44% yield) as a white 
solid. 1H NMR (CDCl3, 400 MHz): δ 3.61 (s, 3H), 4.12 (s, 3H), 5.54 (d, J = 2.0 Hz, 1H), 5.89 
(d, J = 2.0 Hz, 1H), 6.87 (d, J = 8.1 Hz, 1H), 6.95 (t, J = 7.5 Hz, 1H), 7.01 (ddd, J = 8.0, 5.4, 
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1.4 Hz, 1H), 7.27 – 7.39 (m, 5H), 10.02 (s, 1H). 13C NMR (CDCl3, 100 MHz): δ 31.9, 55.7, 
110.2, 111.7, 120.7, 120.8, 122.8, 122.8, 125.9, 127.0, 129.5, 130.7, 131.2, 131.7, 132.9, 137.9, 
139.5, 157.2, 184.4. HRMS (ESI) calcd. for C19H18NO2+ (M+H+) 292.1332, found 292.1330.  
 
3-(1-(3-Fluorophenyl)vinyl)-1-methyl-1H-indole-2-carbaldehyde (1h): 
Prepared according to general procedure B starting from 3-bromo-1-
methyl-1H-indole-2-carbaldehyde (0.357 g, 1.50 mmol), tributyl(1-(3-
fluorophenyl)vinyl)stannane (0.832 g, 1.95 mmol), Pd(PPh3)4 (0.174 g, 
0.150 mmol), CuI (22.9 mg, 0.120 mmol), and CsF (0.456 g, 3.00 mmol). 
The crude product was purified by flash column chromatography (100% hexanes then gradient 
to 90:10 hexanes:EtOAc) to yield 1h (0.230 g, 0.825 mmol, 55% yield) as a white solid. 1H 
NMR (CDCl3, 400 MHz): δ 4.18 (s, 3H), 5.49 (d, J = 1.1 Hz, 1H), 6.04 (d, J = 1.2 Hz, 1H), 
7.01 – 7.05 (m, 1H), 7.06 – 7.13 (m, 2H), 7.20 (ddd, J = 7.8, 1.5, 1.1 Hz, 1H), 7.27 – 7.34 (m, 
2H), 7.42 – 7.47 (m, 2H), 9.94 (s, 1H). 13C NMR (CDCl3, 100 MHz): δ 31.9, 110.5, 114.2 (d, 
J = 22.1 Hz, 1C), 115.2 (d, J = 21.2 Hz, 1C), 120.3, 121.2, 122.7, 123.0 (d, J = 2.8 Hz, 1C), 
126.0, 127.4, 130.1 (d, J = 8.3 Hz, 1C), 130.2, 132.5, 139.1, 139.6, 143.5 (d, J = 7.3 Hz, 1C), 
163.1 (d, J = 245 Hz, 1C), 183.6. 19F NMR (CDCl3, 376 MHz) δ -113.1 (m, 1F). HRMS (ESI) 
calcd. for C18H15FNO+ (M+H+) 280.1132, found 280.1130.  
 
1-Methyl-3-(1-(3-(trifluoromethyl)phenyl)vinyl)-1H-indole-2- 
carbaldehyde (1i): Prepared according to general procedure B starting 
from 3-bromo-1-methyl-1H-indole-2-carbaldehyde (0.238 g, 1.00 mmol), 
tributyl(1-(3-(trifluoromethyl)phenyl)vinyl)stannane (0.922 g, 2.00 
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mmol), Pd(PPh3)4 (0.116 g, 0.100 mmol), CuI (15.2 mg, 0.080 mmol), and CsF (0.304 g, 2.00 
mmol). The crude product was purified by flash column chromatography (100% hexanes then 
gradient to 90:10 hexanes:EtOAc) to yield 1i (0.110 g, 0.333 mmol, 33% yield) as a pale yellow 
solid. 1H NMR (CDCl3, 400 MHz): δ 4.17 (s, 3H), 5.52 (bs, 1H), 6.06 (bs, 1H), 7.07 (ddd, J = 
7.9, 4.2, 3.7 Hz, 1H), 7.24 – 7.26 (m, 1H), 7.41 – 7.45 (m, 3H), 7.53 (bd, J = 7.8 Hz, 1H), 7.58 
(bd, J = 7.8 Hz, 1H), 7.72 (bs, 1H), 9.92 (s, 1H). 13C NMR (CDCl3, 100 MHz): δ 32.0, 110.1, 
120.9, 121.3, 122.6, 123.8 (q, J = 3.8 Hz, 1C), 124.1 (q, J = 271 Hz, 1C), 125.2 (q, J = 3.7 Hz, 
1C), 125.9, 127.5, 129.2, 129.8, 130.8, 131.2 (q, J = 32.1 Hz, 1C), 132.5, 139.0, 139.7, 142.0, 
183.5. 19F NMR (CDCl3, 376 MHz) δ -62.6 (s, 3F). HRMS (ESI) calcd. for C19H15F3NO+ 
(M+H+) 330.1100, found 330.1099.  
 
3-(1-(2-fluorophenyl)vinyl)-1-methyl-1H-indole-2-carbaldehyde (1j): 
Prepared according to general procedure B starting from 3-bromo-1-methyl-
1H-indole-2-carbaldehyde (0.357 g, 1.50 mmol), tributyl(1-(2-
fluorophenyl)vinyl)stannane (0.832 g, 1.95 mmol), Pd(PPh3)4 (0.173 g, 0.150 
mmol), CuI (22.9 mg, 0.120 mmol), and CsF (0.456 g, 3.00 mmol). The crude 
product was purified by flash column chromatography (100% hexanes then gradient to 90:10 
hexanes:EtOAc) to yield 1j (0.230 g, 0.823 mmol, 55% yield) as a pale yellow solid. 1H NMR 
(CDCl3, 400 MHz): δ 4.14 (s, 3H), 5.63 (dd, J = 1.4, 0.8 Hz, 1H), 6.00 (dd, J = 1.4, 1.4 Hz, 
1H), 7.03 – 7.11 (m, 3H), 7.26 – 7.32 (m, 3H), 7.37 – 7.43 (m, 2H), 10.00 (s, 1H). 13C NMR 
(CDCl3, 100 MHz): δ 31.9, 110.4, 116.3 (d, J = 22.4 Hz, 1C), 121.0, 122.4, 123.7, 123.8, 124.3 
(d, J = 3.7 Hz, 1C), 125.8, 129.3 (d, J = 12.0 Hz, 1C), 129.9 (d, J = 8.4 Hz, 1C), 130.9 (d, J = 
3.0 Hz, 1C), 131.2, 132.0, 134.8, 139.5, 160.2 (d, J = 249 Hz, 1C), 183.7. 19F NMR (CDCl3, 
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376 MHz) δ -114.3 (m, 1F). HRMS (ESI) calcd. for C18H15FNO+ (M+H+) 280.1132, found 
280.1131.  
 
1-methyl-3-(1-(o-tolyl)vinyl)-1H-indole-2-carbaldehyde (1k): Prepared 
according to general procedure B starting from 3-bromo-1-methyl-1H-
indole-2-carbaldehyde (0.357 g, 1.50 mmol), tributyl(1-(o-
tolyl)vinyl)stannane (0.672 g, 1.65 mmol), Pd(PPh3)4 (0.173 g, 0.150 mmol), 
CuI (22.9 mg, 0.120 mmol), and CsF (0.456 g, 3.00 mmol). The crude 
product was purified by flash column chromatography (100% hexanes then gradient to 90:10 
hexanes:EtOAc) to yield 1k (0.267 g, 0.971 mmol, 65% yield) as a pale orange solid. 1H NMR 
(CDCl3, 400 MHz): δ 2.10 (s, 3H), 4.12 (s, 3H), 5.61 (d, J = 1.9 Hz, 1H), 5.68 (d, J = 1.9 Hz, 
1H), 7.03 (ddd, J = 8.0, 5.8, 2.0 Hz, 1H), 7.15 (m, 1H), 7.20 – 7.24 (m, 2H), 7.30 (dt, J = 8.2, 
1.0 Hz, 1H), 7.35 – 7.42 (m, 3H), 9.98 (s, 1H). 13C NMR (CDCl3, 100 MHz): δ 20.8, 32.0, 
110.3, 121.1, 122.5, 122.8, 125.6, 126.2, 127.2, 128.2, 129.8, 130.9, 131.6, 131.7, 135.9, 139.6, 
141.2, 142.1, 183.9. HRMS (ESI) calcd. for C19H18NO+ (M+H+) 276.1383, found 276.1381.  
 
3-(1-(2-chlorophenyl)vinyl)-1-methyl-1H-indole-2-carbaldehyde (1l): 
Prepared according to general procedure B starting from 3-bromo-1-methyl-
1H-indole-2-carbaldehyde (0.357 g, 1.50 mmol), tributyl(1-(2-
chlorophenyl)vinyl)stannane (0.836 g, 1.95 mmol), Pd(PPh3)4 (0.173 g, 
0.150 mmol), CuI (22.9 mg, 0.120 mmol), and CsF (0.456 g, 3.00 mmol). 
The crude product was purified by flash column chromatography (100% hexanes then gradient 
to 90:10 hexanes:EtOAc) to yield 1l (0.262 g, 0.885 mmol, 59% yield) as a white solid. 1H 
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NMR (CDCl3, 400 MHz): δ 4.12 (s, 3H), 5.66 (d, J = 1.0 Hz, 1H), 5.81 (d, J = 1.0 Hz, 1H), 
7.04 (ddd, J = 5.4, 4.0, 1.2 Hz, 1H), 7.27 – 7.31 (m, 3H), 7.35 – 7.40 (m, 3H), 7.45 – 7.47 (m, 
1H), 10.02 (s, 1H). 13C NMR (CDCl3, 100 MHz): δ 32.0, 110.5, 121.1, 122.6, 124.1, 125.7, 
127.1, 127.2, 129.5, 130.5, 130.8, 131.3, 131.9, 133.2, 139.0, 139.6, 141.0, 184.1. HRMS 
(ESI) calcd. for C18H15ClNO+ (M+H+) 296.0837, found 296.0834.  
 
3-(1-(furan-2-yl)vinyl)-1-methyl-1H-indole-2-carbaldehyde (1m): 
Prepared according to general procedure B starting from 3-bromo-1-methyl-
1H-indole-2-carbaldehyde (0.169 g, 1.30 mmol), tributyl(1-(furan-2-
yl)vinyl)stannane (0.548 g, 1.43 mmol), Pd(PPh3)4 (0.150 g, 0.130 mmol), 
CuI (19.8 mg, 0.104 mmol), and CsF (0.395 g, 2.60 mmol). The crude product was purified by 
flash column chromatography (100% hexanes then gradient to 90:10 hexanes:EtOAc) to yield 
1m (0.169 g, 0.674 mmol, 52% yield) as a white solid. 1H NMR (CDCl3, 400 MHz): δ 4.15 (s, 
3H), 5.29 (d, J = 1.4 Hz, 1H), 6.09 (bd, J = 3.3 Hz, 1H), 6.14 (d, J = 1.4 Hz, 1H), 6.37 (dd, J 
= 3.3, 1.8 Hz, 1H), 7.14 (ddd, J = 8.0, 6.2, 1.6 Hz, 1H), 7.40 – 7.47 (m, 3H), 7.59 (bd, J = 8.2 
1H), 9.98 (s, 1H). 13C NMR (CDCl3, 100 MHz): δ 31.9, 109.9, 110.4, 111.7, 116.5, 121.0, 
122.6, 126.0, 127.3, 128.4, 129.0, 132.2, 139.5, 142.8, 154.1, 185.6. HRMS (ESI) calcd. for 
C16H14NO2+ (M+H+) 252.1019, found 252.1024.  
 
1-methyl-3-(1-(thiophen-2-yl)vinyl)-1H-indole-2-carbaldehyde (1n): 
Prepared according to general procedure B starting from 3-bromo-1-methyl-
1H-indole-2-carbaldehyde (0.357 g, 1.50 mmol), tributyl(1-(thiophen-2-
yl)vinyl)stannane (0.659 g, 1.65 mmol), Pd(PPh3)4 (0.173 g, 0.150 mmol), 
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CuI (22.9 mg, 0.120 mmol), and CsF (0.456 g, 3.00 mmol). The crude product was purified by 
flash column chromatography (100% hexanes then gradient to 90:10 hexanes:EtOAc) to yield 
1n (0.107 g, 0.401 mmol, 27% yield) as a white solid. 1H NMR (CDCl3, 400 MHz): δ 4.15 (s, 
3H), 5.27 (d, J = 0.6 Hz, 1H), 6.01 (d, J = 0.7 Hz, 1H), 6.85 (dd, J = 3.6, 1.1 Hz 1H), 6.93 (dd, 
J = 5.1, 3.6 Hz 1H), 7.11 (ddd, J = 8.0, 6.0, 1.9 Hz, 1H), 7.25 (dd, J = 5.1, 1.1 Hz, 1H), 7.40 – 
7.46 (m, 2H), 7.52 (ddd, J = 8.2, 0.8, 0.8 Hz, 1H), 9.98 (s, 1H). 13C NMR (CDCl3, 100 MHz): 
δ 32.0, 110.4, 117.8, 121.1, 122.7, 125.7, 126.0, 126.9, 127.4, 127.7, 130.0, 132.1, 133.5, 
139.5, 145.2, 186.6. HRMS (ESI) calcd. for C16H14NOS+ (M+H+) 268.0791, found 268.0796.  
 
methyl 2-(2-formyl-1-methyl-1H-indol-3-yl)acrylate (1o): Prepared 
according to general procedure B starting from 3-bromo-1-methyl-1H-
indole-2-carbaldehyde (0.357 g, 1.50 mmol), methyl 2-
(tributylstannyl)acrylate (0.619 g, 1.65 mmol), Pd(PPh3)4 (0.173 g, 0.150 
mmol), CuI (22.9 mg, 0.120 mmol), and CsF (0.456 g, 3.00 mmol). The crude product was 
purified by flash column chromatography (100% hexanes then gradient to 80:20 
hexanes:EtOAc) to yield a mixture of 1o and 3-bromo-1-methyl-1H-indole-2-carbaldehyde 
(2.9:1 ratio) (0.100 g, 0.411 mmol, 27% yield) as a yellow oil. 1H NMR (CDCl3, 400 MHz): δ 
3.81 (s, 3H), 4.12 (s, 3H), 5.97 (d, J = 1.6 Hz, 1H), 6.83 (d, J = 1.6 Hz, 1H), 7.19 (ddd, J = 8.0, 
6.6, 1.3 Hz, 1H), 7.39 – 7.47 (m, 2H), 7.59 (ddd, J = 8.2, 1.0, 1.0 Hz, 1H), 9.91 (s, 1H). 13C 
NMR (CDCl3, 100 MHz): δ 31.9, 52.7, 110.6, 121.4, 122.0, 125.3, 126.1, 127.4, 127.8, 132.1, 
132.5, 139.4, 166.9, 182.9. HRMS (ESI) calcd. for C14H14NO3+ (M+H+) 244.0968, found 
244.0971.  
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1-benzyl-3-(1-phenylvinyl)-1H-indole-2-carbaldehyde (1p): Prepared 
according to general procedure B starting from 1-benzyl-3-bromo-1H-
indole-2-carbaldehyde (0.314 g, 1.00 mmol), tributyl(1-
phenylvinyl)stannane (0.433 g, 1.10 mmol), Pd(PPh3)4 (0.116 g, 0.100 
mmol), CuI (15.3 mg, 0.080 mmol), and CsF (0.304 g, 2.00 mmol). The 
crude product was purified by flash column chromatography (100% hexanes then gradient to 
90:10 hexanes:EtOAc) to yield 1p (0.193 g, 0.571 mmol, 57% yield) as a white solid. 1H NMR 
(CDCl3, 400 MHz): δ 5.48 (d, J = 1.4 Hz, 1H), 5.92 (s, 2H), 6.05 (d, J = 1.4 Hz, 1H), 7.07 
(ddd, J = 8.0, 6.4, 1.4 Hz, 1H), 7.16 – 7.18 (m, 2H), 7.23 – 7.44 (m, 11H), 9.96 (s, 1H). 13C 
NMR (CDCl3, 100 MHz): δ 48.2, 111.1, 119.6, 121.3, 123.0, 126.4, 126.8, 127.3, 127.5, 127.6, 
128.4, 128.7, 128.8, 131.9, 132.1, 138.0, 139.5, 140.0, 141.1, 183.5. HRMS (ESI) calcd. for 
C24H20NO+ (M+H+) 338.1539, found 338.1544.  
 
1-allyl-3-(1-phenylvinyl)-1H-indole-2-carbaldehyde (1q): Prepared 
according to general procedure B starting from 1-allyl-3-bromo-1H-indole-
2-carbaldehyde (0.198 g, 0.750 mmol), tributyl(1-phenylvinyl)stannane 
(0.324 g, 0.825 mmol), Pd(PPh3)4 (86.7 mg, 0.075 mmol), CuI (11.3 mg, 
0.060 mmol), and CsF (0.228 g, 1.50 mmol). The crude product was purified 
by flash column chromatography (100% hexanes then gradient to 90:10 hexanes:EtOAc) to 
yield 1q (0.121 g, 0.422 mmol, 56% yield) as a white solid. 1H NMR (CDCl3, 400 MHz): δ 
4.99 (ddd, J = 17.2, 2.9, 1.6 Hz, 1H), 5.16 (ddd, J = 17.2, 2.9, 1.6 Hz, 1H), 5.29 (ddd, J = 5.0, 
1.6, 1.6 Hz, 2H), 5.44 (d, J = 1.4 Hz, 1H), 6.00 – 6.09 (m, 2H), 7.05 (m 1H), 7.30 – 7.33 (m, 
4H), 7.39 – 7.41 (m, 4H), 9.92 (s, 1H). 13C NMR (CDCl3, 100 MHz): δ 47.1, 110.8, 116.5, 
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119.5, 121.2, 123.0, 126.3, 127.3, 127.4, 128.4, 128.7, 131.6, 131.9, 133.7, 139.2, 140.0, 141.1, 
183.5. HRMS (ESI) calcd. for C20H18NO+ (M+H+) 288.1383, found 288.1386.  
 
 5-fluoro-1-methyl-3-(1-phenylvinyl)-1H-indole-2-carbaldehyde (1r): 
Prepared according to general procedure B starting from 3-bromo-5-
fluoro-1-methyl-1H-indole-2-carbaldehyde (0.384 g, 1.50 mmol), 
tributyl(1-phenylvinyl)stannane (0.649 g, 1.65 mmol), Pd(PPh3)4 (0.173 
g, 0.150 mmol), CuI (22.9 mg, 0.120 mmol), and CsF (0.456 g, 3.00 
mmol). The crude product was purified by flash column chromatography (100% hexanes then 
gradient to 90:10 hexanes:EtOAc) to yield 1r (0.252 g, 0.903 mmol, 60% yield) as a white 
solid. 1H NMR (CDCl3, 400 MHz): δ 4.14 (s, 3H), 5.40 (d, J = 1.4 Hz, 1H), 5.99 (d, J = 1.4 
Hz, 1H), 6.92 (ddd, J = 9.1, 2.5, 0.5 Hz, 1H), 7.17 (ddd, J = 9.0, 9.0, 2.5 Hz, 1H), 7.31 – 7.41 
(m, 6H), 9.92 (s, 1H). 13C NMR (CDCl3, 100 MHz): δ 32.1, 107.0 (d, J = 23.0 Hz, 1C), 111.5 
(d, J = 9.3 Hz, 1C), 116.6 (d, J = 27.2 Hz, 1C), 119.5, 126.2 (d, J = 9.9 Hz, 1C), 127.3, 128.5, 
128.7, 130.5 (d, J = 5.9 Hz, 1C), 133.6, 136.3, 139.8, 140.8, 158.1 (d, J = 237 Hz, 1C), 183.8. 
19F NMR (CDCl3, 376 MHz) δ -121.6 (m, 1F). HRMS (ESI) calcd. for C18H15FNO+ (M+H+) 
280.1132, found 280.1135.  
 
1-methyl-3-(1-phenylvinyl)-6-(trifluoromethyl)-1H-indole-2- 
carbaldehyde (1s): Prepared according to general procedure B starting 
from 3-bromo-1-methyl-6-(trifluoromethyl)-1H-indole-2-
carbaldehyde (0.505 g, 1.65 mmol), tributyl(1-phenylvinyl)stannane 
(0.714 g, 1.82 mmol), Pd(PPh3)4 (0.191 g, 0.165 mmol), CuI (25.1 mg, 
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0.132 mmol), and CsF (0.501 g, 3.30 mmol). The crude product was purified by flash column 
chromatography (100% hexanes then gradient to 90:10 hexanes:EtOAc) to yield 1s (0.390 g, 
1.19 mmol, 72% yield) as a white solid. 1H NMR (CDCl3, 400 MHz): δ 4.20 (s, 3H), 5.44 (d, 
J = 1.3 Hz, 1H), 6.04 (d, J = 1.3 Hz, 1H), 7.25 – 7.27 (m, 1H), 7.32 – 7.42 (m, 6H), 7.71 (bs, 
1H), 9.98 (s, 1H). 13C NMR (CDCl3, 100 MHz): δ 32.2, 108.3 (q, J = 4.6 Hz, 1C), 117.4 (q, J 
= 3.3 Hz, 1C), 119.9, 123.7, 124.6 (q, J = 271 Hz, 1C), 127.3, 128.1, 128.6, 128.8, 128.9 (q, J 
= 31.9 Hz, 1C), 130.5, 134.2, 138.4, 139.5, 140.8, 184.0. 19F NMR (CDCl3, 376 MHz) δ -61.6 
(s, 3F). HRMS (ESI) calcd. for C19H15F3NO+ (M+H+) 330.1100, found 330.1104.  
 
 3-(1-phenylvinyl)furan-2-carbaldehyde (1t): Prepared according to general 
procedure B starting from 3-bromofuran-2-carbaldehyde (0.263 g, 1.50 
mmol), tributyl(1-phenylvinyl)stannane (0.649 g, 1.65 mmol), Pd(PPh3)4 
(0.173 g, 0.150 mmol), CuI (22.9 mg, 0.120 mmol), and CsF (0.456 g, 3.00 
mmol). The crude product was purified by flash column chromatography 
(100% hexanes then gradient to 90:10 hexanes:EtOAc) to yield 1t (0.199 g, 1.00 mmol, 67% 
yield) as a pale yellow oil. 1H NMR (CDCl3, 400 MHz): δ 5.55 (d, J = 1.0 Hz, 1H), 5.79 (d, J 
= 1.0 Hz, 1H), 6.51 (d, J = 1.8 Hz, 1H), 7.34 – 7.38 (m, 5H), 7.64 (dd, J = 1.7, 0.8 Hz, 1H), 
9.45 (s, 1H). 13C NMR (CDCl3, 100 MHz): δ 114.0, 119.2, 127.4, 128.80, 128.81, 139.0, 
139.2, 139.7, 147.1, 149.2, 177.5. HRMS (ESI) calcd. for C13H11O2+ (M+H+) 199.0754, found 
199.0756.  
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 3-(1-phenylvinyl)thiophene-2-carbaldehyde (1u): Prepared according to 
general procedure B starting from 3-bromothiophene-2-carbaldehyde (0.287 
g, 1.50 mmol), tributyl(1-phenylvinyl)stannane (0.649 g, 1.65 mmol), 
Pd(PPh3)4 (0.173 g, 0.150 mmol), CuI (22.9 mg, 0.120 mmol), and CsF (0.456 
g, 3.00 mmol). The crude product was purified by flash column 
chromatography (100% hexanes then gradient to 90:10 hexanes:EtOAc) to yield 1u (0.158 g, 
0.735 mmol, 49% yield) as a pale yellow oil. 1H NMR (CDCl3, 400 MHz): δ 5.42 (d, J = 1.0 
Hz, 1H), 5.89 (d, J = 1.0 Hz, 1H), 7.02 (d, J = 5.0 Hz, 1H), 7.31 – 7.38 (m, 5H), 7.67 (dd, J = 
5.0, 1.2 Hz, 1H), 9.81 (s, 1H). 13C NMR (CDCl3, 100 MHz): δ 119.2, 127.3, 128.7, 128.8, 
130.9, 133.7, 140.2, 140.7, 142.1, 151.3, 184.0. HRMS (ESI) calcd. for C13H11OS+ (M+H+) 
215.0525, found 215.0527.  
 
 3-(1-phenylvinyl)benzo[b]thiophene-2-carbaldehyde (1v): Prepared 
according to general procedure B starting from 3-bromobenzo[b]thiophene-
2-carbaldehyde (0.362 g, 1.50 mmol), tributyl(1-phenylvinyl)stannane 
(0.649 g, 1.65 mmol), Pd(PPh3)4 (0.173 g, 0.150 mmol), CuI (22.9 mg, 0.120 
mmol), and CsF (0.456 g, 3.00 mmol). The crude product was purified by 
flash column chromatography (100% hexanes then gradient to 90:10 hexanes:EtOAc) to yield 
1v (0.201 g, 0.759 mmol, 51% yield) as a white solid. 1H NMR (CDCl3, 400 MHz): δ 5.53 (d, 
J = 0.7 Hz, 1H), 6.19 (d, J = 0.8 Hz, 1H), 7.26 – 7.30 (m, 1H), 7.32 – 7.37 (m, 5H), 7.47 (ddd, 
J = 8.1, 7.2, 1.0 Hz, 1H), 7.53 (bd, J = 8.2 Hz, 1H), 7.90 (bd, J = 8.2 Hz, 1H), 10.11 (s, 1H). 
13C NMR (CDCl3, 100 MHz): δ 120.3, 123.3, 125.2, 125.8, 126.8, 128.4, 128.8, 128.9, 139.2, 
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139.5, 140.4, 140.7, 141.9, 147.4, 185.7. HRMS (ESI) calcd. for C17H13OS+ (M+H+) 
265.0682, found 265.0687.  
 
 1-methyl-2-(1-phenylvinyl)-1H-indole-3-carbaldehyde (1w): Prepared 
according to general procedure B starting from 2-bromo-1-methyl-1H-
indole-3-carbaldehyde (0.357 g, 1.50 mmol), tributyl(1-
phenylvinyl)stannane (0.649 g, 1.65 mmol), Pd(PPh3)4 (0.173 g, 0.150 
mmol), CuI (22.9 mg, 0.120 mmol), and CsF (0.456 g, 3.00 mmol). The crude product was 
purified by flash column chromatography (100% hexanes then gradient to 80:20 
hexanes:EtOAc) to yield 1w (0.251 g, 0.960 mmol, 64% yield) as a white solid. 1H NMR 
(CDCl3, 400 MHz): δ 3.46 (s, 3H), 5.62 (d, J = 0.8 Hz, 1H), 6.28 (d, J = 0.8 Hz, 1H), 7.26 – 
7.32 (m, 2H), 7.33 – 7.40 (m, 6H), 8.44 – 8.48 (m, 1H), 9.96 (s, 1H). 13C NMR (CDCl3, 100 
MHz): δ 31.0, 109.7, 116.9, 122.4, 122.6, 123.3, 124.2, 125.3, 126.5, 129.1, 129.2, 137.3, 
137.4, 138.3, 151.0, 186.4. HRMS (ESI) calcd. for C18H16NO+ (M+H+) 262.1226, found 
262.1230. 
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General Procedure C: Hydroacylation to Form 2a-2v, 3p 
 
 
 
 In a nitrogen-filled dry box, the appropriate substrate 1a-1v (0.100 mmol, 1.00 equiv) 
was added to an oven dried 1 dram vial. [Rh(cod)Cl]2 (1.2 mg, 0.0025 mmol, 2.5 mol %), (R)-
MeOBiphep (2.9 mg, 0.005 mmol, 5.0 mol %), and NaBARF (4.4 mg, 0.005 mmol, 5.0 mol 
%) were then added to the vial and all components dissolved in tetrahydrofuran (0.25 mL, 0.40 
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M). The 1 dram vial was capped with a teflon-lined screw cap and removed from the dry box 
and stirred at 60 °C for 16 hours. The reaction mixture was cooled to room temperature and 
EtOAc was added. The reaction was filtered through a plug of celite and washed twice with 
EtOAc (2 mL) and twice with DCM (2 mL). The filtrate was concentrated under reduced 
pressure. The crude reaction mixtures were purified by flash column chromatography 
(hexanes:EtOAc) to yield 2a-2v, 3p. 
 
(S)-1,4-dimethyl-1,4-dihydrocyclopenta[b]indol-3(2H)-one (2a): 
Prepared according to general procedure C starting from 1-methyl-3-(prop-
1-en-2-yl)-1H-indole-2-carbaldehyde 1a (19.9 mg, 0.100 mmol). The crude 
product was purified by flash column chromatography (100% hexanes to 
90:10 hexanes:EtOAc) to yield 2a (18.7 mg, 0.094 mmol, 94% yield) as a white solid. The 
enantiomeric excess was determined by HPLC analysis (254 nm, 25 °C) tR 9.10 min (major); 
tR 13.6 min (minor) [Chiracel AS-H (0.46cm x 25 cm) (from Daicel Chemical Ind., Ltd.) 
hexane/iPrOH, 95:5, 1 mL/min] to be 99% ee. [a]D22.4 = +60.4° (c 1.060, CHCl3). 1H NMR 
(CDCl3, 400 MHz): δ 1.48 (d, J = 7.1 Hz, 3H), 2.54 (dd, J = 18.3, 2.0 Hz, 1H), 3.22 (dd, J = 
18.3, 6.2 Hz, 1H), 3.53 (qdd, J = 7.1, 6.2, 2.0 Hz, 1H), 3.91 (s, 3H), 7.18 (ddd, J = 8.0, 6.8, 1.2 
Hz, 1H), 7.35 – 7.44 (m, 2H), 7.72 (ddd, J = 8.1, 0.9, 0.9 Hz, 1H). 13C NMR (CDCl3, 100 
MHz): δ 21.2, 28.2, 30.2, 50.8, 111.2, 120.3, 122.0, 122.7, 126.7, 138.3, 145.0, 149.5, 194.5. 
HRMS (ESI) calcd. for C13H14NO+ (M+H+) 200.1070, found 200.1066. 
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 (R)-1-cyclohexyl-4-methyl-1,4-dihydrocyclopenta[b]indol-3(2H)-one 
 (2b): Prepared according to general procedure C starting from 3-(1-
cyclohexylvinyl)-1-methyl-1H-indole-2-carbaldehyde 1b (26.7 mg, 0.100 
mmol). The crude product was purified by flash column chromatography 
(100% hexanes to 90:10 hexanes:EtOAc) to yield 2b (23.5 mg, 0.088 mmol, 
88% yield) as a white solid. The enantiomeric excess was determined by HPLC analysis (254 
nm, 25 °C) tR 13.7 min (major); tR 15.8 min (minor) [Chiracel OJ-H (0.46cm x 25 cm) (from 
Daicel Chemical Ind., Ltd.) hexane/iPrOH, 95:5, 0.5 mL/min] to be 99% ee. [a]D22.4 = +7.6° 
(c 1.315, CHCl3). 1H NMR (CDCl3, 400 MHz): δ 1.06 – 1.29 (m, 5H), 1.52 – 1.56 (m, 1H), 
1.63 – 1.86 (m, 5H), 2.75 (dd, J = 18.4, 1.8 Hz, 1H), 2.99 (dd, J = 18.4, 6.4 Hz, 1H), 3.53 (ddd, 
J = 6.4, 4.9, 1.5 Hz, 1H),  3.91 (s, 3H), 7.17 (ddd, J = 8.1, 6.8, 1.2 Hz, 1H), 7.35 – 7.43 (m, 
2H), 7.75 (ddd, J = 8.1, 0.9, 0.9 Hz, 1H). 13C NMR (CDCl3, 100 MHz): δ 26.6, 29.6, 30.2, 
31.6, 39.9, 42.5, 45.8, 111.1, 120.3, 122.9, 123.5, 126.7, 139.0, 144.9, 146.9, 194.9. HRMS 
(ESI) calcd. for C18H22NO+ (M+H+) 268.1696, found 268.1694. 
 
(R)-4-methyl-1-phenyl-1,4-dihydrocyclopenta[b]indol-3(2H)-one (2c): 
Prepared according to general procedure C starting from 1-methyl-3-(1-
phenylvinyl)-1H-indole-2-carbaldehyde 1c (26.1 mg, 0.100 mmol). The 
crude product was purified by flash column chromatography (100% 
hexanes to 90:10 hexanes:EtOAc) to yield 2c (25.9 mg, 0.099 mmol, 99% 
yield) as a pale yellow solid. The enantiomeric excess was determined by HPLC analysis (254 
nm, 25 °C) tR 14.0 min (minor); tR 16.6 min (major) [Chiracel AS-H (0.46cm x 25 cm) (from 
Daicel Chemical Ind., Ltd.) hexane/iPrOH, 95:5, 1 mL/min] to be 99% ee. [a]D22.4 = +118.6° 
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(c 1.315, CHCl3). 1H NMR (CDCl3, 400 MHz): δ 2.89 (dd, J = 18.4, 2.4 Hz, 1H), 3.51 (dd, J 
= 18.4, 6.8 Hz, 1H), 3.99 (s, 3H), 4.65 (dd, J = 6.8, 2.4 Hz, 1H), 7.08 (ddd, J = 8.0, 5.0, 3.0 
Hz, 1H), 7.22 – 7.26 (m, 3H), 7.22 – 7.26 (m, 2H), 7.35 – 7.41 (m, 3H). 13C NMR (CDCl3, 
100 MHz): δ 30.3, 39.2, 52.3, 111.1, 120.6, 122.3, 122.8, 126.96, 126.96, 127.3, 128.9, 139.0, 
143.0, 145.2, 146.5, 194.0. HRMS (ESI) calcd. for C18H16NO+ (M+H+) 262.1226, found 
262.1225. 
 
(R)-1-(4-methoxyphenyl)-4-methyl-1,4-dihydrocyclopenta[b]indol- 
3(2H)-one (2d): Prepared according to general procedure C starting from 
3-(1-(4-methoxyphenyl)vinyl)-1-methyl-1H-indole-2-carbaldehyde 1d 
(29.1 mg, 0.100 mmol). The crude product was purified by flash column 
chromatography (100% hexanes to 90:10 hexanes:EtOAc) to yield 2d (22.4 
mg, 0.077 mmol, 77% yield) as a pale yellow solid. The enantiomeric excess was determined 
by HPLC analysis (254 nm, 25 °C) tR 13.7 min (major); tR 16.5 min (minor) [Chiracel OD-H 
(0.46cm x 25 cm) (from Daicel Chemical Ind., Ltd.) hexane/iPrOH, 95:5, 1 mL/min] to be 97% 
ee. [a]D22.3 = +98.3° (c 0.895, CHCl3). 1H NMR (CDCl3, 400 MHz): δ 2.85 (dd, J = 18.4, 2.4 
Hz, 1H), 3.49 (dd, J = 18.4, 6.7 Hz, 1H), 3.79 (s, 3H), 3.98 (s, 3H), 4.61 (dd, J = 6.7, 2.3 Hz, 
1H), 6.82 – 6.85 (m, 2H), 7.08 (ddd, J = 8.0, 5.2, 2.8 Hz, 1H), 7.12 – 7.16 (m, 2H), 7.35 – 7.43 
(m, 3H). 13C NMR (CDCl3, 100 MHz): δ 30.3, 33.4, 52.5, 55.4, 111.1, 114.3, 120.5, 122.4, 
122.8, 126.9, 128.3, 135.1, 139.0, 145.2, 146.8, 158.6, 194.1. HRMS (ESI) calcd. for 
C19H18NO2+ (M+H+) 292.1332, found 292.1329. 
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(R)-1-(4-fluorophenyl)-4-methyl-1,4-dihydrocyclopenta[b]indol- 
3(2H)-one (2e): Prepared according to general procedure C starting from 3-
(1-(4-fluorophenyl)vinyl)-1-methyl-1H-indole-2-carbaldehyde 1e (27.9 
mg, 0.100 mmol). The crude product was purified by flash column 
chromatography (100% hexanes to 90:10 hexanes:EtOAc) to yield 2e (20.1 
mg, 0.072 mmol, 72% yield) as a white solid. The enantiomeric excess was determined by 
HPLC analysis (254 nm, 25 °C) tR 17.6 min (minor); tR 19.4 min (major) [Chiracel AS-H 
(0.46cm x 25 cm) (from Daicel Chemical Ind., Ltd.) hexane/iPrOH, 95:5, 1 mL/min] to be 99% 
ee. [a]D22.3 = +115.8° (c 1.105, CHCl3). 1H NMR (CDCl3, 400 MHz): δ 2.83 (dd, J = 18.4, 2.4 
Hz, 1H), 3.50 (dd, J = 18.4, 6.8 Hz, 1H), 3.98 (s, 3H), 4.63 (dd, J = 6.7, 2.3 Hz, 1H), 6.96 – 
7.02 (m, 2H), 7.09 (ddd, J = 8.0, 5.3, 2.6 Hz, 1H), 7.16 – 7.21 (m, 2H), 7.34 (ddd, J = 8.1, 0.9, 
0.9 Hz, 1H), 7.39 – 7.44 (m, 2H). 13C NMR (CDCl3, 100 MHz): δ 30.3, 38.4, 52.3, 111.2, 
115.7 (d, J = 21.2 Hz, 1C), 120.7, 122.2, 122.7, 127.1, 128.8 (d, J = 8.0 Hz, 1C), 138.7 (d, J = 
3.3 Hz, 1C), 139.0, 145.2, 146.1, 161.9 (d, J = 244 Hz, 1C), 193.7. 19F NMR (CDCl3, 376 
MHz) δ -116.1 (m, 1F). HRMS (ESI) calcd. for C18H15FNO+ (M+H+) 280.1132, found 
280.1131. 
 
(R)-1-(4-chlorophenyl)-4-methyl-1,4-dihydrocyclopenta[b]indol3(2H)-
one (2f): Prepared according to general procedure C starting from 3-(1-(4-
chlorophenyl)vinyl)-1-methyl-1H-indole-2-carbaldehyde 1f (29.6 mg, 
0.100 mmol). The crude product was purified by flash column 
chromatography (100% hexanes to 90:10 hexanes:EtOAc) to yield 2f (25.8 
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g, 0.087 mmol, 87% yield) as a white solid. The enantiomeric excess was determined by HPLC 
analysis (254 nm, 25 °C) tR 19.0 min (major); tR 22.4 min (minor) [Chiracel OJ-H (0.46cm x 
25 cm) (from Daicel Chemical Ind., Ltd.) hexane/iPrOH, 95:5, 1 mL/min] to be 99% ee. [a]D23.1 
= +108.4° (c 1.365, CHCl3). 1H NMR (CDCl3, 400 MHz): δ 2.82 (dd, J = 18.4, 2.5 Hz, 1H), 
3.50 (dd, J = 18.4, 6.8 Hz, 1H), 3.98 (s, 3H), 4.62 (dd, J = 6.8, 2.4 Hz, 1H), 7.09 (ddd, J = 8.0, 
5.5, 2.5 Hz, 1H), 7.14 – 7.17 (m, 2H), 7.25 – 7.29 (m, 2H), 7.34 (ddd, J = 8.1, 0.9, 0.9 Hz, 1H), 
7.39 – 7.44 (m, 2H). 13C NMR (CDCl3, 100 MHz): δ 30.3, 38.5, 52.1, 111.2, 120.7, 122.1, 
122.6, 127.1, 128.7, 129.1, 132.7, 139.0, 141.5, 145.2, 145.8, 193.5. HRMS (ESI) calcd. for 
C18H15ClNO+ (M+H+) 296.08347, found 296.0834. 
 
(R)-1-(3-methoxyphenyl)-4-methyl-1,4-dihydrocyclopenta[b]indol- 
3(2H)-one (2g): Prepared according to general procedure C starting from 
3-(1-(3-methoxyphenyl)vinyl)-1-methyl-1H-indole-2-carbaldehyde 1g 
(29.1 mg, 0.100 mmol). The crude product was purified by flash column 
chromatography (100% hexanes to 90:10 hexanes:EtOAc) to yield 2g 
(26.5 g, 0.091 mmol, 91% yield) as a white solid. The enantiomeric excess was determined by 
HPLC analysis (254 nm, 25 °C) tR 12.9 min (major); tR 19.0 min (minor) [Chiracel OD-H 
(0.46cm x 25 cm) (from Daicel Chemical Ind., Ltd.) hexane/iPrOH, 95:5, 1 mL/min] to be 99% 
ee. [a]D23.1 = +248.1° (c 1.330, CHCl3). 1H NMR (CDCl3, 400 MHz): δ 2.78 (dd, J = 18.6, 2.4 
Hz, 1H), 3.55 (dd, J = 18.6, 6.7 Hz, 1H), 3.91 (s, 3H), 3.99 (s, 3H), 4.98 (dd, J = 6.7, 2.2 Hz, 
1H), 6.81 (ddd, J = 8.4, 7.4, 0.9 Hz, 1H), 6.94 (dd, J = 8.2, 0.8 Hz, 1H), 6.99 (dd, J = 7.5, 1.6 
Hz, 1H), 7.11 (ddd, J = 8.0, 5.2, 2.8 Hz, 1H), 7.23 (ddd, J = 9.2, 8.2, 1.7 Hz, 1H), 7.39 – 7.46 
(m, 3H). 13C NMR (CDCl3, 100 MHz): δ 30.3, 33.1, 51.2, 55.6, 110.5, 111.1, 120.4, 120.7, 
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122.6, 123.1, 126.8, 127.5, 127.9, 131.1, 139.3, 145.1, 145.8, 157.3, 194.6. HRMS (ESI) calcd. 
for C19H18NO2+ (M+H+) 292.1332, found 292.1330. 
 
(R)-1-(3-fluorophenyl)-4-methyl-1,4-dihydrocyclopenta[b]indol- 
3(2H)-one (2h): Prepared according to general procedure C starting from 
3-(1-(3-fluorophenyl)vinyl)-1-methyl-1H-indole-2-carbaldehyde 1h (27.9 
mg, 0.100 mmol). The crude product was purified by flash column 
chromatography (100% hexanes to 90:10 hexanes:EtOAc) to yield 2h (26.7 
mg, 0.096 mmol, 96% yield) as a white solid. The enantiomeric excess was determined by 
HPLC analysis (254 nm, 25 °C) tR 10.0 min (minor); tR 13.9 min (major) [Chiracel OD-H 
(0.46cm x 25 cm) (from Daicel Chemical Ind., Ltd.) hexane/iPrOH, 95:5, 1 mL/min] to be 99% 
ee. [a]D23.1 = +109.9° (c 1.110, CHCl3). 1H NMR (CDCl3, 400 MHz): δ 2.86 (dd, J = 18.4, 2.4 
Hz, 1H), 3.51 (dd, J = 18.4, 6.8 Hz, 1H), 3.98 (s, 3H), 4.64 (dd, J = 6.8, 2.3 Hz, 1H), 6.89 – 
6.96 (m, 2H), 7.02 (bd, J = 7.7 Hz, 1H), 7.10 (ddd, J = 8.0, 5.4, 2.6 Hz, 1H), 7.24 – 7.30 (m, 
1H), 7.37 (ddd, J = 8.0, 0.9, 0.9 Hz, 1H), 7.39 – 7.42 (m, 2H). 13C NMR (CDCl3, 100 MHz): 
δ 30.3, 38.8, 52.0, 111.2, 114.0 (d, J = 21.0 Hz, 1C), 114.2 (d, J = 21.5 Hz, 1C), 120.8, 122.2, 
122.7, 123.0 (d, J = 2.8 Hz, 1C), 127.1, 130.4 (d, J = 8.3 Hz, 1C), 139.0, 145.2, 145.6, 145.7 
(d, J = 6.8 Hz, 1C), 163.3 (d, J = 245 Hz, 1C), 193.4. 19F NMR (CDCl3, 376 MHz) δ -112.7 
(m, 1F). HRMS (ESI) calcd. for C18H15FNO+ (M+H+) 280.1132, found 280.1130. 
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(R)-4-methyl-1-(3-(trifluoromethyl)phenyl)-1,4-dihydrocyclopenta- 
[b]indol-3(2H)-one (2i): Prepared according to general procedure C 
starting from 1-methyl-3-(1-(3-(trifluoromethyl)phenyl)vinyl)-1H-indole-
2-carbaldehyde 1i (32.9 mg, 0.100 mmol). The crude product was purified 
by flash column chromatography (100% hexanes to 90:10 hexanes:EtOAc) 
to yield 2i (28.5 g, 0.087 mmol, 87% yield) as a white solid. The enantiomeric excess was 
determined by HPLC analysis (254 nm, 25 °C) tR 9.41 min (minor); tR 11.2 min (major) 
[Chiracel OD-H (0.46cm x 25 cm) (from Daicel Chemical Ind., Ltd.) hexane/iPrOH, 95:5, 1 
mL/min] to be 99% ee. [a]D23.1 = +92.8° (c 1.465, CHCl3). 1H NMR (CDCl3, 400 MHz): δ 
2.86 (dd, J = 18.4, 2.5 Hz, 1H), 3.54 (dd, J = 18.4, 6.8 Hz, 1H), 4.00 (s, 3H), 4.71 (dd, J = 6.8, 
2.4 Hz, 1H), 7.10 (ddd, J = 8.0, 4.8, 3.1 Hz, 1H), 7.32 (ddd, J = 8.1, 0.9, 0.9 Hz, 1H), 7.37 – 
7.45 (m, 4H), 7.51 – 7.53 (m, 2H). 13C NMR (CDCl3, 100 MHz): δ 30.4, 38.9, 51.9, 111.3, 
120.9, 122.0, 122.8, 124.0 (q, J = 3.8 Hz, 1C), 124.2 (q, J = 271 Hz, 1C), 124.2 (q, J = 3.8 Hz, 
1C), 127.2, 129.5, 130.6, 131.3 (q, J = 32.0 Hz, 1C), 139.1, 144.1, 145.2, 145.2, 193.2. 19F 
NMR (CDCl3, 376 MHz) δ -62.5 (s, 3F). HRMS (ESI) calcd. for C19H15F3NO+ (M+H+) 
330.1100, found 330.1099. 
 
 (S)-1-(2-fluorophenyl)-4-methyl-1,4-dihydrocyclopenta[b]indol-3(2H)-
one (2j): Prepared according to general procedure C starting from 3-(1-(2-
fluorophenyl)vinyl)-1-methyl-1H-indole-2-carbaldehyde 1j (27.9 mg, 
0.100 mmol). The crude product was purified by flash column 
chromatography (100% hexanes to 90:10 hexanes:EtOAc) to yield 2j (21.4 
g, 0.077 mmol, 77% yield) as a white solid. The enantiomeric excess was determined by HPLC 
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analysis (254 nm, 25 °C) tR 14.1 min (major); tR 18.9 min (minor) [Chiracel OJ-H (0.46cm x 
25 cm) (from Daicel Chemical Ind., Ltd.) hexane/iPrOH, 95:5, 1 mL/min] to be 98% ee. [a]D23.0 
= +179.8° (c 0.990, CHCl3). 1H NMR (CDCl3, 400 MHz): δ 2.87 (dd, J = 18.4, 2.4 Hz, 1H), 
3.56 (dd, J = 18.4, 7.4 Hz, 1H), 3.99 (s, 3H), 4.95 (dd, J = 6.8, 2.3 Hz, 1H), 6.98 – 7.14 (m, 
4H), 7.20 – 7.26 (m, 1H), 7.40 – 7.43 (m, 3H). 13C NMR (CDCl3, 100 MHz): δ 30.3, 32.1 (d, 
J = 3.7 Hz, 1C), 50.8, 111.2, 115.6 (d, J = 21.6 Hz, 1C), 120.7, 122.2, 122.8, 124.5 (d, J = 3.6 
Hz, 1C), 127.0, 128.3 (d, J = 4.2 Hz, 1C), 128.5, 128.6, 129.7 (d, J = 14.2 Hz, 1C), 139.1, 
144.9 (d, J = 44.2 Hz, 1C), 161.0 (d, J = 245 Hz, 1C), 193.6. 19F NMR (CDCl3, 376 MHz) δ -
118.6 (m, 1F). HRMS (ESI) calcd. for C18H15FNO+ (M+H+) 280.1132, found 280.1130. 
 
 (R)-4-methyl-1-(o-tolyl)-1,4-dihydrocyclopenta[b]indol-3(2H)-one 
(2k): Prepared according to a modified general procedure C starting from 
1-methyl-3-(1-(o-tolyl)vinyl)-1H-indole-2-carbaldehyde 1k (27.5 mg, 
0.100 mmol). The reaction was run at 100°C in 1,4-dioxane. The crude 
product was purified by flash column chromatography (100% hexanes to 
90:10 hexanes:EtOAc) to yield 2k (26.2 mg, 0.095 mmol, 95% yield) as a white solid. The 
enantiomeric excess was determined by HPLC analysis (254 nm, 25 °C) tR 16.2 min (minor); 
tR 26.3 min (major) [Chiracel AS-H (0.46cm x 25 cm) (from Daicel Chemical Ind., Ltd.) 
hexane/iPrOH, 98:2, 1 mL/min] to be 84% ee. [a]D23.0 = +272.9° (c 1.275, CHCl3). 1H NMR 
(CDCl3, 600 MHz): δ 2.49 (s, 3H), 2.75 (dd, J = 18.2, 2.5 Hz, 1H), 3.54 (dd, J = 18.1, 6.7 Hz, 
1H), 4.00 (s, 3H), 4.81 (dd, J = 6.7, 2.4 Hz, 1H), 6.94 (bd, J = 7.7 Hz, 1H), 7.04 (bt, J = 7.6 
Hz, 1H), 7.11 (ddd, J = 8.0, 5.3, 2.6 Hz, 1H), 7.15 (ddd, J = 8.5, 7.4, 1.1 Hz, 1H), 7.24 (bd, J 
= 7.5 Hz, 1H), 7.38 (bd, J = 8.1 Hz, 1H), 7.41 – 7.45 (m, 2H). 13C NMR (CDCl3, 125 MHz): 
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δ 19.9, 30.3, 35.9, 51.0, 111.2, 120.6, 122.6, 123.0, 136.47, 126.51, 126.8, 127.0, 130.6, 135.7, 
139.3, 140.9, 145.2, 146.0, 193.9. HRMS (ESI) calcd. for C19H18NO+ (M+H+) 276.1383, 
found 276.1381. 
 
 (S)-1-(2-chlorophenyl)-4-methyl-1,4-dihydrocyclopenta[b]indol-
3(2H)-one (2l): Prepared according to a modified general procedure C 
starting from 3-(1-(2-chlorophenyl)vinyl)-1-methyl-1H-indole-2-
carbaldehyde 1l (29.6 mg, 0.100 mmol). The reaction was run at 100°C in 
1,4-dioxane. The crude product was purified by flash column 
chromatography (100% hexanes to 90:10 hexanes:EtOAc) to yield 2l (27.7 g, 0.094 mmol, 
94% yield) as a white solid. The enantiomeric excess was determined by HPLC analysis (254 
nm, 25 °C) tR 9.98 min (minor); tR 16.6 min (major) [Chiracel AS-H (0.46cm x 25 cm) (from 
Daicel Chemical Ind., Ltd.) hexane/iPrOH, 95:5, 1 mL/min] to be 87% ee. [a]D23.0 = +243.0° 
(c 1.465, CHCl3). 1H NMR (CDCl3, 400 MHz): δ 2.77 (dd, J = 18.5, 2.4 Hz, 1H), 3.64 (dd, J 
= 18.6, 6.8 Hz, 1H), 3.99 (s, 3H), 5.07 (dd, J = 6.8, 2.4 Hz, 1H), 7.00 (dd, J = 7.7, 1.4 Hz, 1H), 
7.08 – 7.14 (m, 2H), 7.19 (ddd, J = 9.1, 7.5, 1.7 Hz, 1H), 7.41 – 7.46 (m, 4H). 13C NMR 
(CDCl3, 100 MHz): δ 30.4, 36.1, 50.8, 111.2, 120.7, 122.5, 122.8, 127.1, 127.3, 128.15, 
128.22, 129.8, 133.9, 139.4, 140.3, 144.7, 145.1, 193.6. HRMS (ESI) calcd. for C18H15ClNO+ 
(M+H+) 296.0837, found 296.0834. 
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 (S)-1-(furan-2-yl)-4-methyl-1,4-dihydrocyclopenta[b]indol-3(2H)-one 
(2m): Prepared according to general procedure C starting from 3-(1-(furan-
2-yl)vinyl)-1-methyl-1H-indole-2-carbaldehyde 1m (25.1 mg, 0.100 
mmol). The crude product was purified by flash column chromatography 
(100% hexanes to 90:10 hexanes:EtOAc) to yield 2m (16.4 mg, 0.065 
mmol, 65% yield) as a yellow solid. The enantiomeric excess was determined by HPLC 
analysis (254 nm, 25 °C) tR 11.0 min (minor); tR 12.1 min (major) [Chiracel OD-H (0.46cm x 
25 cm) (from Daicel Chemical Ind., Ltd.) hexane/iPrOH, 95:5, 1 mL/min] to be 98% ee. [a]D22.9 
= +103.3° (c 0.91, CHCl3). 1H NMR (CDCl3, 600 MHz): δ 3.09 (dd, J = 18.2, 2.3 Hz, 1H), 
3.40 (dd, J = 18.1, 6.7 Hz, 1H), 3.95 (s, 3H), 4.73 (d, J = 6.5 Hz, 1H), 6.08 (d, J = 3.1 Hz, 1H), 
6.30 (dd, J = 1.6, 1.2 Hz, 1H), 7.17 (dd, J = 7.9, 7.0 Hz, 1H), 7.36 – 7.44 (m, 3H), 7.68 (d, J = 
8.0 Hz, 1H). 13C NMR (CDCl3, 150 MHz): δ 30.3, 32.6, 48.2, 105.4, 110.4, 111.2, 120.7, 
122.4, 122.9, 127.0, 138.6, 143.0, 143.6, 145.1, 155.4, 193.0. HRMS (ESI) calcd. for 
C16H14NO2+ (M+H+) 252.1019, found 252.1021. 
 
 (S)-4-methyl-1-(thiophen-2-yl)-1,4-dihydrocyclopenta[b]indol-3(2H)-
one (2n): Prepared according to general procedure C starting from 1-
methyl-3-(1-(thiophen-2-yl)vinyl)-1H-indole-2-carbaldehyde 1n (26.7 mg, 
0.100 mmol). The crude product was purified by flash column 
chromatography (100% hexanes to 90:10 hexanes:EtOAc) to yield 2n (18.9 
mg, 0.071 mmol, 71% yield) as a pale orange solid. The enantiomeric excess was determined 
by HPLC analysis (254 nm, 25 °C) tR 20.0 min (minor); tR 22.2 min (major) [Chiracel OD-H 
(0.46cm x 25 cm) (from Daicel Chemical Ind., Ltd.) hexane/iPrOH, 98:2, 1 mL/min] to be 99% 
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ee. [a]D22.7 = +163.1° (c 0.895, CHCl3). 1H NMR (CDCl3, 600 MHz): δ 3.01 (dd, J = 18.2, 2.3 
Hz, 1H), 3.53 (dd, J = 18.2, 6.8 Hz, 1H), 3.97 (s, 3H), 4.95 (dd, J = 6.5, 1.5 Hz, 1H), 6.92 – 
6.94 (m, 2H), 7.13 (ddd, J = 7.9, 6.7, 1.5 Hz, 1H), 7.17 (dd, J = 5.0, 1.1 Hz, 1H), 7.39 – 7.44 
(m, 2H), 7.55 (d, J = 8.1 Hz, 1H). 13C NMR (CDCl3, 150 MHz): δ 30.3, 34.2, 52.6, 111.2, 
120.7, 122.4, 122.7, 124.1, 124.3, 127.0, 127.1, 138.5, 145.1, 145.4, 146.7, 193.0. HRMS 
(ESI) calcd. for C16H14NOS+ (M+H+) 268.0791, found 268.0794. 
 
methyl (S)-4-methyl-3-oxo-1,2,3,4-tetrahydrocyclopenta[b]indole-1-
carboxylate (2o): Prepared according to general procedure C starting from 
a 2.9:1 mixture of methyl 2-(2-formyl-1-methyl-1H-indol-3-yl)acrylate 1o 
(0.100 mmol) and 3-bromo-1-methyl-1H-indole-2-carbaldehyde. The 
crude product was purified by flash column chromatography (100% hexanes to 80:20 
hexanes:EtOAc) to yield 2o (21.4 mg, 0.088 mmol, 88% yield) as a white solid. The 
enantiomeric excess was determined by HPLC analysis (254 nm, 25 °C) tR 20.9 min (major); 
tR 23.2 min (minor) [Chiracel OD-H (0.46cm x 25 cm) (from Daicel Chemical Ind., Ltd.) 
hexane/iPrOH, 90:10, 1 mL/min] to be 99% ee. [a]D22.3 = +99.5° (c 1.055, CHCl3). 1H NMR 
(CDCl3, 600 MHz): δ 3.04 (dd, J = 18.4, 6.8 Hz, 1H), 3.42 (dd, J = 18.4, 2.3 Hz, 1H), 3.79 (s, 
3H), 3.92 (s, 3H), 4.33 (dd, J = 6.8, 2.2 Hz, 1H), 7.22 (ddd, J = 8.0, 6.9, 1.0 Hz, 1H), 7.37 (d, 
J = 8.5, 1H), 7.43 (ddd, J = 8.4, 6.9, 1.1 Hz, 1H), 7.83 (d, J = 8.2 Hz, 1H). 13C NMR (CDCl3, 
150 MHz): δ 30.2, 38.7, 44.4, 52.6, 111.2, 121.0, 122.4, 122.8, 127.1, 138.3, 140.1, 145.0, 
172.3, 192.4. HRMS (ESI) calcd. for C14H14NO3+ (M+H+) 244.0968, found 244.0969. 
 
N
2o
O
MeO2C
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 (R)-4-benzyl-1-phenyl-1,4-dihydrocyclopenta[b]indol-3(2H)-one (2p): 
Prepared according to general procedure C starting from 1-benzyl-3-(1-
phenylvinyl)-1H-indole-2-carbaldehyde 1p (33.7 mg, 0.100 mmol). The 
crude product was purified by flash column chromatography (100% 
hexanes to 90:10 hexanes:EtOAc) to yield 2p (30.7 mg, 0.091 mmol, 91% 
yield) as a pale yellow solid. The enantiomeric excess was determined by HPLC analysis (254 
nm, 25 °C) tR 31.2 min (major); tR 34.3 min (minor) [Chiracel AD-H (0.46cm x 25 cm) (from 
Daicel Chemical Ind., Ltd.) hexane/iPrOH, 95:5, 0.5 mL/min] to be 99% ee. [a]D22.8 = +61.9° 
(c 1.550, CHCl3). 1H NMR (CDCl3, 600 MHz): δ 2.89 (dd, J = 18.4, 2.0 Hz, 1H), 3.51 (dd, J 
= 18.4, 6.7 Hz, 1H), 4.65 (dd, J = 6.7, 1.9 Hz, 1H), 5.55 (d, J = 15.7 Hz, 1H), 5.59 (d, J = 15.7 
Hz, 1H), 7.02 (t, J = 7.1 Hz, 1H), 7.20 – 7.35 (m, 13H). 13C NMR (CDCl3, 150 MHz): δ 39.2, 
47.7, 52.3, 112.0, 120.8, 122.4, 123.2, 127.0, 127.1, 127.3, 127.4, 127.8, 128.9, 128.9, 137.4, 
138.8, 142.9, 144.6, 147.1, 193.7. HRMS (ESI) calcd. for C24H20NO+ (M+H+) 338.1539, 
found 338.1543. 
 
 (R)-4-allyl-1-phenyl-1,4-dihydrocyclopenta[b]indol-3(2H)-one (2q): 
Prepared according to general procedure C starting from 1-allyl-3-(1-
phenylvinyl)-1H-indole-2-carbaldehyde 1q (28.7 mg, 0.100 mmol). The 
crude product was purified by flash column chromatography (100% 
hexanes to 90:10 hexanes:EtOAc) to yield 2q (19.7 mg, 0.069 mmol, 69% 
yield) as a pale yellow solid. The enantiomeric excess was determined by HPLC analysis (254 
nm, 25 °C) tR 14.4 min (minor); tR 15.9 min (major) [Chiracel OD-H (0.46cm x 25 cm) (from 
Daicel Chemical Ind., Ltd.) hexane/iPrOH, 98:2, 1 mL/min] to be 99% ee. [a]D22.7 = +66.7° (c 
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1.080, CHCl3). 1H NMR (CDCl3, 400 MHz): δ 2.90 (dd, J = 18.5, 2.4 Hz, 1H), 3.52 (dd, J = 
18.5, 6.8 Hz, 1H), 4.67 (dd, J = 6.8, 2.4 Hz, 1H), 5.03 – 5.05 (m, 2H), 5.10 (ddd, J = 17.1, 1.6, 
1.2 Hz, 1H), 5.20 (ddd, J = 10.3, 1.4, 1.2 Hz, 1H), 6.04 (dddd, J = 17.0, 10.5, 5.4, 5.2 Hz, 1H), 
7.07 (ddd, J = 8.1, 6.2, 1.7 Hz, 1H), 7.21 – 7.41 (m, 8H). 13C NMR (CDCl3, 100 MHz): δ 39.2, 
46.3, 52.2, 111.9, 117.2, 120.7, 122.4, 123.1, 127.96, 126.98, 127.3, 128.9, 133.3, 138.6, 142.9, 
144.6, 146.9, 193.6. HRMS (ESI) calcd. for C20H18NO+ (M+H+) 288.1383, found 288.1384. 
 
(R,E)-1-phenyl-4-(prop-1-en-1-yl)-1,4-dihydrocyclopenta[b]indol- 
3(2H)-one (3q): Prepared according to general procedure C starting from 
1-allyl-3-(1-phenylvinyl)-1H-indole-2-carbaldehyde 1q (28.7 mg, 0.100 
mmol). The crude product was purified by flash column chromatography 
(100% hexanes to 90:10 hexanes:EtOAc) to yield 3q (5.8 mg, 0.02 mmol, 
20% yield) as a pale yellow solid. The enantiomeric excess was determined by HPLC analysis 
(254 nm, 25 °C) tR 12.2 min (minor); tR 18.8 min (major) [Chiracel OD-H (0.46cm x 25 cm) 
(from Daicel Chemical Ind., Ltd.) hexane/iPrOH, 98:2, 1 mL/min] to be 99% ee. [a]D22.6 = 
+10.8° (c 0.37, CHCl3). 1H NMR (CDCl3, 400 MHz): δ 1.95 (dd, J = 6.8, 1.7 Hz, 3H), 2.92 
(dd, J = 18.4, 2.5 Hz, 1H), 3.54 (dd, J = 18.4, 6.8 Hz, 1H), 4.65 (dd, J = 6.8, 2.4 Hz, 1H), 6.45 
(dq, J = 13.6, 6.8 Hz, 1H), 7.06 – 7.12 (m, 2H), 7.21 – 7.27 (m, 3H), 7.29 – 7.33 (m, 3 H), 7.37 
– 7.42 (m, 1H), 7.61 (ddd, J = 8.6, 0.9, 0.9 Hz, 1H). 13C NMR (CDCl3, 100 MHz): δ 15.9, 
39.2, 52.2, 116.4, 116.7, 121.3, 122.4, 123.0, 123.2, 127.3, 127.5, 128.9, 129.1, 138.2, 142.6, 
143.6, 149.3, 192.7. HRMS (ESI) calcd. for C20H18NO+ (M+H+) 288.1383, found 288.1385. 
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 (R)-7-fluoro-4-methyl-1-phenyl-1,4-dihydrocyclopenta[b]indol-
3(2H)-one (2r): Prepared according to general procedure C starting from 
5-fluoro-1-methyl-3-(1-phenylvinyl)-1H-indole-2-carbaldehyde 1r 
(27.9 mg, 0.100 mmol). The crude product was purified by flash column 
chromatography (100% hexanes to 90:10 hexanes:EtOAc) to yield 2r 
(26.0 mg, 0.093 mmol, 93% yield) as a white solid. The enantiomeric excess was determined 
by HPLC analysis (254 nm, 25 °C) tR 14.9 min (minor); tR 18.4 min (major) [Chiracel OD-H 
(0.46cm x 25 cm) (from Daicel Chemical Ind., Ltd.) hexane/iPrOH, 95:5, 1 mL/min] to be 99% 
ee. [a]D22.6 = +103.9° (c 1.425, CHCl3). 1H NMR (CDCl3, 400 MHz): δ 2.89 (dd, J = 18.6, 2.5 
Hz, 1H), 3.50 (dd, J = 18.6, 6.8 Hz, 1H), 3.97 (s, 3H), 4.61 (dd, J = 6.7, 2.3 Hz, 1H), 6.99 (dd, 
J = 8.9, 2.5 Hz, 1H), 7.16 (ddd, J = 9.0, 9.0, 2.5 Hz, 1H), 7.17 – 7.27 (m, 3H), 7.29 – 7.35 (m, 
3H). 13C NMR (CDCl3, 100 MHz): δ 30.5, 39.0, 52.2, 106.7 (d, J = 23.1 Hz, 1C), 112.1 (d, J 
= 9.4 Hz, 1C), 115.8 (d, 26.8 Hz, 1C), 122.7 (d, J = 10.0 Hz, 1C), 127.1, 127.2, 129.0, 140.2, 
141.8, 142.6, 145.6 (d, J = 5.5 Hz, 1C), 157.9 (d, J = 237 Hz, 1C), 194.0. 19F NMR (CDCl3, 
376 MHz) δ -122.5 (m, 1F). HRMS (ESI) calcd. for C18H15FNO+ (M+H+) 280.1132, found 
280.1137. 
 
(R)-4-methyl-1-phenyl-6-(trifluoromethyl)-1,4-dihydrocyclo- 
penta[b]indol-3(2H)-one (2s): Prepared according to general 
procedure C starting from 1-methyl-3-(1-phenylvinyl)-6-
(trifluoromethyl)-1H-indole-2-carbaldehyde 1s (32.9 mg, 0.100 
mmol). The crude product was purified by flash column 
chromatography (100% hexanes to 90:10 hexanes:EtOAc) to yield 2s (31.3 g, 0.095 mmol, 
N
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F
O
N
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95% yield) as a yellow solid. The enantiomeric excess was determined by HPLC analysis (254 
nm, 25 °C) tR 13.8 min (minor); tR 16.6 min (major) [Chiracel OD-H (0.46cm x 25 cm) (from 
Daicel Chemical Ind., Ltd.) hexane/iPrOH, 95:5, 1 mL/min] to be 99% ee. [a]D22.6 = +94.7° (c 
1.710, CHCl3). 1H NMR (CDCl3, 400 MHz): δ 2.92 (dd, J = 18.6, 2.4 Hz, 1H), 3.54 (dd, J = 
18.6, 6.8 Hz, 1H), 4.03 (s, 3H), 4.68 (dd, J = 6.8, 2.4 Hz, 1H), 7.19 – 7.34 (m, 6H), 7.45 – 7.47 
(m, 1H), 7.69 (m, 1H). 13C NMR (CDCl3, 100 MHz): δ 30.5, 39.0, 52.2, 108.9 (q, J = 4.4 Hz, 
1C), 117.1 (q, J = 3.4 Hz, 1C), 122.9, 123.3, 126.4, 126.7 (q, J = 247 Hz, 1C), 127.2, 128.5 (q, 
J = 31.9 Hz, 1C), 129.1, 141.1, 142.5, 143.9, 145.5, 194.2. 19F NMR (CDCl3, 376 MHz) δ -
61.5 (s, 3F). HRMS (ESI) calcd. for C19H15F3NO+ (M+H+) 330.1100, found 330.1104. 
 
 (R)-4-phenyl-4,5-dihydro-6H-cyclopenta[b]furan-6-one (2t): Prepared 
according to modified general procedure C starting from 3-(1-
phenylvinyl)furan-2-carbaldehyde 1t (19.8 mg, 0.100 mmol). The reaction was 
run at 100°C in 1,4-dioxane. The crude product was purified by flash column 
chromatography (100% hexanes to 90:10 hexanes:EtOAc) to yield 2t (14.9 mg, 0.075 mmol, 
75% yield) as a pale yellow solid. The enantiomeric excess was determined by HPLC analysis 
(254 nm, 25 °C) tR 22.9 min (minor); tR 25.7 min (major) [Chiracel OD-H (0.46cm x 25 cm) 
(from Daicel Chemical Ind., Ltd.) hexane/iPrOH, 95:5, 1 mL/min] to be 95% ee. [a]D22.4 = -
25.7 ° (c 0.855, MeOH). The absolute configuration of compound 2t was determined to be (R) 
by comparing the sign of the optical rotation with a literature value.36 1H NMR (CDCl3, 600 
MHz): δ 2.83 (dd, J = 18.4, 2.8 Hz, 1H), 3.43 (dd, J = 18.4, 6.7 Hz, 1H), 4.38 (dd, J = 6.6, 1.7 
Hz, 1H), 6.45 (d, J = 1.4 Hz, 1H), 7.16 (d, J = 7.4 Hz, 2H), 7.27 (t, J = 7.3 Hz, 1H), 7.33 (t, J 
= 7.4 Hz, 2H), 7.80 (d, J = 1.5 Hz, 1H). 13C NMR (CDCl3, 150 MHz): δ 38.0, 51.3, 110.1, 
O
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127.1, 127.4, 129.1, 141.6, 154.1, 155.2, 158.6, 187.4. HRMS (ESI) calcd. for C13H11O2+ 
(M+H+) 199.0754, found 199.0754. 
 
 (R)-4-phenyl-4,5-dihydro-6H-cyclopenta[b]thiophen-6-one (2u): Prepared 
according to general procedure C starting from 3-(1-phenylvinyl)thiophene-2-
carbaldehyde 1u (21.4 mg, 0.100 mmol). The crude product was purified by flash 
column chromatography (100% hexanes to 90:10 hexanes:EtOAc) to yield 2u 
(19.3 mg, 0.090 mmol, 90% yield) as a pale yellow solid. The enantiomeric excess was 
determined by HPLC analysis (254 nm, 25 °C) tR 12.5 min (minor); tR 16.2 min (major) 
[Chiracel OD-H (0.46cm x 25 cm) (from Daicel Chemical Ind., Ltd.) hexane/iPrOH, 95:5, 1 
mL/min] to be 99% ee. [a]D22.5 = -44.4 ° (c 1.260, CHCl3). 1H NMR (CDCl3, 400 MHz): δ 
2.92 (dd, J = 18.6, 2.8 Hz, 1H), 3.49 (dd, J = 18.6, 7.2 Hz, 1H), 4.52 (dd, J = 7.2, 2.8 Hz, 1H), 
6.89 (d, J = 4.8 Hz, 1H), 7.13 – 7.15 (m, 2H), 7.23 – 7.34 (m, 3H), 7.89 (d, J = 4.8 Hz, 1H). 
13C NMR (CDCl3, 150 MHz): δ 42.7, 51.6, 124.1, 127.3, 127.3, 129.1, 141.0, 141.4, 142.4, 
171.2, 196.3. HRMS (ESI) calcd. for C13H11OS+ (M+H+) 215.0525, found 215.0527. 
 
 (R)-1-phenyl-1,2-dihydro-3H-benzo[b]cyclopenta[d]thiophen-3-one 
(2v): Prepared according to general procedure C starting from 3-(1-
phenylvinyl)benzo[b]thiophene-2-carbaldehyde 1v (26.4 mg, 0.100 mmol). 
The crude product was purified by flash column chromatography (100% 
hexanes to 90:10 hexanes:EtOAc) to yield 2v (24.1 mg, 0.091 mmol, 91% yield) as a white 
solid. The enantiomeric excess was determined by HPLC analysis (254 nm, 25 °C) tR 11.4 min 
(minor); tR 24.7 min (major) [Chiracel OD-H (0.46cm x 25 cm) (from Daicel Chemical Ind., 
S
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Ltd.) hexane/iPrOH, 95:5, 1 mL/min] to be 99% ee. [a]D22.5 = +12.2 ° (c 1.260, CHCl3). 1H 
NMR (CDCl3, 400 MHz): δ 2.96 (dd, J = 18.6, 2.6 Hz, 1H), 3.58 (dd, J = 18.6, 7.1 Hz, 1H), 
4.73 (dd, J = 7.0, 2.6 Hz, 1H), 7.18 – 7.21 (m, 2H), 7.25 – 7.35 (m, 4H), 7.40 – 7.46 (m, 2H), 
7.90 (d, J = 8.2 Hz, 1H). 13C NMR (CDCl3, 100 MHz): δ 42.8, 51.2, 124.60, 124.64, 125.2, 
127.4, 127.5, 128.2, 129.2, 133.9, 141.59, 141.62, 148.7, 166.4, 197.8. HRMS (ESI) calcd. for 
C17H13OS+ (M+H+) 265.0682, found 265.0685. 
 
 (S)-4-methyl-3-phenyl-3,4-dihydrocyclopenta[b]indol-1(2H)-one 
(2w): Prepared according to general procedure C starting from 1-
methyl-2-(1-phenylvinyl)-1H-indole-3-carbaldehyde 1w (26.1 mg, 
0.100 mmol). The crude product was purified by flash column 
chromatography (100% hexanes to 80:10 hexanes:EtOAc) to yield 2w (18.6 mg, 0.0712 mmol, 
71% yield) as a white solid. The enantiomeric excess was determined by HPLC analysis (254 
nm, 25 °C) tR 27.1 min (minor); tR 32.0 min (major) [Chiracel OJ-H (0.46cm x 25 cm) (from 
Daicel Chemical Ind., Ltd.) hexane/iPrOH, 90:10, 1 mL/min] to be 97% ee. [a]D22.5 = -118.6° 
(c 0.995, CHCl3). 1H NMR (CDCl3, 600 MHz): δ 2.83 (dd, J = 17.8, 2.3 Hz, 1H), 3.36 (s, 3H), 
3.49 (dd, J = 17.8, 7.3 Hz, 1H), 4.53 (dd, J = 7.1, 2.0 Hz, 1H), 7.12 (d, J = 7.2 Hz, 2H), 7.22 – 
7.30 (m, 6H), 7.97 (d, J = 7.8 Hz, 1H). 13C NMR (CDCl3, 150 MHz): δ 30.8, 40.3, 52.5, 110.2, 
120.3, 121.2, 121.5, 122.7, 123.9, 127.3, 127.7, 129.4, 140.7, 143.4, 168.5, 194.5. HRMS 
(ESI) calcd. for C18H16NO+ (M+H+) 262.1226, found 262.1230. 
 
 
 
N
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Grignard Addition to 2c to Form 4a-b  
 
(1R,3S)-4-methyl-1-phenyl-3-vinyl-1,2,3,4-tetrahydrocyclopenta- 
[b]indol-3-ol (4a): 2c (30.5 mg, 0.115 mmol) was dissolved in ether in an 
oven dried round bottom flask under a N2 environment. The solution was 
then cooled to 0 °C and a solution of vinylmagnesium bromide in THF 
(0.17 mL, 0.17 mmol, 1.0 M) was added dropwise. The reaction was warmed to rt and stirred 
for 1 h. The reaction was quenched with sat. aqueous NH4Cl and extracted three times with 
ether. The organic layer was dried with MgSO4 and concentrated down. The crude product was 
purified by flash column chromatography (80:20 hexanes:EtOAc) to yield 4a (28.1 mg, 0.097 
mmol, 84% yield) as a white solid. The diastereomeric ratio was determined to be 10:1 and the 
major diastereomer is reported. 1H NMR (CDCl3, 400 MHz): δ 2.16 (s, 1H), 2.47 (dd, J = 13.3, 
6.3 Hz, 1H), 3.28 (dd, J = 13.3, 7.7 Hz, 1H), 3.76 (s, 3H), 4.39 (dd, J = 7.6, 6.4 Hz, 1H), 5.20 
(dd, J = 10.6, 1.2 Hz, 1H), 5.25 (dd, J = 17.2, 1.2 Hz, 1H), 6.20 (dd, J = 17.2, 10.6 Hz, 1H), 
7.02 (m, 1H), 7.20 – 7.25 (m, 3H), 7.29 – 7.36 (m, 5 H). 13C NMR (CDCl3, 100 MHz): δ 30.1, 
41.8, 58.5, 79.4, 109.9, 113.0, 119.4, 119.9, 121.1, 121.8, 123.4, 126.5, 127.5, 128.7, 140.9, 
142.4, 144.8, 145.4. HRMS (ESI) calcd. for C20H20NO+ (M+H+) 290.1539, found 290.1538. 
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(1R,3R)-3-allyl-4-methyl-1-phenyl-1,2,3,4-tetrahydrocyclopenta- 
[b]indol-3-ol (4b): 2c (30.5 mg, 0.115 mmol) was dissolved in ether in 
an oven dried round bottom flask under a N2 environment. The solution 
was then cooled to 0 °C and a solution of allylmagnesium bromide in 
THF (0.09 mL, 0.17 mmol, 2.0 M) was added dropwise. The reaction was warmed to rt and 
stirred for 1 h. The reaction was quenched with sat. aqueous NH4Cl and extracted three times 
with ether. The organic layer was dried with MgSO4 and concentrated down. The crude product 
was purified by flash column chromatography (80:20 hexanes:EtOAc) to yield 4b (27.5 mg, 
0.091 mmol, 79% yield) as a white solid. The diastereomeric ratio was determined to be 3:1 
and the major diastereomer is reported. 1H NMR (CDCl3, 400 MHz): δ 2.12 (s, 1H), 2.32 (dd, 
J = 12.8, 6.0 Hz, 1H), 2.74 – 2.78 (m, 1H), 3.28 (dd, J = 13.2, 7.6 Hz, 1H), 3.87 (s, 3H), 4.30 
(dd, J = 7.8, 7.8 Hz, 1H), 5.10 – 5.30 (m, 2H), 5.73 – 5.86 (m, 1H), 6.99 – 7.05 (m, 1H), 7.16 
– 7.35 (m, 9H). 13C NMR (CDCl3, 100 MHz): δ 30.6, 42.0, 44.6, 56.6, 78.8, 109.8, 119.4, 
119.4, 119.9, 120.8, 121.7, 123.4, 126.4, 127.5, 128.6, 133.2, 142.6, 145.0, 146.4. HRMS 
(ESI) calcd. for C21H22NO+ (M+H+) 304.1696, found 304.1670. 
 
Reduction of 2c to Form 4c 
 
(1R,3R)-4-methyl-1-phenyl-1,2,3,4-tetrahydrocyclopenta[b]indol-3-
ol (4c): 2c (30.5 mg, 0.115 mmol) was dissolved in THF in an oven dried 
round bottom flask under a N2 environment, cooled to -78 °C and lithium 
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aluminum hydride (10.9 mg, 0.288 mmol) was added. The reaction was allowed to warm to rt 
and stirred for 3 h. The reaction was quenched with sat. rochelle salt and extracted three times 
with EtOAc. The organic layer was dried with MgSO4 and concentrated down. The crude 
product was purified by flash column chromatography (80:20 hexanes:EtOAc) to yield 4c 
(28.8 mg, 0.109 mmol, 95% yield) as a white solid. The diastereomeric ratio was determined 
to be 10:1 and the major diastereomer is reported. 1H NMR (CDCl3, 400 MHz): δ 1.78 (bs, 
1H), 2.21 (ddd, J = 13.9, 4.5, 4.4 Hz, 1H), 3.51 (ddd, J = 13.8, 7.6, 7.6 Hz, 1H), 3.84 (s, 3H), 
4.37 (dd, J = 8.1, 5.0 Hz, 1H), 5.38 (dd, J = 6.4, 3.9 Hz, 1H), 7.03 (dd, J = 7.6, 7.3 Hz, 1H), 
7.21 – 7.35 (m, 8H). 13C NMR (CDCl3, 100 MHz): δ 30.5, 42.4, 51.4, 69.7, 110.0, 119.5, 
120.0, 121.6, 121.9, 123.5, 126.4, 127.4, 128.7, 142.5, 145.6, 146.0. HRMS (ESI) calcd. for 
C18H18NO+ (M+H+) 264.1383, found 264.1378. 
 
Debenzylation of 2p to Form 4d 
 
 (R)-1-phenyl-1,4-dihydrocyclopenta[b]indol-3(2H)-one (4d): A 
solution of 2p (30.0 mg, 0.090 mmol) dissolved in benzene (0.15 M) was 
added to a 1 dram vial containing AlCl3 and stirred for 30 minutes at rt. The 
reaction was transferred and washed into a round bottom flask with benzene 
and concentrated down onto silica. The crude product was purified by flash column 
chromatography (80:20 hexanes:EtOAc) to yield 4d (18.2 mg, 0.074 mmol, 83% yield) as a 
N
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O
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99% ee
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white solid. The enantiomeric excess was determined by HPLC analysis (254 nm, 25 °C) tR 
17.1 min (major); tR 20.2 min (minor) [Chiracel AD-H (0.46cm x 25 cm) (from Daicel 
Chemical Ind., Ltd.) hexane/iPrOH, 90:10, 1 mL/min] to be 98% ee. [a]D22.2 = +179.7° (c 
0.935, CHCl3). 1H NMR (CDCl3, 400 MHz): δ 2.97 (dd, J = 18.6, 2.3 Hz, 1H), 3.60 (dd, J = 
18.6, 6.6 Hz, 1H), 4.72 (dd, J = 6.6, 2.1 Hz, 1H), 7.09 (ddd, J = 7.9, 7.2, 0.7 Hz, 1H), 7.24 – 
7.28 (m, 3H), 7.31 – 7.34 (m, 2H), 7.38 – 7.42 (m, 2H), 7.61 (d, J = 8.32 Hz, 1H), 10.12 (s, 
1H). 13C NMR (CDCl3, 100 MHz): δ 39.7, 51.9, 114.0, 121.0, 122.1, 123.2, 127.1, 127.3, 
127.6, 129.0, 138.9, 142.7, 144.5, 149.1, 194.4. HRMS (ESI) calcd. for C17H14NO+ (M+H+) 
248.1070, found 248.1073. 
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CHAPTER 3.     
NICKEL-CATALYZED ALKENE CARBOACYLATION VIA ACTIVATION OF 
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Abstract 
We report Ni-catalyzed formal carboacylation of ortho-allylbenzamides with 
arylboronic acid pinacol esters. The reaction is triggered by oxidative addition of an activated 
amide C−N bond to a Ni(0) catalyst and proceeds via alkene insertion into a Ni(II)-acyl bond. 
The exo-selective carboacylation reaction generates 2-benzyl-2,3-dihydro-1H-inden-1-ones in 
moderate to high yields (46−99%) from a variety of arylboronic acid pinacol esters and 
substituted ortho-allylbenzamides. These results show that amides are practical substrates for 
alkene carboacylation via amide C−N bond activation, and this approach bypasses challenges 
associated with alkene carboacylation triggered by C−C bond activation. 
Introduction 
Carboacylation of alkenes in the presence of a transition-metal catalyst is an emerging 
reaction that enables the difunctionalization of an alkene with the formation of two C−C 
bonds.1-16 Among the most studied and developed approaches to alkene carboacylation are 
reactions initiated by activation of a C−C bond of a ketone. While much progress has been 
made to understand the mechanistic pathways and utility of these carboacylation reactions, the 
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development of alkene carboacylation reactions is limited by the requirement for substrates 
containing either a quinoline directing group1-5 or a strained cyclic ketone.6-12 The ability to 
perform alkene carboacylation reactions on substrates without a strained ketone or a directing 
group has the potential to expand the utility of these reactions with readily accessible 
substrates.13-16,17-21 
 
Scheme 1. Synthesis of Ketones via Transition-Metal Catalyzed Activation of Amide C−N 
Bonds 
Recently, studies by a number of groups have demonstrated Suzuki-Miyaura coupling 
of benzamides with arylboron compounds to generate a variety of aromatic ketones.22-33 The 
Suzuki-Miyaura-type coupling reactions involve C−N activation of an activated benzamide via 
oxidative addition and transmetalation with an arylboron compound to generate acyl- metal-
aryl intermediate A (Scheme 1a). Subsequent reductive elimination forms a diaryl ketone. The 
ability to intercept acylmetal intermediates with alkenes offers the potential to develop a new 
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class of alkene functionalization reactions. During the course of our studies, Garg and co-
workers reported Mizoroki-Heck cyclizations of ortho-allylbenzamides that involve insertion 
of an alkene into acyl-Ni(II)-amido intermediate B (Scheme 1b).34 Subsequent β-hydride 
elimination forms 2-vinylindanones containing a quaternary carbon center. 
The potential to develop a new class of alkene carboacylation reactions via activation 
of amide C−N bonds22-33,35-40 led us to investigate nickel-catalyzed carboacylations of ortho-
allylbenzamides. We envisioned a process involving activation of the C−N bond of a 
benzamide via oxidative addition and transmetalation with an arylboron compound to generate 
acyl-Ni(II)-aryl intermediate C (Scheme 1c). Migratory insertion of the tethered alkene and 
reductive elimination would generate a 2-benzylindanone, the product of a formal alkene 
carboacylation reaction. In contrast to the recently reported Mizoroki-Heck cyclization 
reactions, which involve the formation of a single C−C bond, the proposed formal 
carboacylation reactions involve difunctionalization of an alkene with the formation of two 
C−C σ bonds. The development of this approach to alkene carboacylation offers the potential 
to expand these reactions beyond strained cyclic ketones and ketones containing a quinoline 
directing group. We now report the first nickel-catalyzed carboacylations triggered by C−N 
bond activation of ortho-allylbenzamides to form a variety of 2-benzyl-2,3-dihydro-1H-inden-
1-ones in up to 99% yield. 
Results and Discussion 
To identify reaction conditions for the Nickel-catalyzed carboacylation of ortho-
allylbenazamides, we evaluated the model reaction of tert-butyl (2-
allylbenzoyl)(benzyl)carbamate (1a) with phenylboronic acid pinacol ester (PhBpin) in the 
presence of a catalyst generated from Ni(cod)2 and 1,3-bis(2,6-diisopropylphenyl)-4,5-
dihydroimidazol-2-ylidine (SIPr) (Table 1). The nickel carbene complex catalyzed the model 
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reaction to form indanone 2a in 20% yield when the reaction was conducted in toluene at 90 
°C with 1.2 equivalents of PhBpin (entry 1). The yield of indanone 2a increased to 30% when 
the reaction was run with 3.0 equivalents of PhBpin (entry 3). However, the major product of 
these reactions was generated from isomerization of the ortho-allylbenzamide starting 
material. To further improve the yield of the model reaction and minimize alkene 
isomerization, we investigated the impact of the identity of the solvent (entries 3-7). When the 
model reaction was carried out in THF, indanone 2a was generated in 75% yield along with 
the isomerized starting material in 24% yield (entry 7). 
Table 1. Identification of Reaction Conditions for Nickel-Catalyzed Carboacylation of 1a with 
PhBpina  
 
entry temperature (°C) solvent conversion (%)b yield (%)b,c 
1d 90 toluene 67 20 (35) 
2e 90 toluene 49 21 (27) 
3 90 toluene 100 30 (43) 
4 90 benzene 70 27 (45) 
5 90 1,4-dioxane 84 26 (46) 
6f 90 DME 82 46 (9) 
7 f  90 THF 99 75 (24) 
8 f 80 THF 100 78 (9) 
9 f 70 THF 100 83 (4) 
10 f 60 THF 100 97 (0) 
11 40 THF 48 39 (0) 
12e 60 THF 65 55 (0) 
13d 60 THF 39 39 (0) 
14f,g 60 THF 100 95 (0) 
15h 60 THF 40 38 (0) 
16i 60 THF 100 88 (11) 
aReaction conditions: 1a (0.100 mmol), Ni(cod)2 (0.010 mmol), SIPr (0.010 mmol), K3PO4 
(0.200 mmol), H2O (0.200 mmol), solvent (1.0 M), 12 h. bDetermined by 1H NMR 
spectroscopy of the crude reaction mixture using dibromomethane as an internal standard. c1H 
NMR yields of the alkene isomerization product, tert-butyl (benzyl)(2-(prop-1-en-1-
O
N
Boc
Bn
O
1a 2a
Ni(cod)2 (10 mol %)
SIPr (10 mol %)
PhBpin (3 equiv)
K3PO4 (2 equiv)
H2O (2 equiv)
solvent, temp
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yl)benzoyl)carbamate, are shown in parentheses. dPhBpin (1.2 equiv). ePhBpin (2 equiv). 
fIsolated yield of 2a. g5 mol % Ni(cod)2 and 5 mol % SIPr. h2.5 mol % Ni(cod)2 and 2.5 mol 
% SIPr. iSIPr·HCl (0.010 mmol) in place of SIPr. 
 
To further increase the ratio of indanone 2a relative to the isomerized starting material, 
we investigated the impact of the reaction temperature (entries 7-11). Lowering the reaction 
temperature to 60 °C led to the formation of indanone 2a in 97% yield without observable 
isomerization of the ortho-allylbenzamide (entry 10). Consistent with our observations of 
reactions run in toluene (entries 1-3), the yield of indanone 2a decreased as the number of 
equivalents of PhBpin was decreased when the reaction was run in THF at 60 °C (compare 
entry 10 with entries 12 and 13). The model reaction catalyzed with 5 mol % Ni catalyst formed 
2a in 95% yield (entry 14). However, decreasing the catalyst loading to 2.5 mol % led to 
incomplete conversion and formation of 2a in only 38% yield (entry 15). The model reaction 
formed 2a in 88% yield with 11% isomerization of 1a when the nickel carbene catalyst was 
generated in situ from Ni(cod)2 and SIPr·HCl (entry 16). 
With a practical catalyst system identified for the model reaction of 1a with PhBpin, 
we next evaluated carboacylation reactions of 1a with a broad range of arylboronic acid pinacol 
esters (ArBpin) (Scheme 2). Carboacylation of 1a with a range of para-substituted, electron-
rich ArBpin reagents generated ketones 2b-2e in good to excellent yields (78-99%). The 
reaction of 1a with para-substituted, electron-deficient ArBpin reagents formed indanones 2f-
2j in moderate to high yields (54-85%). Carboacylation of 1a with ArBpin compounds 
containing electron-donating groups at the meta position formed ketones 2k and 2l in 85-99% 
yield, while meta-halogenated ArBpin compounds reacted with 1a to form 2m and 2n in 54-
67% yield. Reactions of 1a with ArBpin reagents containing electron-donating groups at the 
ortho position were also possible and generated the carboacylation products 2o and 2p in 50% 
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and 90% yield. However, reactions of 1a with ortho-halogenated ArBpin reagents did not 
occur under our reaction conditions. The scope of alkene carboacylation is not limited to 
substituted ArBpin compounds but also includes boronic acid pinacol esters of polycyclic 
arenes and heteroarenes. The carboacylation reactions of 1a with heteroarylboronic acid 
pinacol esters formed ketone products 2r and 2s in 63-88% yield. Reactions of 1a with 
arylboronic acids and alkylboronic acid pinacol esters did not occur under our standard reaction 
conditions. 
 
aReaction conditions: 1a (0.100 mmol), Ni(cod)2 (0.010 mmol), SIPr (0.010 mmol), K3PO4 
(0.200 mmol), H2O (0.200 mmol), ArBPin (0.300 mmol), THF (0.100 mL), 16 h. Yields of 
2b-2t are isolated yields after column chromatography. 1H NMR yields of the alkene 
isomerization product, tert-butyl (benzyl)(2-(prop-1-en-1-yl)benzoyl)carbamate, are shown in 
parentheses. b20 mol % Ni(cod)2, 20 mol % SIPr, and 0.200 mL of THF. 
 
Scheme 2. Scope of Arylboronic Acid Pinacol Estersa,b 
With the scope of arylboronic acid pinacol esters established, we sought to evaluate 
Nickel-catalyzed carboacylations of a variety of substituted ortho-allylbenzamides 3a-3j 
(Scheme 3). Reactions of PhBpin with 3a-3c containing electron-donating and electron- 
O
N
Boc
Bn O
Ar
1a 2b-t
Ni(cod)2 (10 mol %)
SIPr (10 mol %)
ArBpin (3 equiv)
2b, R = OMe, 98%
2c, R = Me, 99%
2d, R = Ph, 94%
2e, R = CH2OMe, 78%
2k, R = OMe, 99%
2l, R = Me, 85%
2m, R = F, 67% (12%)
2n, R = Cl, 54% (28%)
2o, R = OMe, 50% (32%)
2p, R = Me, 90%
2q, 99% 2s, X = O, 63%
2t, X = S, 88%
2f, R = F, 80%
2g, R = Cl, 85% (14%)
2h, R = C(O)Me, 76% (15%)
2i, R = C(O)Ph, 54% (13%)
K3PO4 (2 equiv)
H2O (2 equiv)
THF, 60 °C
2j, R = CF3, 69% (6%)b
Ar  =
R
R
R
X
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withdrawing groups at the 5-position formed indanones 4a-4c in moderate-to-excellent yields 
(51-99%). Carboacylations of 4-substituted ortho-allylbenzamides containing either electron-
donating or electron-withdrawing groups generated ketones 4d-4g in 80-99% yield. 
Carboacylations of 3- and 6-fluorinated ortho-allylbenzamides generated indanones 4h and 4i 
in excellent yields (84-95%), while the reaction of a 4,5-difluorinated ortho-allylbenzamide 
formed indanone 4j in 46% yield. ortho-Allylbenzamides containing substituted allyl units 
were unreactive under our standard reaction conditions, and reactions conducted at elevated 
temperatures led exclusively to isomerization of the alkene. Carboacylation of the acyclic 5-
hexenamide derivative, tert-butyl (benzyl)(hex-5-enoyl)carbamate, with PhBpin to form the 
corresponding cyclic ketone did not occur. 
 
aReaction conditions: 3a−3j (0.100 mmol), Ni(cod)2 (0.010 mmol), SIPr (0.010 mmol), K3PO4 
(0.200 mmol), H2O (0.200 mmol), PhBpin (0.300 mmol), THF (0.100 mL), 12 h. Yields of 
4a−4j are isolated yields after column chromatography. 
 
Scheme 3. Carboacylation of Benzamides 3a−3ja 
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To highlight the utility of our alkene carboacylation reaction, we conducted a series of 
experiments to show that the carboacylation reaction (1) can be conducted on the gram scale, 
(2) encompasses an ortho-allylbenzoate ester, and (3) can be sequenced with nickel-catalyzed 
enantioselective α-arylation to form indanone derivatives containing a quaternary stereogenic 
center. The reaction of 4-fluorinated ortho-allylbenzamide 3f with PhBpin can be conducted 
on a gram scale to form the product 4f in nearly quantitative yield (eq 1). In addition, the 
carboacylation of methyl 2-allylbenzoate (5) with PhBpin forms indanone 2a in 50% yield (eq 
2).41-47 The modest yield of 2a can be attributed to alkene isomerization of 5 to form methyl 2-
(prop-1-en-1-yl)benzoate in 25% yield. Highly enantioenriched indanone derivatives 
containing a quaternary stereogenic center are readily prepared by nickel-catalyzed α-arylation 
of the racemic 2-benzylindanones generated from our carboacylation reactions.48 For example, 
α-arylation of 2a occurs in the presence of a catalyst generated from Ni(cod)2 and (S)-BINAP 
to form indanone 6 in 65% yield with 98% ee (eq 3). 
 
O
N
F
Bn
Boc
O
PhF
Ni(cod)2 (10 mol %)
SIPr (10 mol %)
PhBpin (3 equiv)
K3PO4 (2 equiv)
H2O (2 equiv)
THF, 60 °C, 12 h
2.71 mmol 2.68 mmol, 99% yield
3f 4f
(1)
O
Ph
2a
Ni(cod)2 (10 mol %)
(S)-BINAP (12 mol %)
Ph-Cl (2 equiv)
NaOt-Bu (2 equiv)
toluene, 80 °C, 24 h
O
Ph
6
Ph
65% yield, 96% ee
(2)
O
OMe
O
Ph
Ni(cod)2 (10 mol %)
SIPr (10 mol %)
PhBpin (3 equiv)
K3PO4 (2 equiv)
H2O (2 equiv)
THF, 60 °C, 12 h5 2a
50% yield
(3)
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Two potential mechanistic pathways for the carboacylation of 1a with ArBpin are 
presented in Scheme 4. After coordination of the NHC-Ni(0) catalyst to 1a to form complex I, 
oxidative addition of the amide C−N bond to the Ni(0) center is likely to form the acyl-Ni(II)-
amido complex II. At this stage, the mechanism of the formal carboacylation may diverge 
depending on the order of the subsequent transmetalation and migratory insertion events. If 
transmetalation of ArBpin with II occurs first, acyl-Ni(II)-aryl complex III would be 
generated. Subsequent migratory insertion of the tethered alkene into the Ni-C(acyl) bond 
would form alkyl-Ni(II)-aryl complex V. Reductive elimination of the indanone product 2a 
from V and coordination of another molecule of 1a would close the catalytic cycle. 
Alternatively, if migratory insertion precedes transmetalation, alkyl-Ni(II)-amido complex IV 
would be formed by insertion of the tethered alkene into the Ni-C(acyl) bond of II.34 
Transmetalation of ArBpin with IV would form V and indanone 2a upon reductive elimination. 
 
Scheme 4. Potential Mechanistic Pathways  
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Our working hypothesis is that transmetalation of ArBpin with II precedes migratory 
insertion of the tethered alkene, on the basis of two observations. First, the identity of the 
ArBpin significantly impacts the amount of alkene isomerization observed under our reaction 
conditions (see Scheme 2). Second, alkene isomerization is not observed in the absence of 
ArBpin (eq 4). Taken together, these results are consistent with transmetalation of ArBpin with 
II occurring first to form III followed by migratory insertion to generate V. 
 
To gain additional insight into the mechanism of the formal carboacylation reaction, 
we conducted a series of competition experiments (Scheme 5). The competition experiment 
between 4-(trifluoromethyl)benzamide 3g and 4-methylbenzamide 3e formed ketones 4g and 
4e in a 6.8:1 ratio favoring the trifluoromethyl-substituted ketone 4g. Although this result is 
consistent with the relative reactivity of electron-deficient and electron-rich benzamides in the 
context of Suzuki-Miyaura and Negishi coupling,23,49 it contrasts with the more facile nature 
of oxidative addition into electron-rich benzamide 3e versus electron-deficient benzamide 3g 
due to the increased amidic resonance that would be expected for 3g versus 3e.50 In addition, 
this result suggests that the ratio of products observed is not determined by the relative rates 
of oxidative addition of 3g and 3e. Competition experiments between the pinacol ester of 4- 
tolylboronic acid and the pinacol esters of 2-tolylboronic acid and 4-
(trifluoromethyl)phenylboronic acid formed ketones 2p and 2c in an 8.3:1 ratio and ketones 2j 
and 2c in a 10.5:1 ratio, respectively. The observation that ketones derived from reactions with 
sterically hindered and electron-deficient arylboron nucleophiles are favored suggests that 
O
N
Boc
Bn Ni(cod)2 (10 mol %)
SIPr (10 mol %)
K3PO4 (2 equiv)
H2O (2 equiv)
THF, 60 °C
O
OH
+
O
N
Boc
Bn
O
OH
+
not observed observed not observed
(4)
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transmetalation is fast relative to reductive elimination and that the ratio of products is 
determined by the relative rates of either reductive elimination or migratory insertion into the 
Ni-C(acyl) bond of complex III. Given that a nearly equimolar ratio of 4g and 4e would be 
expected from the competition between 3g and 3e if reductive elimination were turnover-
limiting, we propose that migratory insertion of the alkene into the Ni-C(acyl) bond is the 
elementary step critical to determining the product ratio. 
 
 
 
 
Scheme 5. Competition Experiments 
Conclusion 
In summary, we have developed the first Ni-catalyzed alkene carboacylation reactions 
initiated by activation of amide C−N bonds. These processes enable coupling of a variety of 
ortho-allylbenzamides and arylboronic acid pinacol esters to form two new C−C bonds and 
the indanone products in up to 99% yield. Moreover, the development of this approach to 
alkene carboacylation bypasses challenges associated with related alkene carboacylation 
reactions that rely on C−C bond activation and further demonstrates the utility of amides as 
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powerful building blocks in organic synthesis. Studies to further leverage the synthetic 
potential of this transformation and to gain additional mechanistic understanding of the nickel-
catalyzed alkene carboacylation reaction are ongoing in our laboratory. 
Experimental 
General synthetic details. All air-sensitive procedures were conducted under inert 
atmosphere in a nitrogen-filled dry box or by standard Schlenk techniques.  All reactions were 
performed under an atmosphere of nitrogen unless otherwise stated.  All glassware for moisture 
sensitive reactions were dried at 140 °C in an oven.  Tetrahydrofuran, methylene chloride and 
N,N-dimethylformamide were degassed by purging with argon for 45 minutes and dried with 
a solvent purification system by passing through a one-meter column of activated alumina.  
Anhydrous 1,4-dioxane was purchased from Sigma Aldrich. Flash column chromatography 
was performed on SiliFlash® P60 silica gel (40-63 µm, 60Å) or using a Teledyne Isco 
Combiflash® Rf system with RediSep Gold™ columns using hexanes/ethyl acetate, 
dichloromethane/methanol, or pentane/ether mixtures as eluents.  Reactions products were 
visualized on TLC by UV light or by staining with KMnO4. 
Instrumentation. HRMS (ESI) analysis was performed at the Iowa State University 
Chemical Instrumentation Facility on an Agilent 6540 QTOF spectrometer. HPLC analyses 
were carried out on a Waters Alliance HPLC system with an e2695 separations module and a 
2489 dual wavelength detector. NMR spectra were acquired on Varian MR-400 and Bruker 
Avance III 600 spectrometers at the Iowa State University Chemical Instrumentation Facility. 
Chemicals shifts are reported in ppm relative to residual solvent peaks (CDCl3 = 7.26 ppm for 
1H and 77.16 ppm for 13C). Coupling constants are reported in hertz. 19F NMR shifts are 
reported based on indirect reference to CDCl3.51 
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Materials. 2-iodobenzoic acid (S1a) was purchased from Sigma Aldrich. 2-Iodo-5-
methylbenzoic acid (S1b), 2-bromo-4-methylbenzoic acid (S1c), 2-iodo-5-methoxybenzoic 
acid (S1d), 2-bromo-4-methoxybenzoic acid (S1e), 2-bromo-6-fluorobenzoic acid (S1f), 2-
bromo-4-fluorobenzoic acid (S1g), 2-bromo-3-fluorobenzoic acid (S1h), 2-bromo-5-
(trifluoromethyl)benzoic acid (S1i), 2-iodo-4-(trifluoromethyl)benzoic acid (S1j), and 2-
bromo-4,5-difluorobenzoic acid (S1k) were purchased from Combi-Blocks. Arylboronic acid 
pinacol esters were synthesized according to known a literature procedure.52 
Tetrakis(triphenylphosphine), cesium fluoride, and di-tert-butyl dicarbonate were purchased 
from Ak Scientific. Tribasic potassium phosphate was purchased from Sigma Aldrich.  
Bis(1,5-cyclooctadiene)nickel(0), and 1,3-bis(2,6-di-i-propylphenyl)-4,5-dihydroimidazol-2-
ylidine were purchased from Strem Chemicals. 
General Procedure A: Synthesis of o-Halobenzamides S2a-S2k: 
 
ortho-Halobenzamides (S2a-S2k) were prepared from the appropriate ortho-halobenzoic acid 
(S1a-S1k).  To the appropriate ortho-halobenzoic acid (S1a-S1k) in anhydrous DCM (0.3 M) 
at 0 °C under N2 was added 2 M oxalyl chloride (1.20 equiv) dropwise and a catalytic amount 
OH
O
R
X
1. (COCl)2 (1.2 equiv)
DCM, rt 1h
2. BnNH2 (1.1 equiv)
Et3N (1.25 equiv), DCM, rt 1h
3. Boc2O (1.3 equiv)
DMAP (10 mol %)
MeCN, rt 16 h
N
O
R
X
Bn
Boc
S1a-S1k S2a-S2k
S1a: R = H, X = I
S1b: R = 5-Me, X = I
S1c: R = 4-Me, X = Br
S1d: R = 5-MeO, X = I
S1e: R = 4-MeO, X = Br
S1f: R = 6-F, X = Br
S1g: R = 4-F, X = Br
S1h: R = 3-F, X = Br
S1i: R = 5-CF3, X = Br
S1j: R = 4-CF3, X = I
S1k: R = 4,5-F, X = Br
S2a: R = H, X = I
S2b: R = 5-Me, X = I
S2c: R = 4-Me, X = Br
S2d: R = 5-MeO, X = I
S2e: R = 4-MeO, X = Br
S2f: R = 6-F, X = Br
S2g: R = 4-F, X = Br
S2h: R = 3-F, X = Br
S2i: R = 5-CF3, X = Br
S2j: R = 4-CF3, X = I
S2k: R = 4,5-F, X = Br
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of DMF (1-2 drops).  The reaction was allowed to warm to room temperature and stirred for 1 
h. The solvent was removed under reduced pressure to afford the corresponding crude acid 
chloride.  To the crude acid chloride was added DCM (0.9 M) and triethylamine (1.25 equiv).  
Next, a solution of benzylamine (1.10 equiv) in DCM (0.5 M) was added dropwise.  The 
reaction mixture was stirred at room temperature for 1 h, then diluted with ethyl acetate, and 
washed successively with 1M HCl and brine.  The organic layer was dried over anhydrous 
sodium sulfate, and concentrated under reduced pressure.  The resulting crude material was 
used directly in the next step.  To the round-bottom flask containing the crude benzamide was 
added DMAP (0.10 equiv), acetonitrile (0.2 M) and Boc2O (1.30 equiv).  The reaction flask 
was then flushed with N2 and allowed to stir at room temperature for 16 h.  The reaction was 
quenched by addition of water, and extracted three times with ethyl acetate.  The organic layers 
were combined, dried over Na2SO4, filtered, and evaporated under reduced pressure.  The 
resulting crude ortho-halobenzamides (S2a-S2k) were used directly in the next step without 
further purification. 
 
tert-butyl benzyl(2-iodobenzoyl)carbamate (S2a):  Prepared according to 
general procedure A from ortho-iodobenzoic acid  S1a (7.61 g, 30.7 mmol).  
The reactions afforded crude product S2a as white solid in 80% yield (10.7 
g, 24.7 mmol). 1H NMR (400 MHz, CDCl3) d 1.14 (s, 9H), 5.05 (s, 2H), 
7.07 (td, J = 7.1, 1.5 Hz, 1H), 7.17 (dd, J = 7.6, 1.2 Hz, 1H), 7.29 (d, J = 7.2 Hz, 1H), 7.31-
7.38 (m, 3H), 7.47 (d, J = 8.0 Hz, 2H), 7.80 (d, J = 8.0 Hz, 1H). 13C NMR (101 MHz, CDCl3) 
d 27.5, 47.6, 83.9, 91.7, 127.0, 127.6, 127.9, 128.5, 128.6, 130.3, 137.5, 139.2, 144.6, 15.1, 
171.6. HRMS (ESI): Calcd. for C19H21INO3+ ([M+H]+): 438.0561, Found: 438.0556. 
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tert-butyl benzyl(2-iodo-5-methylbenzoyl)carbamate (S2b): Prepared 
according to general procedure A from 2-iodo-5-methylbenzoic acid S1b 
(2.62 g, 10.0 mmol). The reactions afforded crude product S2b as a 
colorless oil in 91% yield (4.01 g, 9.10 mmol). 1H NMR (400 MHz, CDCl3) δ 1.16 (s, 9H), 
2.30 (s, 3H), 5.05 (s, 2H), 6.90 (dd, J = 8.1, 1.5 Hz, 1H), 7.01 (d, J = 1.5 Hz, 1H), 7.28 (t, J = 
7.2 Hz, 1H), 7.32-7.38 (m, 2H), 7.48 (d, J = 7.2 Hz, 2H), 7.66 (d, J = 8.1 Hz, 1H). 13C NMR 
(101 MHz, CDCl3) δ 21.0, 27.5, 48.0, 83.7, 87.5, 127.5, 127.9, 128.5, 128.6, 131.3, 137.5, 
138.1, 138.9, 144.3, 152.1, 171.8. HRMS (ESI): Calcd. for C20H23INO3+ ([M+H]+): 452.0717, 
Found: 452.0720. 
 
tert-butyl benzyl(2-bromo-4-methylbenzoyl)carbamate (S2c): 
Prepared according to general procedure A from 2-bromo-4-
methylbenzoic acid S1c (2.15 g, 10.0 mmol). The reactions afforded crude 
product S2c as a colorless oil in 83% yield (3.36 g, 8.32 mmol).   1H NMR 
(400 MHz, CDCl3) d 1.17 (s, 9H), 2.35 (s, 3H), 5.05 (s, 2H), 7.12-7.18 (m, 2H), 7.26-7.30 (m, 
1H), 7.32-7.37 (m, 3H), 7.45-7.47 (m, 2H).  13C NMR (101 MHz, CDCl3) d 27.5, 48.0, 83.6, 
118.5, 127.4, 127.7, 128.0, 128.4, 128.5, 133.0, 133.1, 137.5, 137.6, 140.9, 152.3, 170.5. 
HRMS (ESI): Calcd. for C20H23BrNO3+ ([M+H]+): 404.0856, Found: 404.0828. 
 
tert-butyl benzyl(2-iodo-5-methoxybenzoyl)carbamate (S2d): 
Prepared according to general procedure A from 2-iodo-5-
methoxybenzoic acid S1d (2.78 g, 10.0 mmol). The reactions afforded 
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crude product S2d as a colorless oil in 81% yield (3.79 g, 8.10 mmol). 1H NMR (400 MHz, 
CDCl3) δ 1.17 (s, 9H), 3.75 (s, 3H), 5.04 (s, 2H), 6.67 (dd, J = 8.7, 3.0 Hz, 1H) 6.74 (d, J = 3.0 
Hz, 1H), 7.28 (d, J = 7.3 Hz, 1H), 7.31-7.37 (m, 2H), 7.47 (d, J = 7.3 Hz, 2H), 7.63 (d, J = 8.7 
Hz, 1H). 13C NMR (101 MHz, CDCl3) δ 27.5, 48.0, 55.6, 80.1, 83.8, 112.9, 116.9, 127.5, 
128.5, 128.6, 137.4, 139.8, 145.2, 152.0, 159.7, 171.3. HRMS (ESI): Calcd. for C20H23INO4+ 
([M+H]+): 468.0666, Found: 468.0665. 
 
tert-butyl benzyl(2-bromo-4-methoxybenzoyl)carbamate (S2e): 
Prepared according to general procedure A from 2-bromo-4-
methoxybenzoic acid S1e (2.31 g, 10.0 mmol). The reactions afforded 
crude product S2e as a yellow oil in 90% yield (3.80 g, 9.00 mmol). 
1H NMR (400 MHz, CDCl3) d 1.19 (s, 9H), 3.81 (s, 3H), 5.03 (s, 2H), 6.86 (dd, J = 8.6, 2.4 
Hz, 1H), 7.07 (d, J = 2.4 Hz, 1H), 7.21 (d, J = 8.6 Hz, 1H), 7.26-7.29 (m, 1H), 7.31-7.35 (m, 
2H), 7.42-7.46 (m, 2H). 13C NMR (101 MHz, CDCl3) d 27.6, 48.2, 53.6, 55.8, 83.5, 113.2, 
118.1, 119.7, 127.5, 128.5, 129.2, 132.6, 137.7, 152.4, 160.7, 170.5. HRMS (ESI): Calcd. for 
C20H22BrNO4+Na ([M+Na]+): 442.0624, Found: 442.0587. 
 
tert-butyl benzyl(2-bromo-6-fluorobenzoyl)carbamate (S2f): Prepared 
according to general procedure A from 2-bromo-6-fluorobenzoic acid S1f 
(2.19 g, 10.0 mmol). The reactions afforded crude product S2f as a white 
solid in 75% yield (3.05 g, 7.50 mmol). 1H NMR (400 MHz, CDCl3) d 1.18 
(s, 9H), 5.10 (s, 2H), 7.04-7.08 (m, 1H), 7.21 (m, 1H), 7.24-7.30 (m, 1H), 7.31-7.37 (m, 3H), 
7.41-7.45 (m, 2H). 13C NMR (101 MHz, CDCl3) d 27.5, 47.6, 84.2, 114.6 (d, J = 21.2 Hz, 1C), 
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119.2 (d, J = 5.05 Hz, 1C), 127.5, 128.1, 128.3 (d, J = 4.04 Hz, 1C), 128.5, 129.7, (d, J = 21.2 
Hz, 1C), 130.6 (d, J = 8.08 Hz, 1C), 137.2, 151.6, 158.4 (d J = 252.5 Hz, 1C), 165.4. 19F NMR 
(CDCl3, 376 MHz): d -114.1 (m, 1F). HRMS (ESI): Calcd. for C19H19BrFNO3+Na ([M+Na]+): 
430.0425, Found: 430.0387. 
 
tert-butyl benzyl(2-bromo-4-fluorobenzoyl)carbamate (S2g): 
Prepared according to general procedure A from 2-bromo-4-
fluorobenzoic acid S1g (2.19 g, 10.0 mmol). The reactions afforded crude 
product S2g as a white solid in 85% yield (3.47 g, 8.50 mmol). 1H NMR 
(400 MHz, CDCl3) d 1.20 (s, 9H), 5.04 (s, 2H), 7.06 (td, J = 8.0, 2.5 Hz, 1H), 7.24-7.36 (m, 
5H), 7.43-7.45 (m, 2H). 13C NMR (101 MHz, CDCl3) d 27.6, 48.1, 84.0. 114.7 (d, J = 21.2, 
1C), 119.3 (d, J = 9.09 Hz, 1C), 120.0 (d, J = 13.1 Hz, 1C), 120.2 (d, J = 14.1 Hz, 1C), 127.6, 
128.5, 129.2, 136.7 (d, J = 4.04 Hz, 1C), 137.4, 152.1, 162.5 (d, J = 254.5 Hz, 1C), 169.6. 19F 
NMR (CDCl3, 376 MHz): d -109.4 (m, 1F). HRMS (ESI): Calcd. for C19H19BrFNO3+Na 
([M+Na]+): 430.0425, Found: 430.0384. 
 
tert-butyl benzyl(2-bromo-3-fluorobenzoyl)carbamate (S2h): Prepared 
according to general procedure A from 2-bromo-3-fluorobenzoic acid S1h 
(2.19 g, 10.0 mmol). The reactions afforded crude product S2h as a white 
solid in 84% yield (3.43 g, 8.40 mmol). 1H NMR (400 MHz, CDCl3) d 1.17 
(s, 9H), 5.06 (s, 2H), 7.04 (dt, J = 7.6, 1.0 Hz, 1H), 7.14 (td, J = 8.4, 1.4 Hz, 1H), 7.27-7.37 
(m, 4H), 7.42-7.47 (m, 2H). 13C NMR (101 MHz, CDCl3) d 27.5, 47.9, 84.1, 106.4 (d, J = 23.2 
Hz, 1C), 116.7 (d, J = 22.2 Hz, 1C), 122.8 (d, J = 3.0 Hz, 1C), 127.7, 128.5, 128.6, 128.9 (d, J 
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= 8.1 Hz, 1C), 137.3, 142.6, 151.9, 159.0 (d, J = 248.5 Hz, 1C), 169.1. 19F NMR (CDCl3, 376 
MHz): d -106.1 (m, 1F). HRMS (ESI): Calcd. for C19H19BrFNO3+Na ([M+Na]+): 430.0425, 
Found: 430.0393. 
 
tert-butyl benzyl(2-bromo-5-(trifluoromethyl)benzoyl)carbamate 
(S2i): Prepared according to general procedure A from 2-bromo-5-
(trifluoromethyl)benzoic acid S1i (2.69 g, 10.0 mmol). The reactions 
afforded crude product S2i as a white solid in 88% yield (4.03 g, 8.80 
mmol). 1H NMR (400 MHz, CDCl3) d 1.16 (s, 9H), 5.07 (s, 2H), 7.28-7.38 (m, 3H), 7.45-7.51 
(m, 4H), 7.67 (d, J = 8.2 Hz, 1H). 13C NMR (101 MHz, CDCl3) d 27.5, 48.0, 84.4, 122.5, 
124.7 (q, J = 3.8 Hz, 1C), 126.1 (q, J = 274.0 Hz, 1C), 126.8 (q, J = 3.7 Hz, 1C), 127.7, 128.6, 
128.6, 130.3, 133.3, 137.1, 141.4, 151.7, 168.9. 19F NMR (CDCl3, 376 MHz): d -62.9 (s, 3F). 
HRMS (ESI): Calcd. for C20H19BrF3NO3+Na ([M+Na]+): 480.0393, Found: 480.0344. 
 
tert-butyl benzyl(2-iodo-4-(trifluoromethyl)benzoyl)carbamate 
(S2j): Prepared according to general procedure A from 2-iodo-4-
(trifluoromethyl)benzoic acid S1j (3.16 g, 10.0 mmol). The reactions 
afforded crude product S2j as a colorless oil in 91% yield (4.60 g, 9.10 
mmol). 1H NMR (400 MHz, CDCl3) d 1.19 (s, 9H), 5.08 (s, 2H), 7.27-7.38 (m, 4H), 7.49 (d, 
J = 8.0 Hz, 2H), 7.64 (dd, J = 8.0, 0.9 Hz, 1H), 8.06 (s, 1H). 13C NMR (101 MHz, CDCl3) d 
27.6, 47.8, 84.5, 91.1, 122.7 (q, J = 274.7, 1C), 124.5 (d, J = 22.2 Hz, 1C), 126.9 (d, J = 11.1 
Hz, 1C), 127.7 (q, J = 6.1 Hz, 1C), 128.6 (m, 1C), 128.7 (d, J = 9.1 Hz, 1C), 132.0 (q, J = 33.3 
Hz, 1C), 135.9 (dd, J = 15.2, 4.0 Hz, 1C), 137.1, 148.1, 151.6, 170.5. 19F NMR (CDCl3, 376 
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MHz): d -62.8 (s, 3F). HRMS (ESI): Calcd. for C20H20F3INO3+ ([M+H]+): 506.0434, Found: 
506.0450. 
 
tert-butyl benzyl(2-bromo-4,5-difluorobenzoyl)carbamate (S2k): 
Prepared according to general procedure A from 2-bromo-4,5-
difluorobenzoic acid S1k (2.37 g, 10.0 mmol). The reactions afforded 
crude product S2k as a white solid in 74% yield (3.16 g, 7.40 mmol). 1H 
NMR (400 MHz, CDCl3) d 1.24 (s, 9H), 5.03 (s, 2H), 7.14 (dd, J = 9.8, 7.9 Hz, 1H), 7.27-7.43 
(m, 6H). 13C NMR (101 MHz, CDCl3) d 27.6, 48.1, 84.4, 112.6 (dd, J = 7.4, 4.1 Hz, 1C), 
116.9, 117.1 (d, J = 2.0 Hz, 1C), 127.7, 128.5, 128.6 (d, J = 2.0 Hz, 1C), 137.0 (dd, J = 6.1, 
5.1 Hz, 1C), 137.1, 149.7 (dd, J = 252.5, 13.1 Hz, 1C), 150.4 (dd, J = 257.6, 14.1 Hz, 1C), 
151.9, 168.4. 19F NMR (CDCl3, 376 MHz): d -137.8 (m, 1F), -133.4 (m, 1F). HRMS (ESI): 
Calcd. for C19H19BrF2NO3+ ([M+H]+): 426.0511, Found: 426.0502. 
 
General Procedure B: Synthesis of o-Allylbenzamides 1a, 3a-j  
 
Pd(PPh3)4 (10 mol %)
CsF (3.88 equiv)
allylBpin (1.8 equiv)
THF, reflux, 24h
N
O
R
X
Bn
Boc
S2a-S2k
S2a: R = H, X = I
S2b: R = 5-Me, X = I
S2c: R = 4-Me, X = Br
S2d: R = 5-MeO, X = I
S2e: R = 4-MeO, X = Br
S2f: R = 6-F, X = Br
S2g: R = 4-F, X = Br
S2h: R = 3-F, X = Br
S2i: R = 5-CF3, X = Br
S2j: R = 4-CF3, X = I
S2k: R = 4,5-F, X = Br
N
O
R
Bn
Boc
1a, 3a-3j
1a: R = H
3a: R = 5-Me
3b: R = 4-Me
3c: R = 5-MeO
3d: R = 4-MeO
3e: R = 6-F
3f: R = 4-F
3g: R = 3-F
3h: R = 5-CF3
3i: R = 4-CF3
3j: R = 4,5-F
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  ortho-Allylbenzamides (1a, 3a-j) were prepared according to the following procedure. A 
round-bottom flask was charged with 3.00 mmol of ortho-iodobenzamide (S2a-S2k), CsF 
(1.77 g, 11.6 mmol), Pd(PPh3)4 (0.347 g, 0.300 mmol), and THF (37.5 mL).  The resulting 
solution was stirred at room temperature for 30 minutes.  Then 2-allyl-4,4,5,5-tetramethyl-
1,3,2-dioxaborolane (allylBpin) (0.907 g, 5.40 mmol) in THF (37.5 mL) was added.  The 
resulting solution was stirred at reflux for 24 hours. The reaction mixture was diluted with 
hexanes (100 mL) followed by water (100 mL).  The layers were separated, and the organic 
layer extracted with hexanes (2 x 100 mL).  The combined organic layers were washed with 
water (200 mL) and brine (200 mL), dried over Na2SO4, filtered, and concentrated under 
reduced pressure. Purifications of the crude products were carried out by flash column 
chromatography to give ortho-allylbenzamides 1a, 3a-j.  
 
tert-butyl (2-allylbenzoyl)(benzyl)carbamate (1a): Prepared according to 
general procedure B from tert-butyl benzyl(2-iodobenzoyl)carbamate S2a 
(1.31 g, 3.00 mmol).  The crude reaction mixture was purified by flash 
column chromatography (100:0 hexanes:EtOAc to 90:10 hexanes EtOAc) to 
give 1a as a colorless oil in 79% yield (0.830 g, 2.37 mmol).  1H NMR (400 MHz, CDCl3) d 
1.08 (s, 9H), 3.45 (d, J = 6.8 Hz, 1H), 5.03 (s, 2H), 5.03-5.10 (m, 2H), 5.92 (ddt, J = 17.0, 10.0, 
6.8 Hz, 1H), 7.12 (d, J = 7.6 Hz, 1H), 7.19 (t, J = 7.6 Hz, 1H), 7.22-7.37 (m, 5H), 7.45 (d, J = 
7.4 Hz, 2H).  13C NMR (101 MHz, CDCl3) d 27.5, 37.6, 48.1, 83.4, 116.6, 125.9, 126.1, 127.5, 
128.4, 128.6, 129.6, 129.8, 136.6, 137.3, 137.9, 138.2, 153.0, 172.4. HRMS (ESI): Calcd. for 
C22H26NO3+ ([M+H]+): 352.1907, Found: 352.1883. 
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tert-butyl (2-allyl-5-methylbenzoyl)(benzyl)carbamate (3a): Prepared 
according to general procedure B from tert-butyl (2-iodo-5-
methylbenzoyl)(benzyl)carbamate S2b (1.35 g, 3.00 mmol). The crude 
reaction mixture was purified by flash column chromatography (100:0 
hexanes:EtOAc to 90:10 Hexanes:EtOAc) to give 3a as a colorless oil in 78% yield (0.856 g, 
2.34 mmol).  1H NMR (400 MHz, CDCl3) d 1.09 (s, 9H), 2.30 (s, 3H), 3.41 (d, J = 8.0 Hz, 
2H), 5.03 (s, 2H), 5.01-5.08 (m, 2H), 5.91 (ddt, J = 17.0, 10.0, 8.0 Hz, 1H), 6.96 (s, 1H), 7.11-
7.16 (m, 2H), 7.26-7.30 (m, 1H), 7.33-7.37 (m, 2H), 7.45-7.47 (m, 2H).  13C NMR (101 MHz, 
CDCl3) d 20.9, 27.4, 37.2, 48.1, 83.3, 116.2, 126.7, 127.5, 128.4, 128.5, 129.8, 130.3, 134.3, 
135.4, 136.81, 137.9, 137.9, 153.1, 172.5. HRMS (ESI): Calcd. for C23H28NO3+ ([M+H]+): 
366.2064, Found: 366.2024. 
 
tert-butyl (2-allyl-5methoxybenzoyl)(benzyl)carbamate (3b): 
Prepared according to general procedure B from tert-butyl benzyl(2-
iodo-5-methoxybenzoyl)carbamate S2d (1.40 g, 3.00 mmol). The 
crude reaction mixture was purified by flash column chromatography 
(100:0 hexanes:EtOAc to 90:10 hexanes:EtOAc) to give 3b as a dark-green oil in 61% yield 
(0.698 g, 1.83 mmol).  1H NMR (400 MHz, CDCl3) d 1.14 (s, 9H), 3.38 (d, J = 6.8 Hz, 2H), 
3.76 (s, 3H), 5.02-5.08 (m, 2H), 5.04 (s, 2H), 5.91 (ddt, J = 17.0, 10.1, 6.8 Hz, 1H), 6.69 (d, J 
= 2.8 Hz, 1H), 6.89 (dd, J = 8.5, 2.8 Hz, 1H), 7.16 (d, J = 8.5 Hz, 1H), 7.28-7.31 (m, 1H), 7.34-
7.38 (m, 2H), 7.46-7.48 (m, 2H). 13C NMR (101 MHz, CDCl3) d 27.5, 36.7, 48.1, 55.5, 83.4, 
111.5, 115.4, 116.1, 127.5, 128.4, 128.5, 129.2, 130.9, 136.9, 137.8, 138.9, 152.9, 157.6, 172.1. 
HRMS (ESI): Calcd. for C23H27NO4+Na ([M+Na]+): 404.1832, Found: 404.1786. 
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tert-butyl (2-allyl-5-(trifluoromethyl)benzoyl)(benzyl)carbamate 
(3c): Prepared according to general procedure B from tert-butyl 
benzyl(2-bromo-5-(trifluoromethyl)benzoyl)carbamate S2i (1.37 g, 
3.00 mmol). The crude reaction mixture was purified by flash column 
chromatography (100:0 hexanes:EtOAc to 95:5 hexanes:EtOAc) to give 3c as a colorless oil 
as an 84:16 mixture of 3c and the olefin isomerization product in 70% yield  (0.879 g, 2.10 
mmol). 1H NMR (400 MHz, CDCl3) d 1.10 (s, 9H), 3.46 (d, J = 6.8 Hz, 2H), 5.05 (s, 2H), 
5.06-5.11 (m, 2H), 5.81-5.93 (m, 1H), 7.27-7.40 (m, 5H), 7.45 (d, J = 7.2 Hz, 2H) 7.58 (dd, J 
= 7.9, 3.1 Hz, 1H). 13C NMR (101 MHz, CDCl3) d 27.3, 37.3, 48.0, 83.9, 117.4, 122.9 (q, J = 
3.7 Hz, 1C), 125.9 (q, J = 3.8 Hz, 1C), 127.0 (q, J = 273.4 Hz, 1C), 127.6, 128.3, 128.5, 128.7, 
130.2, 131.5, 135.2, 137.3, 138.7, 141.0, 152.3, 170.8,. 19F NMR (376 MHz, CDCl3) d -62.6 
(m, 1F). HRMS (ESI): Calcd. for C23H25F3NO3+ ([M+H]+): 420.1781, Found: 420.1720. 
 
tert-butyl benzyl(2-allyl-4-methoxybenzoyl)carbamate (3d): 
Prepared according to general procedure B from tert-butyl benzyl(2-
bromo-4-methoxybenzoyl)carbamate S2e (1.26 g, 3.00 mmol). The 
crude reaction mixture was purified by flash column chromatography 
(100:0 hexanes:EtOAc to 90:10 hexanes:EtOAc) to give 3d as a colorless oil in 34% yield 
(0.386 g, 1.01 mmol). 1H NMR (400 MHz, CDCl3) d 1.13 (s, 9H), 3.48 (d, J = 6.8 Hz, 2H), 
3.80 (s, 3H), 4.99 (s, 2H), 5.04-5.12 (m, 2H), 5.92 (ddt, J = 17.2, 10.0, 6.8 Hz, 1H), 6.70 (dd, 
J = 8.5, 2.4 Hz, 1H), 6.78 (d, J = 2.4 Hz, 1H), 7.12 (d, J = 8.5 Hz, 1H), 7.24-7.29 (m, 1H), 
7.31-7.35 (m, 2H), 7.42-7.44 (m, 2H). 13C NMR (101 MHz, CDCl3) d 27.6, 37.7, 48.4, 55.4, 
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83.1, 110.9, 115.5, 116.6, 127.5, 128.3, 128.4, 128.5, 130.5, 136.5, 138.0, 140.2, 153.3, 160.8, 
172.4. HRMS (ESI): Calcd. for C23H27NO4+Na ([M+Na]+): 404.1832, Found: 404.1782. 
 
 tert-butyl (2-allyl-4-methylbenzoyl)(benzyl)carbamate (3e): Prepared 
according to general procedure B from tert-butyl benzyl(2-bromo-4-
methylbenzoyl)carbamate S2c (1.21 g, 3.00 mmol). The crude reaction 
mixture was purified by flash column chromatography (100:0 
hexanes:EtOAc to 90:10 hexanes:EtOAc) to give 3e as a colorless oil in 28% yield (0.310 g, 
0.848 mmol). 1H NMR (400 MHz, CDCl3) d 1.11 (s, 9H), 2.34 (s, 3H), 3.44 (d, J = 8.0 Hz, 
2H), 5.01 (s, 2H), 5.05-5.10 (m, 2H), 5.93 (ddt, J = 17.0, 10.0, 6.9 Hz, 1H), 6.99 (d, J = 8.0 
Hz, 1H), 7.05 (d, J = 8.0 Hz, 1H), 7.05-7.07 (m, 1H), 7.24-7.30 (m, 1H), 7.30-7.37 (m, 2H), 
7.44 (d, J = 8.0 Hz, 2H). 13C NMR (101 MHz, CDCl3) d 21.5, 27.5, 37.6, 48.2, 83.2, 116.3, 
126.4, 126.5, 127.5, 128.3, 128.5, 130.6, 135.3, 136.8 137.5, 138.0, 139.8, 153.1, 172.6.  
HRMS (ESI): Calcd. for C23H28NO3+ ([M+H]+): 366.2064, Found: 366.2027. 
 
tert-butyl (2-allyl-4-fluorobenzoyl)(benzyl)carbamate (3f): Prepared 
according to general procedure B from tert-butyl benzyl(2-bromo-4-
fluorobenzoyl)carbamate S2g (1.22 g, 3.00 mmol). The crude reaction 
mixture was purified by flash column chromatography (100:0 
hexanes:EtOAc to 90:10 hexanes:EtOAc) to give 3f as a colorless oil in 51% yield (0.568 g, 
1.54 mmol). 1H NMR (400 MHz, CDCl3) d 1.14 (s, 9H), 3.44 (d, J = 6.9 Hz, 2H), 5.01 (s, 2H), 
5.06-5.12 (m, 2H), 5.89 (ddt, J = 17.4, 9.6, 6.9 Hz, 1H), 6.89 (td, J = 8.5, 2.4 Hz, 1H), 6.97 
(dd, J = 9.8, 2.4 Hz, 1H), 7.12 (dd, J = 8.5, 5.7 Hz, 1H), 7.26-7.30 (m, 1H), 7.32-7.36 (m, 2H), 
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7.42-7.44 (m, 2H). 13C NMR (101 MHz, CDCl3) d 27.6, 37.4, 48.2, 83.6, 112.8 (d, J = 21.2 
Hz, 1C), 116.7 (d, J = 22.2 Hz, 1C), 117.4, 127.61, 128.1 (d, J = 9.1 Hz, 1C), 128.4, 128.6, 
134.3 (d, J = 3.0 Hz, 1C), 135.6, 137.7 140.6 (d, J = 7.1 Hz, 1C), 152.9, 163.3 (d, J = 250.5 
Hz, 1C), 171.6. 19F NMR (376 MHz, CDCl3) d -110.9 (m, 1F). HRMS (ESI): Calcd. for 
C22H24FNO3+Na ([M+Na]+): 392.1632, Found: 392.1596. 
 
tert-butyl (2-allyl-4-(trifluoromethyl)benzoyl)(benzyl)carbamate 
(3g): Prepared according to general procedure B from tert-butyl 
benzyl(2-iodo-4-(trifluoromethyl)benzoyl)carbamate S2j (1.52 g, 3.00 
mmol). The crude reaction mixture was purified by flash column 
chromatography (100:0 hexnaes:EtOAc to 90:10 hexanes:EtOAc) to give 3g as a colorless oil 
in 81% yield (1.02 g, 2.43 mmol). 1H NMR (400 MHz, CDCl3) d 1.12 (s, 9H), 3.45 (d, J = 6.8 
Hz, 2H), 5.05 (s, 2H), 5.06-5.12 (m, 2H), 5.89 (ddt, J = 16.8, 10.3, 6.8 Hz, 1H), 7.23 (d, J = 
8.0 Hz, 1H), 7.27-7.32 (m, 1H), 7.34-7.38 (m, 2H), 7.43-7.51 (m, 4H).  13C NMR (101 MHz, 
CDCl3) d 22.5, 37.4, 47.9, 84.1, 117.7, 122.9 (q, J = 3.75 Hz, 1C), 126.1, 126.5 (q, J = 4.0 Hz, 
1C), 127.0 (q, J = 274.1 Hz, 1C), 127.7, 128.5, 128.6, 131.2, 135.2, 137.5, 137.9, 141.8, 152.4, 
171.1. 19F NMR (376 MHz, CDCl3) d -62.6 (s, 3F). HRMS (ESI): Calcd. for C23H24F3NO3+Na 
([M+Na]+): 442.1600, Found: 442.1550. 
 
tert-butyl (2-allyl-3-fluorobenzoyl)(benzyl)carbamate (3h): Prepared 
according to general procedure B from tert-butyl benzyl(3-fluoro-2-
bromobenzoyl)carbamate S2h (1.22 g, 3.00 mmol). The crude reaction 
mixture was purified by flash column chromatography (100:0 
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hexanes:EtOAc to 90:10 hexanes:EtOAc) to give 3h as a colorless oil in 71% yield (0.787 g, 
2.13 mmol). 1H NMR (400 MHz, CDCl3) d 1.12, (s, 9H), 3.43 (d, J = 6.0 Hz, 2H), 4.97-5.05 
(m, 2H), 5.03 (s, 2H), 5.89 (ddt, J = 17.1, 10.0, 6.6 Hz, 1H), 6.93 (dd, J = 7.6, 0.6 Hz, 1H), 
7.05-7.09 (m, 1H), 7.18 (m, 1H), 7.27-7.30 (m, 1H), 7.33-7.37 (m, 2H), 7.43-7.45 (m, 2H). 13C 
NMR (101 MHz, CDCl3) d 27.5, 30.7, 48.0, 83.8, 116.27, 116.3, 116.5, 121.7 (d, J = 3.0 Hz, 
1C), 124.6 (d, J = 17.2 Hz, 1C), 127.4 (d, J = 9.1 Hz, 1C), 127.6, 128.5 (d, J = 15.2 Hz, 1C), 
135.2, 137.7, 140.4 (d, J = 5.1 Hz, 1C), 152.7, 161.4 (d, J = 248.5 Hz, 1C), 170.9 (d, J = 3.0 
Hz, 1C). 19F NMR (376 MHz, CDCl3) d -116.6 (m, 1F). HRMS (ESI): Calcd. for 
C22H24FNO3+Na ([M+Na]+): 392.1632, Found: 392.1587. 
 
tert-butyl (2-allyl-6-fluorobenzoyl)(benzyl)carbamate (3i): Prepared 
according to general procedure B from tert-butyl benzyl(2-bromo-6-
fluorobenzoyl)carbamate S2f (1.22 g, 3.00 mmol). The crude reaction 
mixture was purified by flash column chromatography (100:0 
hexanes:EtOAc to 90:10 hexanes:EtOAc) to give 3i as a colorless oil in 89% yield (0.984 g, 
2.66 mmol). 1H NMR (400 MHz, CDCl3) d 1.16 (s, 9H), 3.37 (dd, J = 22.6, 7.2 Hz, 2H), 4.99-
5.05 (m, 2H), 5.09 (d, J = 4.6 Hz, 2H), 5.86 (ddt, J = 17.6, 9.6, 6.8 Hz, 1H), 6.91 (t, J = 9.6 
Hz, 1H), 7.03 (d, J = 7.6 Hz, 1H), 7.24-7.30 (m, 2H), 7.32-7.36 (m, 2H), 7.42-7.44 (m, 2H).  
13C NMR (101 MHz, CDCl3) d 27.4 (d, J = 4.0 Hz, 1C), 37.4, 47.6, 83.7, 112.9, 113.1, 116.9, 
125.3 (d, J = 2.0 Hz, 1C), 126.9 (d, J = 17.2 Hz, 1C), 127.8 (d, J = 74.7 Hz, 1C), 128.5, 130.1 
(d, J = 8.1 Hz, 1C), 135.8 (d, J = 6.1 Hz, 1C), 137.6, 139.1 (d, J = 3.0 Hz, 1C), 152.1, 158.3 
(d, J = 247.5 Hz, 1C), 167.25. 19F NMR (376 MHz, CDCl3) d -117.7 (m, 1F). HRMS (ESI): 
Calcd. for C22H24FNO3+Na ([M+Na]+): 392.1632, Found: 392.1598.  
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tert-butyl (2-allyl-4,5-difluorobenzoyl)(benzyl)carbamate (3j): 
Prepared according to general procedure B from tert-butyl benzyl(4,5-
difluoro-2-bromobenzoyl)carbamate S2k (1.28 g, 3.00 mmol). The crude 
reaction mixture was purified by flash column chromatography (100:0 
DCM:EtOAc to 90:10 DCM:EtOAc) to give 3j as a colorless oil in 61% yield (0.709 g, 1.83 
mmol). 1H NMR (400 MHz, CDCl3) d 1.19 (s, 9H), 3.36 (d, J = 6.8 Hz, 2H), 5.00 (s, 2H), 
5.03-5.10 (m, 2H), 5.84 (ddt, J = 16.9, 10.2, 6.8 Hz, 1H), 6.97 (dd, J = 10.2, 7.8 Hz, 1H), 7.06 
(dd, J = 11.2, 7.6 Hz, 1H), 7.27-7.31 (m, 1H), 7.33-7.38 (m, 2H), 7.39-7.43 (m, 2H).  13C NMR 
(101 MHz, CDCl3) d 27.5, 36.6, 48.1, 83.9, 115.3 (d, J = 19.2 Hz, 1C), 117.4, 118.5 (d, J = 
18.2 Hz, 1C), 127.6, 128.36 (d, J = 29.3 Hz, 1C), 128.37 (d, J = 10.1 Hz, 1C), 134.2 (dd, J = 
5.1 Hz, 1C), 134.5 (dd, J = 5.1 Hz, 1C), 135.3, 137.3, 148.2 (dd, J = 249.6, 13.2 Hz, 1C), 150.5 
(dd, J = 248.2, 12.6 Hz, 1C), 152.4, 170.1. 19F NMR (376 MHz, CDCl3) d -141.3 (m, 1F) -
135.8 (m, 1F). HRMS (ESI): Calcd. for C22H23F2NO3+Na ([M+Na]+): 410.1538, Found: 
410.1492. 
 
General Procedure C: Synthesis of 2-Benzyl-2,3-dihydro-1H-inden-1-ones 2a-2t, 4a-4j 
 
N
O
Bn
Boc
1a
O
Ar
2a-t
Ni(cod)2 (10 mol %)
SIPr (10 mol %)
ArBpin (3 equiv)
K3PO4 (2 equiv)
H2O (2 equiv)
THF, 60 °C
O
R
2a: R = H
2b: R = OMe
2c: R = Me
2d: R = Ph
2e: R = CH2OMe
2f: R = F
2g: R = Cl
2h: R = C(O)Me
2i: R = C(O)Ph
2j: R = CF3
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2-benzyl-2,3-dihydro-1H-inden-1-ones 2a-2t, 4a-4j were prepared by the following 
procedure. A 1-dram vial was charged with 0.100 mmol of the appropriate o-allylbenzamide 
1a, 3a-3j, Ni(cod)2 (2.8 mg, 0.010 mmol ), SIPr (3.9 mg, 0.010 mmol), K3PO4 (42.5 mg, 0.200 
mmol), H2O (3.6 µL, 0.20 mmol), the appropriate ArBpin (0.300 mmol), and THF (0.10-0.20 
mL, 0.50-1.0 M).   The resulting solution stirred at 60 °C for 12-16 hours.  Upon completion 
of the reaction, the reaction mixture was filtered through a short plug of silica gel eluting with 
70:30 hexanes:EtOAc and concentrated under reduced pressure. The crude product was 
purified by column chromatography with a gradient of 100:0 hexanes:EtOAc to 90:10 
hexanes:EtOAc over a 25 minute period on a Combiflash system. 
O
R
2k: R = OMe
2l: R = Me
2m: R = F
2n: R = Cl
O
R
2o: R = OMe
2p: R = Me
O O
X
2q 2s: X = O
2t: X = S
N
O
R
Bn
Boc
3a-3j
3a: R = 5-Me
3b: R = 4-Me
3c: R = 5-MeO
3d: R = 4-MeO
3e: R = 6-F
3f: R = 4-F
3g: R = 3-F
3h: R = 5-CF3
3i: R = 4-CF3
3j: R = 4,5-F
O
Ph
4a-4j
Ni(cod)2 (10 mol %)
SIPr (10 mol %)
PhBpin (3 equiv)
K3PO4 (2 equiv)
H2O (2 equiv)
THF, 60 °C
4a: R = 5-Me
4b: R = 4-Me
4c: R = 5-MeO
4d: R = 4-MeO
4e: R = 6-F
4f: R = 4-F
4g: R = 3-F
4h: R = 5-CF3
4i: R = 4-CF3
4j: R = 4,5-F
R
101 
2-benzyl-2,3-dihydro-1H-inden-1-one (2a): Prepared according to 
general procedure C from tert-butyl (2-allylbenzoyl)(benzyl)carbamate 
1a (35.1 mg, 0.100 mmol) and phenylboronic acid pinacol ester (61.2 
mg, 0.300 mmol).  The crude reaction mixture was purified by flash 
column chromatography (100:0 hexanes:EtOAc to 90:10 hexanes:EtOAc) to give 2a as a 
colorless oil in 97% yield (21.6 mg, 0.097 mmol). 1H NMR (400 MHz, CDCl3) d 2.68 (dd, J 
= 14.0, 10.4 Hz, 1H), 2.88 (dd, J = 17.2, 4.0 Hz, 1H), 2.97-3.06 (m, 1H), 3.18 (dd, J = 17.2, 
7.8 Hz, 1H), 3.42 (dd, J = 14.0, 4.2 Hz, 1H), 7.20-7.34 (m, 5H), 7.35-7.43 (m, 2H), 7.58 (t, J 
= 7.6 Hz, 1H), 7.80 (d, J = 7.6 Hz, 1H). 13C NMR (101 MHz, CDCl3) d 32.3, 37.1, 49.1, 124.1, 
126.5, 126.7, 127.5, 128.6, 129.0, 134.9, 136.7, 139.8, 153.7, 207.9. HRMS (ESI): Calcd. for 
C16H14O+Na ([M+Na]+): 245.0937, Found: 245.0902. 
 
2-(4-methoxybenzyl)-2,3-dihydro-1H-inden-1-one (2b): Prepared 
according to general procedure C from tert-butyl (2-
allylbenzoyl)(benzyl)carbamate 1a (35.1 mg, 0.100 mmol) and 4-
methoxyphenylboronic acid pinacol ester (70.2 mg, 0.300 mmol).  
The crude reaction mixture was purified by flash column chromatography (100:0 
hexanes:EtOAC to 90:10 hexanes:EtOAc) to give 2b as a colorless oil in 98% yield (24.8 mg, 
0.098 mmol).  1H NMR (400 MHz, CDCl3) d 2.65 (dd, J = 14.0, 10.1 Hz, 1H), 2.86 (dd, J = 
17.2, 4.0 Hz, 1H), 2.93-3.00 (m, 1H), 3.17 (dd, J = 17.2, 7.7 Hz, 1H), 3.31 (dd, J = 14.0, 4.3 
Hz, 1H), 3.79 (s, 3H), 6.84 (ddd, J = 8.7, 3.0, 2.1 Hz, 2H), 7.16 (ddd, J = 8.7, 3.0, 2.0 Hz, 2H), 
7.35-7.41 (m, 2H), 7.57 (ddd, J = 7.6, 7.6, 1.2 Hz, 1H), 7.78 (d, J = 8.0 Hz, 1H). 13C NMR 
(101 MHz, CDCl3) d 32.2, 36.2, 49.3, 55.4, 114.0, 124.1, 126.7, 127.5, 130.0, 131.7, 134.9, 
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136.7, 153.8, 158.3, 208.1. HRMS (ESI): Calcd. for C17H17O2+ ([M+H]+): 253.1223, Found: 
253.1225. 
 
2-(4-methylbenzyl)-2,3-dihydro-1H-inden-1-one (2c): Prepared 
according to general procedure C from tert-butyl (2-
allylbenzoyl)(benzyl)carbamate 1a (35.1 mg, 0.100 mmol) and 4-
tolylboronic acid pinacol ester (65.4 mg, 0.300 mmol).  The crude 
reaction mixture was purified by flash column chromatography (100:0 hexanes:EtOAc to 
90:10 hexanes:EtOAc) to give 2c as a colorless oil in 99% yield (23.4 mg, 0.099 mmol). 1H 
NMR (400 MHz, CDCl3) d 2.33 (s, 3H), 2.64 (dd, J = 14.0, 10.4 Hz, 1H), 2.86 (dd, J = 17.2, 
3.9 Hz, 1H), 2.95-3.02 (m, 1H), 3.17 (dd, J = 17.2, 7.8 Hz, 1H), 3.36 (dd, J = 14.0, 4.2 Hz, 
1H), 7.10-7.15 (m, 4H), 7.35-7.41 (m, 2H), 7.57 (ddd, J = 7.6, 7.6, 1.1 Hz, 1H), 7.78 (d, J = 
7.7 Hz, 1H). 13C NMR (101 MHz, CDCl3) d 21.3, 32.3, 36.7, 49.2, 124.1, 126.6, 127.5, 128.9, 
129.3, 134.8, 136.0, 136.66, 136.73, 153.8, 208.1. HRMS (ESI): Calcd. for C17H17O+ 
([M+H]+): 237.1274, Found: 237.1272. 
 
2-([1,1’-biphenyl]-4-ylmethyl)-2,3-dihydro-1H-inden-1-one (2d): 
Prepared according to general procedure C from tert-butyl (2-
allylbenzoyl)(benzyl)carbamate 1a (35.1 mg, 0.100 mmol) and 4-
biphenylboronic acid pinacol ester (84.1 mg, 0.300 mmol).  The crude 
reaction mixture was purified by flash column chromatography (100:0 hexanes:EtOAc to 
90:10 hexanes:EtOAc) to give 2d as a colorless oil in 94% yield (27.9 mg, 0.094 mmol). 1H 
NMR (400 MHz, CDCl3) d 2.73 (dd, J = 14.0, 10.4 Hz, 1H), 2.91 (dd, J = 17.2, 4.0 Hz, 1H), 
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3.02-3.08 (m, 1H), 3.23 (dd, J = 17.2, 7.8 Hz, 1H), 3.44 (dd, J = 14.0, 4.3 Hz, 1H), 7.32-7.46 
(m, 7H), 7.53-7.60 (m, 5H), 7.81 (d, J = 7.5 Hz, 1H). 13C NMR (101 MHz, CDCl3) d 32.4, 
36.8, 49.0, 124.2, 126.7, 127.1, 127.3, 127.4, 127.6, 128.9, 129.5, 135.0, 136.7, 138.9, 139.4, 
141.0, 153.8, 207.9. HRMS (ESI): Calcd. for C22H19O+ ([M+H]+): 299.1430, Found: 
299.1433. 
 
2-(4-(methoxymethyl)benzyl)-2,3-dihydro-1H-inden-1-one (2e): 
Prepared according to general procedure C from tert-butyl (2-
allylbenzoyl)(benzyl)carbamate 1a (35.1 mg, 0.100 mmol) and 4-
(methoxymethyl)phenylboronic acid pinacol ester (74.4 mg, 0.300 
mmol).  The crude reaction mixture was purified by flash column chromatography (100:0 
hexanes:EtOAc to 90:10 hexanes:EtOAc) to give 2e as a colorless oil in 78% yield (20.7 mg, 
0.078 mmol). 1H NMR (400 MHz, CDCl3) d 2.68 (dd, J = 13.8, 11.0 Hz, 1H), 2.84 (dd, J = 
17.2, 3.8 Hz, 1H), 2.96-3.03 (m, 1H), 3.16 (dd, J = 17.1, 7.8 Hz, 1H), 3.36-3.40 (m, 4H), 4.42 
(s, 2H), 7.22-7.28 (m, 4H), 7.34-7.40 (m, 2H), 7.56 (dd, J = 7.5, 7.5 Hz, 1H), 7.78 (d, J = 7.7 
Hz, 1H). 13C NMR (101 MHz, CDCl3) d 32.3, 36.8, 49.0, 58.3, 74.6, 124.2, 126.7, 127.6, 
128.2, 129.1, 134.9, 136.4, 136.8, 138.2, 153.8, 207.91. HRMS (ESI): Calcd. for C18H19O2+ 
([M+H]+): 267.1380, Found: 267.1383. 
 
2-(4-fluorobenzyl)-2,3-dihydro-1H-inden-1-one (2f): Prepared 
according to general procedure C from tert-butyl (2-
allylbenzoyl)(benzyl)carbamate 1a  (35.1 mg, 0.100 mmol) and 4-
fluorophenylboronic acid pinacol ester (66.7 mg, 0.300 mmol).  The 
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crude reaction mixture was purified by flash column chromatography (100:0 hexanes:EtOAc 
to 90:10 hexanes:EtOAc) to give 2f as a colorless oil in 98% yield (23.6 mg, 0.098 mmol). 1H 
NMR (400 MHz, CDCl3) d 2.70 (dd, J = 14.0, 10.0 Hz, 1H), 2.83 (dd, J = 17.1, 4.0 Hz, 1H), 
2.93-3.00 (m, 1H), 3.18 (dd, J = 17.1, 7.8 Hz, 1H), 3.33 (dd, J = 14.0, 4.3 Hz, 1H), 6.95-7.00 
(m, 2H), 7.18-7.21 (m, 2H), 7.35-7.41 (m, 2H), 7.57 (ddd, J = 7.7, 7.7, 1.0 Hz, 1H), 7.77 (d, J 
= 7.6 Hz, 1H). 13C NMR (101 MHz, CDCl3) d 32.2, 36.2, 49.0, 115.4 (d, J = 21.0 Hz), 124.2, 
126.7, 127.6, 130.5 (d, J = 7.8 Hz), 135.0, 135.3 (d, J = 3.2 Hz), 136.6, 153.6, 161.6 (d, J = 
243 Hz), 207.7. 19F NMR (376 MHz, CDCl3) d -116.9 (m, 1F). HRMS (ESI): Calcd. for 
C16H14FO+ ([M+H]+): 241.1023, Found: 241.1023. 
 
2-(4-chlorobenzyl)-2,3-dihydro-1H-inden-1-one (2g): Prepared 
according to general procedure C from tert-butyl (2-
allylbenzoyl)(benzyl)carbamate 1a  (35.1 mg, 0.100 mmol) and 4-
chlorophenylboronic acid pinacol ester (71.5 mg, 0.300 mmol). The 
crude reaction mixture was purified by flash column chromatography (100:0 hexanes:EtOAc 
to 90:10 hexanes:EtOAc) to give 2g as a colorless oil in 85% yield (21.8 mg, 0.085 mmol). 1H 
NMR (400 MHz, CDCl3) d 2.70 (dd, J = 14.0, 10.0 Hz, 1H), 2.83 (dd, J = 17.2, 4.2 Hz, 1H), 
2.94-3.00 (m, 1H), 3.18 (dd, J = 17.1, 7.8 Hz, 1H), 3.34 (dd, J = 14.0, 4.4 Hz, 1H), 7.18 (d, J 
= 8.5, 2H), 7.26 (d, J = 8.5 Hz, 2H), 7.36-7.42 (m, 2H), 7.58 (td, J = 7.6, 1.2 Hz, 1H), 7.78 (d, 
J = 7.7 Hz, 1H).   13C NMR (101 MHz, CDCl3) d 32.2, 36.4, 48.8, 124.3, 126.7, 127.7, 128.8, 
130.4, 132.3, 135.1, 136.6, 138.1, 153.6, 207.6. HRMS (ESI): Calcd. for C16H14ClO+ 
([M+H]+): 257.0728, Found: 257.0726. 
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2-(4-acetylbenzyl)-2,3-dihydro-1H-inden-1-one (2h): Prepared 
according to general procedure C from tert-butyl (2-
allylbenzoyl)(benzyl)carbamate 1a  (35.1 mg, 0.100 mmol) and 4-
acetylboronic acid pinacol ester (73.8 mg, 0.300 mmol).  The crude 
reaction mixture was purified by flash column chromatography (100:0 hexanes:EtOAc to 
90:10 hexanes:EtOAc) to give 2h as a white solid in 76 % yield (20.1 mg, 0.076 mmol). 1H 
NMR (400 MHz, CDCl3) d 2.58 (s, 3H), 2.75-2.85 (m, 2H), 2.98-3.05 (m, 1H), 3.18 (dd, J = 
17.1, 7.9 Hz, 1H), 3.42 (dd, J = 14.0, 4.4 Hz, 1H), 7.34 (d, J = 8.1 Hz, 2H), 7.39 (dd, J = 7.5., 
7.5 Hz, 2H), 7.58 (dd, J = 7.5, 7.5 Hz, 1H), 7.78 (d, J = 7.6 Hz, 1H), 7.90 (d, J = 7.7 Hz, 1H). 
13C NMR (101 MHz, CDCl3) d 23.7, 32.2, 37.0, 48.6, 124.2, 126.7, 127.7, 128.8, 129.3, 135.1, 
135.7, 136.5, 145.5, 153.5, 197.9, 207.4. HRMS (ESI): Calcd. for C18H17O2+ ([M+H]+): 
265.1223, Found: 265.1226. 
 
2-(4-benzoylbenzyl)-2,3-dihydro-1H-inden-1-one (2i): Prepared 
according to general procedure C from tert-butyl (2-
allylbenzoyl)(benzyl)carbamate 1a (35.1 mg, 0.100 mmol) and 4-
benzoylphenylboronic acid pinacol ester (92.5 mg, 0.300 mmol).  
The crude reaction mixture was purified by flash column chromatography (100:0 
hexanes:EtOAc to 80:20 hexanes:EtOAc) to give 2i as a white solid in 54% yield (17.5 mg, 
0.054 mmol). 1H NMR (400 MHz, CDCl3) d 2.80 (dd, J = 14.0, 10.2 Hz, 1H), 2.87 (dd, J = 
17.1, 3.9 Hz, 1H), 3.02-3.08 (m, 1H), 3.22 (dd, J = 17.0, 7.8 Hz, 1H), 3.47 (dd, J = 17.0, 4.3 
Hz, 1H), 7.36-7.43 (m, 4H), 7.47-7.50 (m, 2H), 7.57-7.61 (m, 2H), 7.75-7.80 (m, 5H). 13C 
NMR (101 MHz, CDCl3) d 32.3, 37.1, 48.7, 124.2, 126.7, 127.7, 128.4, 129.0, 130.1, 130.6, 
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132.4, 135.1, 135.9, 136.5, 137.8, 144.9, 153.5, 196.5, 207.4. HRMS (ESI): Calcd. for 
C23H19O2+ ([M+H]+): 327.1380, Found: 327.1382. 
 
2-(4-(trifluoromethyl)benzyl)-2,3-dihydro-1H-inden-1-one (2j): 
Prepared according to general procedure C from tert-butyl (2-
allylbenzoyl)(benzyl)carbamate 1a (35.1 mg, 0.100 mmol) and 4-
(trifluoromethyl)phenylboronic acid pinacol ester (81.6 mg, 0.300 
mmol).  The crude reaction mixture was purified by flash column chromatography (100:0 
hexanes:EtOAc to 90:10 hexanes:EtOAc) to give 2j as colorless oil in 69% yield (19.9 mg, 
0.069 mmol). 1H NMR (400 MHz, CDCl3) d 2.74-2.85 (m, 2H), 2.93-3.00 (m, 1H), 3.20 (dd, 
J = 17.0, 7.8 Hz, 1H), 3.43 (dd, J = 14.0, 4.3 Hz, 1H), 7.35-7.42 (m, 4H), 7.55-7.61 (m, 3H), 
7.79 (d, J = 7.7 Hz, 1H). 13C NMR (101 MHz, CDCl3) d 32.3, 36.9, 48.7, 110.2, 124.3, 125.6 
(q, J = 3.8 Hz), 126.7, 127.8, 129.1 (q, J = 235 Hz), 129.4, 132.6, 135.2, 136.5, 143.9, 207.31. 
19F NMR (376 MHz, CDCl3) d -62.4 (s, 1F). HRMS (ESI): Calcd. for C17H14F3O+ ([M+H]+): 
291.0991, Found: 291.0992. 
 
2-(3-methoxybenzyl)-2,3-dihydro-1H-inden-1-one (2k):  Prepared 
according to general procedure C from tert-butyl (2-
allylbenzoyl)(benzyl)carbamate 1a (35.1 mg, 0.100 mmol) and 3-
methoxyphenylboronic acid pinacol ester (70.2 mg, 0.300 mmol).  The 
crude reaction mixture was purified by flash column chromatography (100:0 hexanes:EtOAc 
to 90:10 hexanes:EtOAc) to give 2k as a colorless oil in 96% yield (24.3 mg, 0.096 mmol). 1H 
NMR (400 MHz, CDCl3) d 2.64 (dd, J = 13.9, 10.5 Hz, 1H), 2.87 (dd, J = 17.2, 4.0 Hz, 1H), 
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2.96-3.03 (m, 1H), 3.18 (dd, J = 17.2, 7.8 Hz, 1H), 3.38 (dd, J = 14.0, 4.2 Hz, 1H), 3.79 (s, 
3H), 6.75-6.85 (m, 3H), 7.22 (dd, J = 7.9, 7.9 Hz, 1H), 7.35-7.42 (m, 2H), 7.57 (ddd, J = 7.6, 
7.6, 1.2 Hz, 1H), 7.78 (d, J = 7.7 Hz, 1H). 13C NMR (101 MHz, CDCl3) d 32.4, 37.2, 49.0, 
55.3, 111.8, 114.7, 121.4, 124.2, 126.7, 127.6, 129.6, 135.0, 136.7, 141.4, 153.8, 160.0, 207.9. 
HRMS (ESI): Calcd. for C17H17O2+ ([M+H]+): 253.1223, Found: 253.1227. 
 
2-(3-methylbenzyl)-2,3-dihydro-1H-inden-1-one (2l): Prepared 
according to general procedure C from tert-butyl (2-
allylbenzoyl)(benzyl)carbamate 1a (35.1 mg, 0.100 mmol) and 3-
tolylboronic acid pinacol ester (65.4 mg, 0.300 mmol).  The crude 
reaction mixture was purified by flash column chromatography (100:0 hexanes:EtOAc to 
90:10 hexanes:EtOAc) to give 2l as a white solid in 85% yield (20.0 mg, 0.085 mmol). 1H 
NMR (400 MHz, CDCl3) d 2.34 (s, 3), 2.61 (dd, J = 13.9, 10.6 Hz, 1H), 2.86 (dd, J = 17.2, 3.9 
Hz, 1H), 2.96-3.03 (m, 1H), 3.17 (dd, J = 17.2, 7.7 Hz, 1H), 3.38 (dd, J = 13.9, 4.1 Hz, 1H), 
7.03-7.07 (m, 3H), 7.19 (dd, J = 7.5 Hz, 1H), 7.36-7.42 (m, 2H), 7.58 (d, J = 7.7 Hz, 1H) 7.79 
(d, J = 7.6 Hz, 1H). 13C NMR (101 MHz, CDCl3) d 21.5, 32.4, 37.1, 49.1, 124.1, 126.0, 126.8, 
127.2, 127.6, 128.6, 129.8, 134.8, 136.7, 138.3, 139.8, 153.8, 208.0. HRMS (ESI): Calcd. for 
C17H17O+ ([M+H]+): 237.1274, Found: 237.1276. 
 
2-(3-fluorobenzyl)-2,3-dihydro-1H-inden-1-one (2m): Prepared 
according to general procedure C from tert-butyl (2-
allylbenzoyl)(benzyl)carbamate 1a (35.1 mg, 0.100 mmol) and 3-
fluorophenylboronic acid pinacol ester (66.7 mg, 0.300 mmol).  The 
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crude reaction mixture was purified by flash column chromatography (100:0 hexanes:EtOAc 
to 90:10 hexanes:EtOAc) to give 2m as a colorless oil in 67% yield (16.1 mg, 0.067 mmol). 
1H NMR (400 MHz, CDCl3) d 2.68 (dd, J = 14.0, 10.3 Hz, 1H), 2.84 (dd, J = 17.1, 4.1 Hz, 
1H), 2.95-3.02 (m, 1H), 3.20 (dd, J = 17.2, 7.8 Hz, 1H), 3.38 (dd, J = 14.0, 4.3 Hz, 1H), 6.89-
6.97 (m, 2H), 7.02 (d, J = 7.6 Hz, 1H), 7.23-7.28 (m, 1H), 7.36-7.42 (m, 2H), 7.58 (ddd, J = 
7.7, 7.7, 1.1 Hz, 1H), 7.78 (d, J = 7.7 Hz, 1H). 13C NMR (101 MHz, CDCl3) d 32.3, 36.8, 48.8, 
113.4 (d, J = 21.0 Hz), 115.9 (d, J = 21.0 Hz), 124.2, 124.7 (d, J = 2.8 Hz), 126.7, 127.7, 130.1 
(d, J = 8.3 Hz), 135.6, 136.6, 142.3 (d, J = 7.2 Hz), 153.6, 163.0 (d, J = 245 Hz), 207.5. 19F 
NMR (376 MHz, CDCl3) d -113.3 (m, 1F). HRMS (ESI): Calcd. for C16H14FO+ ([M+H]+): 
241.1023, Found: 241.1023. 
 
2-(3-chlorobenzyl)-2,3-dihydro-1H-inden-1-one (2n): Prepared 
according to general procedure C from tert-butyl (2-
allylbenzoyl)(benzyl)carbamate 1a (35.1 mg, 0.100 mmol) and 3-
chlorophenylboronic acid pinacol ester (71.6 mg, 0.300 mmol).   The 
crude reaction mixture was purified by flash column chromatography (100:0 hexanes:EtOAc 
to 90:10 hexanes:EtOAc) to give 2n as a colorless oil in 54% yield (13.9 mg, 0.054 mmol). 1H 
NMR (400 MHz, CDCl3) d 2.65 (dd, J = 14.0, 10.4 Hz, 1H), 2.84 (dd, J = 17.0, 4.1 Hz, 1H), 
2.95-3.01 (m, 1H), 3.20 (dd, J = 17.2, 7.7 Hz, 1H), 3.37 (dd, J = 14.1, 4.2 Hz, 1H), 7.13 (ddd, 
J = 7.0, 1.7, 1.7 Hz, 1H), 7.18-7.25 (m, 3H), 7.36-7.43 (m, 2H), 7.58 (ddd, J = 7.6, 7.6, 1.2 Hz, 
1H), 7.78 (d, J = 7.7 Hz, 1H). 13C NMR (101 MHz, CDCl3) d 32.3, 36.8, 48.8, 124.2, 126.74, 
126.75, 127.2, 127.7, 129.1, 130.0, 134.4, 135.1, 136.6, 141.9, 153.5, 207.4. HRMS (ESI): 
Calcd. for C16H14ClO+ ([M+H]+): 257.0728, Found: 257.0725. 
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2-(2-methoxybenzyl)-2,3-dihydro-1H-inden-1-one (2o): Prepared 
according to general procedure C from tert-butyl (2-
allylbenzoyl)(benzyl)carbamate 1a (35.1 mg, 0.100 mmol) and 2-
methoxyphenylboronic acid pinacol ester (70.2 mg, 0.300 mmol).   
The crude reaction mixture was purified by flash column chromatography (100:0 
hexanes:EtOAc to 90:10 hexanes:EtOAc) to give 2o as a colorless oil in 50% yield (12.6 mg, 
0.050 mmol). 1H NMR (400 MHz, CDCl3) d 2.63 (dd, J = 13.6, 9.9 Hz, 1H), 2.86 (dd, J = 
20.5, 7.2 Hz, 1H), 3.07-3.16 (m, 2H), 3.42 (dd, J = 13.6, 4.2 Hz, 1H), 3.82 (s, 3H), 6.86-6.92 
(m, 2H), 7.17-7.24 (m, 2H), 7.34-7.40 (m, 2H), 7.56 (ddd, J = 7.6, 7.6, 1.2 Hz, 1H) 7.78 (d, J 
= 7.9 Hz, 1H). 13C NMR (101 MHz, CDCl3) d 31.9, 32.5, 47.7, 55.3, 110.4, 120.6, 124.1, 
126.7, 127.4, 127.8, 128.3, 130.6, 134.7, 136.9, 154.0, 157.9, 208.5. HRMS (ESI): Calcd. for 
C17H17O2+ ([M+H]+): 253.1223, Found: 253.1221. 
 
2-(2-methylbenzyl)-2,3-dihydro-1H-inden-1-one (2p): Prepared 
according to general procedure C from tert-butyl (2-
allylbenzoyl)(benzyl)carbamate 1a (35.1 mg, 0.100 mmol) and 2-
tolylboronic acid pinacol ester (65.4 mg, 0.300 mmol).   The crude 
reaction mixture was purified by flash column chromatography (100:0 hexanes:EtOAc to 
90:10 hexanes:EtOAc) to give 2p as a colorless oil in 90% yield (21.3 mg, 0.090 mmol). 1H 
NMR (400 MHz, CDCl3) d 2.38 (s, 3H), 2.59 (dd, J = 14.5, 11.1 Hz, 1H), 2.87 (dd, J = 17.2, 
4.0 Hz, 1H), 2.99-3.06 (m, 1H), 3.21 (dd, J = 17.2, 7.8 Hz, 1H), 3.49 (dd, J = 14.5, 4.1 Hz, 
1H), 7.14-7.21 (m, 4H), 7.37-7.44 (m, 2 H), 7.59 (ddd, J = 7.6, 7.6, 1.1 Hz, 1H) 7.81 (d, J = 
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7.6 Hz, 1H). 13C NMR (101 MHz, CDCl3) d 19.6, 32.8, 34.6, 47.7, 124.1, 124.3, 126.1, 126.6, 
126.8, 127.5, 129.1, 130.6, 135.0, 136.6, 138.1, 153.7, 208.1. HRMS (ESI): Calcd. for 
C17H17O+ ([M+H]+): 237.1274, Found: 237.1273. 
 
2-(naphthalen-2-ylmethyl)-2,3-dihydro-1H-inden-1-one (2q): 
Prepared according to general procedure C from tert-butyl (2-
allylbenzoyl)(benzyl)carbamate 1a (35.1 mg, 0.100 mmol) and 2-
naphthylboronic acid pinacol ester (76.2 mg, 0.300 mmol). The 
crude reaction mixture was purified by flash column chromatography (100:0 DCM:EtOAc to 
90:10 DCM:EtOAc) to give 2q as a white solid in 99% (27.0 mg, 0.099 mmol). 1H NMR (400 
MHz, CDCl3) d 2.84 (dd, J = 14.1, 10.0 Hz, 1H), 2.92 (dd, J = 16.5, 3.2 Hz, 1H), 3.06-3.23 
(m, 2H), 3.57 (dd, J = 14.1, 4.1 Hz, 1H), 7.34-7.50 (m, 5H), 7.57 (dt, J = 7.7, 1.2 Hz, 1H), 7.68 
(broad s, 1H), 7.76-7.84 (m, 4H). 13C NMR (101 MHz, CDCl3) d 32.3, 37.3, 49.0, 124.2, 
125.6, 126.2, 126.7, 127.4, 127.5, 127.6, 127.61, 127.8, 128.4, 132.3, 133.7, 135.0, 136.7, 
137.3, 153.8, 208.0. HRMS (ESI): Calcd. for C20H16O+Na ([M+Na]+): 295.1093, Found: 
295.1057. 
 
2-(furan-3-ylmethyl)-2,3-dihydro-1H-inden-1-one (2s): Prepared 
according to general procedure C from tert-butyl (2-
allylbenzoyl)(benzyl)carbamate 1a (35.1 mg, 0.100 mmol) and 3-
furanylboronic acid pinacol ester (58.2 mg, 0.300 mmol). The crude reaction mixture was 
purified by flash column chromatography (100:0 hexanes:EtOAc to 90:10 hexanes:EtOAc) to 
give 2s as a colorless oil in 63% yield (13.4 mg, 0.063 mmol). 1H NMR (400 MHz, CDCl3) d 
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2.67 (dd, J = 14.2, 8.8 Hz, 1H), 2.89 (dd, J = 16.6, 4.2 Hz, 1H), 2.87-2.95 (m, 2H),  3.08 (dd, 
J = 14.2, 3.7 Hz, 1H), 3.26 (dd, J = 16.6, 7.2 Hz, 1H), 6.27 (s, 1H), 7.32 (t, J = 1.6 Hz, 1H), 
7.36 (t, J = 7.8 Hz, 1H), 7.42 (d, J = 7.7 Hz, 1H), 7.57 (td, J = 7.6, 1.2 Hz, 1H), 7.76 (d, J = 
8.0 Hz, 1H).  13C NMR (101 MHz, CDCl3) d 26.2, 32.4, 47.8, 111.3, 122.3, 124.1, 126.7, 
127.6, 135.0, 136.8, 139.8, 143.1, 153.8, 208.0. HRMS (ESI): Calcd. for C14H13O2+ ([M+H]+): 
213.0910, Found: 213.0916. 
 
2-(thiophen-3-ylmethyl)-2,3-dihydro-1H-inden-1-one (2t): Prepared 
according to general procedure C from tert-butyl (2-
allylbenzoyl)(benzyl)carbamate 1a (35.1 mg, 0.100 mmol) and 3-
thienylboronic acid pinacol ester (63.0 mg, 0.300 mmol). The crude reaction mixture was 
purified by flash column chromatography (100:0 hexanes:EtOAc to 90:10 hexanes:EtOAc) to 
give 2t as a white solid in 88% yield (20.1 g, 0.088 mmol). 1H NMR (400 MHz, CDCl3) d 
2.82 (dd, J = 14.4, 9.8 Hz, 1H), 2.88 (dd, J = 17.2, 4.0 Hz, 1H), 2.96-3.02 (m, 1H), 3.25 (dd, J 
= 17.2, 7.7 Hz, 1H), 3.33 (dd, J = 14.4, 4.1 Hz, 1H), 6.98 (dd, J = 4.9, 1.2 Hz, 1H), 7.00-7.02 
(m, 1H), 7.25 (dd, J = 4.9, 3.0 Hz, 1H), 7.37 (t, J = 7.8 Hz, 1H), 7.41 (d, J = 7.7 Hz, 1H), 7.57 
(td, J = 7.6, 1.2 Hz, 1H), 7.77 (d, J = 7.7 Hz, 1H). 13C NMR (101 MHz, CDCl3) d 31.5, 32.5, 
48.3, 121.5, 124.1, 125.8, 126.7, 127.5, 128.4, 134.9, 136.7, 139.8, 153.8, 207.9. HRMS (ESI): 
Calcd. for C14H13OS+ ([M+H]+): 229.0682, Found: 222.0684. 
 
2-benzyl-6-methyl-2,3-dihydro-1H-inden-1-one (4a): Prepared 
according to general procedure C from tert-butyl (2-allyl-5-
methyl)(benzyl)carbamate 3a (36.5 mg, 0.100 mmol) and 
112 
phenylboronic acid pinacol ester (61.2 mg, 0.300 mmol).  The crude reaction mixture was 
purified by flash column chromatography (100:0 hexanes:EtOAc to 90:10 hexanes:EtOAc) to 
give 4a as a colorless oil in 92% yield (21.7 mg, 0.092 mmol). 1H NMR (400 MHz, CDCl3) d 
2.41 (s, 3H), 2.66 (dd, J = 14.0, 10.4 Hz, 1H), 2.81 (dd, J = 17.0, 3.8 Hz, 1H), 2.97-3.04 (m, 
1H), 3.13 (dd, J = 17.0, 7.8 Hz, 1H), 3.40 (dd, J = 14.0, 4.2 Hz, 1H), 7.21-7.36 (m, 6H), 7.40 
(dd, J = 7.8. 1.1 Hz, 1H), 7.59 (s, 1H). 13C NMR (101 MHz, CDCl3) d 21.2, 32.0, 37.2, 49.4, 
124.1, 126.4, 126.4, 128.6, 129.0, 136.2, 136.8, 137.5, 139.9, 151.1, 208.1. HRMS (ESI): 
Calcd. for C17H17O+ ([M+H]+): 237.1274, Found: 237.1270. 
 
2-benzyl-6-methoxy-2,3-dihydro-1H-inden-1-one (4b): 
Prepared according to a modified version of general procedure C 
from tert-butyl (2-allyl-5-methoxy)(benzyl)carbamate 3b (38.1 
mg, 0.100 mmol) and phenylboronic acid pinacol ester (61.2 mg, 
0.300 mmol). Upon completion of the reaction, the reaction mixture was filtered through a 
short plug of silica gel.  The filtrate was concentrated under reduced pressure.  To the crude 
product was dissolved in DCM (2.0 mL).  The resulting solution was cooled to 0 °C, and TFA 
(0.400 mL) was added slowly.  The mixture was allowed to warm to room temperature and 
stirred for 1 h. The reaction was concentrated under reduced pressure. The crude reaction 
mixture was purified by flash column chromatography (100:0 hexanes:EtOAc to 90:10 
hexanes:EtOAc) to give 4b as a white solid in 96% yield (24.0 mg, 0.096 mmol). 1H NMR 
(400 MHz, CDCl3) d 2.66 (dd, J = 14.0, 10.2 Hz, 1H), 2.78 (dd, J = 16.4, 3.2 Hz, 1H), 2.97-
3.07 (m, 1H), 3.09 (dd, J = 16.4, 7.6 Hz, 1H), 3.39 (dd, J = 14.0, 4.2 Hz, 1H), 3.84 (s, 3H), 
7.17 (dd, J = 8.3, 2.5 Hz, 1H), 7.19-7.33 (m, 6H) 13C NMR (101 MHz, CDCl3) d 31.6, 37.2, 
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49.8, 55.7, 105.2, 124.4, 126.5, 127.4, 128.6, 129.0, 137.8, 139.8, 146.6, 159.5, 208.0 HRMS 
(ESI): Calcd. for C17H17O2+ ([M+H]+): 253.1223, Found: 253.1226. 
 
2-benzyl-6-(trifuoromethyl)-2,3-dihydro-1H-inden-1-one (4c): 
Prepared according to general procedure C from tert-butyl (2-
allyl-5-(trifluoromethyl)benzoyl)(benzyl)carbamate 3c (41.9 mg, 
0.100 mmol) and phenylboronic acid pinacol ester (61.2 mg, 0.300 mmol). The crude reaction 
mixture was purified by flash column chromatography (100:0 hexanes:EtOAc to 90:10 
hexanes:EtOAc) to give 4c as a white solid in 51% yield (14.8 mg, 0.051 mmol). 1H NMR 
(400 MHz, CDCl3) d 2.73 (dd, J = 14.0, 10.1 Hz, 1H), 2.93 (dd, J = 17.6, 4.0 Hz, 1H), 3.05-
3.12 (m, 1H), 3.24 (dd, J = 17.6, 7.9 Hz, 1H), 3.40 (dd, J = 14.0, 4.4 Hz, 1H), 7.21-7.25(m, 
3H), 7.28-7.34 (m, 2H), 7.52 (d, J = 8.0 Hz, 1H), 7.81 (dd, J = 8.0, 1.3 Hz, 1H), 8.04 (s, 1H). 
13C NMR (101 MHz, CDCl3) d 32.3, 36.9, 49.4, 121.4 (q, J = 4.0 Hz, 1H), 126.6 (q, J = 274 
Hz, 1C), 126.7, 127.5, 128.8, 129.0. 130.5 (q, J = 33.3 Hz, 1C), 131.4 (q, J = 3.0 Hz, 1C), 
137.1, 139.2, 156.9, 206.6. 19F NMR (CDCl3, 376 MHz): d -62.5 (s, 1F). HRMS (ESI): Calcd. 
for C17H14F3O+ ([M+H]+): 291.0991, Found: 291.0995. 
 
2-benzyl-5-methoxy-2,3-dihydro-1H-inden-1-one (4d): Prepared 
according to general procedure C from tert-butyl (2-
allylbenzoyl)(benzyl)carbamate 3d (38.1 mg, 0.100 mmol) and 
phenylboronic acid pinacol ester (61.2 mg, 0.300 mmol). The crude reaction mixture was 
purified by flash column chromatography (100:0 hexanes:EtOAc to 90:10 hexanes:EtOAc) to 
give 4d as a white solid in 88% yield (22.2 mg, 0.088 mmol). 1H NMR (400 MHz, CDCl3) d 
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2.65 (dd, J = 14.0, 10.4 Hz, 1H), 2.80 (dd, J = 17.2, 3.8 Hz, 1H), 2.96-3.02 (m, 1H), 3.11 (dd, 
J = 17.2, 7.8 Hz, 1H), 3.39 (dd, J = 14.0, 4.2 Hz, 1H), 3.86 (s, 3H), 6.82 (s, 1H), 6.90 (dd, J = 
8.5, 2.2 Hz, 1H), 7.19-7.32 (m, 5H), 7.72 (d, J = 8.5 Hz, 1H). 13C NMR (101 MHz, CDCl3) d 
32.3, 37.3, 49.2, 55.7, 109.8, 115.5, 125.8, 126.4, 128.6, 129.0, 129.9, 139.9, 156.7, 165.5, 
206.1. HRMS (ESI): Calcd. for C17H17O2+ ([M+H]+): 253.1223, Found: 253.1226. 
 
2-benzyl-5-methyl-2,3-dihydro-1H-inden-1-one (4e): Prepared 
according to general procedure C from tert-butyl (2-allyl-4-
methylbenzoyl)(benzyl)carbamate 3e (36.5 mg, 0.100 mmol) and 
phenylboronic acid pinacol ester (61.2 mg, 0.300 mmol).  The crude 
reaction mixture was purified by flash column chromatography (100:0 hexanes:EtOAc to 
90:10 hexanes:EtOAc) to give 4e as a colorless oil in 97% yield (22.9 mg, 0.097 mmol). 1H 
NMR (400 MHz, CDCl3) d 2.42 (s, 3H), 2.65 (dd, J = 14.0, 10.5 Hz, 1H), 2.81 (dd, J = 17.1, 
3.7 Hz, 1H), 2.95-3.02 (m, 1H), 3.11 (dd, J = 17.1, 7.7 Hz, 1H), 3.39 (dd, J = 13.9, 4.1 Hz, 
1H), 7.17-7.32 (m, 7H), 7.68 (d, J = 7.8 Hz, 1H). 13C NMR (101 MHz, CDCl3) d 22.2, 32.1, 
37.3, 49.2, 123.9, 126.4, 127.0, 128.6, 128.8, 129.1, 134.4, 139.9, 146.1, 154.3, 207.4. HRMS 
(ESI): Calcd. for C17H17O+ ([M+H]+): 237.1274, Found: 237.1276. 
 
2-benzyl-5-fluoro-2,3-dihydro-1H-inden-1-one (4f): Prepared 
according to general procedure C from tert-butyl (2-allyl-4-
fluorobenzoyl)(benzyl)carbamate 3f (36.9 mg, 0.100 mmol) and 
phenylboronic acid pinacol ester (61.2 mg, 0.300 mmol). The crude 
reaction mixture was purified by flash column chromatography (100:0 hexanes:EtOAc to 
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90:10 hexanes:EtOAc) to give 4f as a yellow oil in 99% yield (23.8 mg, 0.099 mmol). 1H NMR 
(400 MHz, CDCl3) d 2.69 (dd, J = 14.0, 10.2 Hz, 1H), 2.85 (dd, J = 17.3, 3.8 Hz, 1H), 2.98-
3.07 (m, 1H), 3.15 (dd, J = 17.3, 7.8 Hz, 1H), 3.38 (dd, J = 14.0, 4.3 Hz, 1H), 7.02-7.95 (m, 
2H), 7.19-7.25 (m, 3H), 7.27-7.33 (m, 2H), 7.78 (dd, J = 8.2, 5.3 Hz, 1H). 13C NMR (101 
MHz, CDCl3) d 32.2 (d, J = 2.0 Hz, 1C), 37.1, 49.3, 113.3 (d, J = 22.2 Hz, 1C), 115.9 (d, J = 
24.2 Hz, 1C), 126.4 (d, J = 11.1 Hz, 1C), 126.6, 128.7, 129.0, 133.1 (d, J = 2.0 Hz, 1C), 139.4, 
156.6 (d, J = 10.1 Hz, 1C), 167.3 (d, J = 257.6 Hz, 1C), 206.0. 19F NMR (CDCl3, 376 MHz): 
d -102.7 (m, 1F). HRMS (ESI): Calcd. for C16H14FO+ ([M+H]+): 241.1023, Found: 241.1027. 
 
2-benzyl-5-(trifluoromethyl)-2,3-dihydro-1H-inden-1-one (4g): 
Prepared according to general procedure C from tert-butyl(2-allyl-
4-(trifluoromethyl)(benzyl)carbamate 3g (41.9 mg, 0.100 mmol) 
and phenylboronic acid pinacol ester (61.2 mg, 0.300 mmol).  The 
crude reaction mixture was purified by flash column chromatography (100:0 hexanes:EtOAc 
to 90:10 hexanes:EtOAc) to give 4g as a white solid in 85% yield (24.7 mg, 0.085 mmol). 1H 
NMR (400 MHz, CDCl3) d 2.73 (dd, J = 14.0, 10.1 Hz, 1H), 2.93 (dd, J = 17.4, 4.0 Hz, 1H), 
3.03-3.11 (m, 1H), 3.24 (dd, J = 17.4, 7.8 Hz, 1H), 3.39 (dd, J = 14.0, 4.4 Hz, 1H), 7.20-7.25 
(m, 3H), 7.28-7.34 (m, 2H), 7.63 (d, J = 8.0 Hz, 1H), 7.67 (s, 1H), 7.88 (d, J = 8.0 Hz, 1H) 13C 
NMR (101 MHz, CDCl3) d 32.2, 36.9, 49.4, 123.9 (q, J = 4.0 Hz, 1C), 124.7, 125.2 (q, J = 4.0 
Hz, 1C), 126.5 (q, J = 274.7 Hz, 1C), 126.7, 128.8, 129.0, 136.2 (q, J = 31.3 Hz, 1C), 139.2, 
139.31-139.35 (m, 1C), 153.8, 206.9. 19F NMR (CDCl3, 376 MHz): d -62.9 (s, 3F). HRMS 
(ESI): Calcd. for C17H14F3O+ ([M+H]+): 291.0991, Found: 291.0978. 
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2-benzyl-4-fluoro-2,3-dihydro-1H-inden-1-one (4h): Prepared 
according to general procedure C from tert-butyl(2-allyl-3-
fluorobenzoyl)(benzyl)carbamate 3h (36.9 mg, 0.100 mmol) and 
phenylboronic acid pinacol ester (61.2 mg, 0.300 mmol). The crude 
reaction mixture was purified by flash column chromatography (100:0 hexanes:EtOAc to 
90:10 hexanes:EtOAc) to give 4h as a yellow oil in 95% yield (22.8 mg, 0.095 mmol). 1H 
NMR (400 MHz, CDCl3) d 2.71 (dd, J = 14.0, 10.2 Hz, 1H), 2.85 (dd, J = 17.5, 4.0 Hz, 1H), 
3.00-3.06 (m, 1H), 3.20 (dd, J = 17.5, 7.8 Hz, 1H), 3.39 (dd, J = 14.0, 4.3 Hz, 1H), 7.21-7.27 
(m, 4H), 7.29-7.33 (m, 2H), 7.34-7.39 (m, 1H), 7.58 (d, J = 7.5 Hz, 1H). 13C NMR (101 MHz, 
CDCl3) d 28.0, 37.0, 49.0, 119.9, 121.0 (d, J = 20.2 Hz, 1C), 126.6, 128.7, 129.0, 129.5 (d, J 
= 6.1 Hz, 1C), 139.3, 139.5 (d, J = 8.1 Hz, 1C), 139.6 (d, J = 8.1 Hz, 1C), 160.2 (d, J = 251.5 
Hz, 1C), 206.6. 19F NMR (376 MHz, CDCl3) d -118.9 (m, 1F). HRMS (ESI): Calcd. for 
C16H14FO+ ([M+H]+): 241.1023, Found: 241.1019. 
 
2-benzyl-4-fluoro-2,3-dihydro-1H-inden-1-one (4i): Prepared 
according to general procedure C from tert-butyl(2-allyl-6-
fluorobenzoyl)(benyl)carbamate 3i (36.9 mg, 0.100 mmol) and 
phenylboronic acid pinacol ester (61.2 mg, 0.300 mmol). The crude 
reaction mixture was purified by flash column chromatography (100:0 hexanes:EtOAc to 
90:10 hexanes:EtOAc) to give 4i as a yellow oil in 84% yield (20.2  mg, 0.084 mmol). 1H 
NMR (400 MHz, CDCl3) d 2.70 (dd, J = 14.0, 10.2 Hz, 1H), 2.87 (dd, J = 17.3, 4.2 Hz, 1H), 
3.00-3.06 (m, 1H), 3.17 (dd, J = 17.3, 7.9 Hz, 1H), 3.39 (dd, J = 14.0, 4.3 Hz, 1H), 6.97 (t, J = 
9.0 Hz, 1H), 7.16 (d, J = 7.3 Hz, 1H), 7.19-7.33 (m, 5H), 7.54 (m, 1H) 13C NMR (101 MHz, 
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CDCl3) d 32.2, 37.0, 49.6, 114.4 (d, J = 19.2 Hz, 1C), 122.5 (d, J = 5.1 Hz, 1C), 124.5 (d, J = 
13.1 Hz, 1C), 126.6, 128.7, 129.1, 136.7-136.9 (m, 1C), 139.4, 155.8 (d, J = 2.0 Hz, 1C), 159.2 
(d, J = 265.6 Hz, 1C), 204.1 (d, J = 1.0 Hz, 1C). 19F NMR (376 MHz, CDCl3) d -114.4 (m, 
1F). HRMS (ESI): Calcd. for C16H14FO+ ([M+H]+): 241.1023, Found: 241.1018. 
 
2-benzyl-5,6-difluoro-2,3-dihydro-1H-inden-1-one (4j): Prepared 
according to general procedure C from tert-butyl(2-allyl-4,5-
difluorobenzoyl)(benyl)carbamate 3j (38.7 mg, 0.100 mmol) and 
phenylboronic acid pinacol ester (61.2 mg, 0.300 mmol). The crude 
reaction mixture was purified by flash column chromatography (100:0 hexanes:EtOAc to 
90:10 hexanes:EtOAc) to give 4j as a off-white solid in 46% yield (11.9  mg, 0.046 mmol). 1H 
NMR (400 MHz, CDCl3) d 2.70 (dd, J = 14.0, 10.0 Hz, 1H), 2.82 (dd, J = 17.0, 1.2 Hz, 1H), 
2.99-3.08 (m, 1H), 3.13 (ddd, J = 17.0, 7.7, 0.6 Hz, 1H), 3.36 (dd, J = 14.0, 4.3 Hz, 1H), 7.17 
(dd, J = 9.4, 6.7 Hz, 1H), 7.20-7.24 (m, 3H), 7.27-7.33 (m, 2H), 7.54 (dd, J = 8.2, 0.4 Hz, 1H). 
13C NMR (101 MHz, CDCl3) d 31.8 (d, J = 1.0 Hz, 1C), 40.0, 49.4 (d, J = 1.0 Hz, 1C), 112.2 
(dd, J = 17.2, 2.0 Hz, 1C), 114.9 (d, J = 18.2 Hz, 1C), 126.7, 128.7, 129.0, 133.0 (dd, J = 6.1, 
3.0 Hz, 1C), 139.1, 150.3 (dd, J = 8.1, 3.0 Hz, 1C), 150.8 (dd, J = 252.5, 14.1 Hz, 1C), 155.4 
(dd, J = 260.6, 14.1 Hz, 1C), 205.7 (d, J = 2.0 Hz, 1C). 19F NMR (376 MHz, CDCl3) d -136.8 
(m, 1F), -125.2 (m, 1F). HRMS (ESI): Calcd. for C16H13F2O+ ([M+H]+): 259.0929, Found: 
259.0918. 
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Nickel-Catalyzed Carboacylation of Methyl-2-Allylbenzoate 5  
 
A 1-dram vial was charged with 0.100 mmol of methyl 2-allylbenzoate 5 (17.6 mg, 0.100 
mmol), Ni(cod)2 (2.8 mg, 0.010 mmol), SIPr (3.9 mg, 0.010 mmol), K3PO4 (42.5 mg, 0.200 
mmol), H2O (3.6 µL, 0.20 mmol), phenylboronic acid pinacol ester (61.2 mg, 0.300 mmol), 
and THF (0.100 mL).   The resulting solution stirred at 60 °C for 12 hours.  Upon completion 
of the reaction, the reaction mixture was filtered through a plug of silica with 70:30 
hexanes:EtOAc. The crude product was purified by column chromatography with a gradient 
of 100:0 hexanes:EtOAc to 90:10 hexanes:EtOAc over a 25 minute period on a Combiflash 
system to 2a as colorless oil in 50% yield (11.0 mg, 0.049 mmol).  NMR data match those 
reported for synthesis of 2a from benzamide 1a. 
 
Enantioselective α-Arylation of 2a to Form (S)-2-Benzyl-2-phenyl-2,3-dihydro-1H-inden-
1-one 6 
 
2-Benzyl-2-phenyl-2,3-dihydro-1H-inden-1-one 6 was prepared according to a known 
literature procedure.48 Inside of a glovebox, to a 1-dram vial containing a magnetic stir bar was 
added Ni(cod)2 (5.5 mg, 0.020 mmol), (S)-BINAP (14.9 mg, 0.024 mmol), NaOtBu (38.4 mg, 
0.400 mmol), chlorobenzene (40.5 µL, 0.400 mmol), 2a (44.5 mg, 0.200 mmol), and toluene 
(1.00 mL).  The vial was sealed with a cap containing a PTFE septum and removed from the 
OMe
O
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O
Ph
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Ni(cod)2 (10 mol %)
SIPr (10 mol %)
PhBpin (3 equiv)
K3PO4 (2 equiv)
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O
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Ph-Cl (2 equiv)
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toluene, 80 °C, 24 h
O
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glovebox. The reaction was stirred at 80 °C for 36 h.  Upon completion, the reaction was cooled 
to room temperature.  The reaction was quenched with a saturated aqueous NH4Cl solution and 
extracted with Et2O (2 x 10 mL).  The combined organic layers were dried over Na2SO4, 
filtered, and concentrated under reduced pressure.  The crude product was purified by flash 
column chromatography (98:2, hexanes:EtOAc) to give 6 as a white solid in 65% yield (39.0 
mg, 0.130 mmol). The enantiomeric excess was determined by HPLC analysis (254 nm, 25 
°C) tR 27.2 min (minor); tR 36.0 min (major) [Chiracel AD-H (0.46 cm x 25 cm)(from Daicel 
Chemical Ind., Ltd.) hexane/i-PrOH, 98:2, 1.0 mL/min] to be 96% ee. NMR data are consistent 
with known literature values.48  
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Experimental Procedures for Competition Experiments: 
 
A competition experiment generating 2-benzyl-2,3-dihydro-1H-inden-1-ones 4b and 4k was 
carried out by the following procedure. A 1-dram vial was charged with o-allylbenzamides 3b 
Ni(cod)2 (10 mol %)
SIPr (10 mol %)
PhBpin (5 equiv)
K3PO4 (2 equiv)
H2O (2 equiv)
THF (1 M), 60 °C, 12 h
O
PhF3C
+
O
PhMe
6.8:1
F3C
+
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N
O
Bn
Boc
N
O
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Boc
3g 4g3e 4e
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(36.5 mg, 0.100 mmol) and 3k (41.9 mg, 0.100 mmol), Ni(cod)2 (2.8 mg, 0.010 mmol), SIPr 
(3.9 mg, 0.010 mmol), K3PO4 (42.4 mg, 0.200 mmol), H2O (3.6 µL, 0.20 mmol), 
phenylboronic acid pinacol ester (102 mg, 0.500 mmol), and THF (0.10 mL).   The resulting 
solution was stirred at 60 °C for 12 hours.  Upon completion of the reaction, the reaction 
mixture was filtered through a plug of silica with hexanes:EtOAc (70:30), and concentrated 
under reduced pressure. The crude mixture was dissolved in CDCl3 with CH2Br2 as internal 
standard. The ratio of products 4k:4b was determined to be 6.8:1 by 1H NMR spectroscopy.  
The NMR yields of 4k and 4b were determined to be 75% and 11%, respectively. 
 
 
A competition experiment generating 2-benzyl-2,3-dihydro-1H-inden-1-ones 2p and 2c was 
carried out by the following procedure. A 1-dram vial was charged with o-allylbenzamide 1a 
(35.1 mg, 0.100 mmol), Ni(cod)2 (2.8 mg, 0.010 mmol), SIPr (3.9 mg, 0.010 mmol), K3PO4 
(42.5 mg, 0.200 mmol), H2O (3.6 µL, 0.20 mmol), 4-tolylboronic acid pinacol ester (109 mg, 
0.500 mmol), 2-tolylboronic acid pinacol ester (109 mg, 0.500 mmol), and THF (0.10 mL).   
The resulting solution was stirred at 60 °C for 12 hours.  Upon completion of the reaction, the 
reaction mixture was filtered through a plug of silica with hexanes:EtOAc (70:30), and 
concentrated under reduced pressure. The crude mixture was dissolved in CDCl3 with CH2Br2 
as internal standard. The ratio of products 2p:2c was determined to be 8.3:1 by 1H NMR 
spectroscopy.  The NMR yields of 2p and 2c were determined to be 58% and 7%, respectively. 
 
+
Bpin
+
Bpin
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SIPr (10 mol %)
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H2O (2 equiv)
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A competition experiment generating 2-benzyl-2,3-dihydro-1H-inden-1-ones 2j and 2c was 
carried out by the following procedure. A 1-dram vial was charged with o-allylbenzamide 1a 
(35.1 mg, 0.100 mmol), Ni(cod)2 (2.8 mg, 0.010 mmol), SIPr (3.9 mg, 0.010 mmol), K3PO4 
(42.5 mg, 0.200 mmol), H2O (3.6 µL, 0.20 mmol), 4-tolylboronic acid pinacol ester (109 mg, 
0.500 mmol), 4-(trifluoromethyl)phenylboronic acid pinacol ester (136 mg, 0.500 mmol), and 
THF (0.10 mL).   The resulting solution was stirred at 60 °C for 12 hours.  Upon completion 
of the reaction, the reaction mixture was filtered through a plug of silica with hexanes:EtOAc 
(70:30), and concentrated under reduced pressure. The crude mixture was dissolved in CDCl3 
with CH2Br2 as internal standard. The ratio of products 2j:2c was determined to be 10.5:1 by 
1H NMR spectroscopy.  The NMR yields of 2j and 2c were determined to be 84% and 8%, 
respectively. 
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Abstract 
We report palladium-catalyzed formal intermolecular carboacylation of norbornene 
with aryl benzoates and sodium tetraarylborates. The reaction is triggered by oxidative addition 
of an activated ester C−O bond to a Pd(0) catalyst. The three-component intermolecular 
carboacylation reaction generates phenyl(3-phenylbicyclo[2.2.1]heptan-2-yl)methanones in 
up to 99% yield with 1:1 diastereomeric ratio and in moderate-to-high enantiomeric excess 
from a variety of aryl benzoate esters and sodium tetraarylborates. The cis-carboacylation 
diastereomer can be converted to the trans-diastereomer in high yields with >20:1 dr under 
mild conditions. These results show that esters are practical substrates for enantioselective, 
intermolecular alkene carboacylation via ester C−O bond activation. This represents the first 
enantioselective, intermolecular carboacylation of esters, and bypasses the challenges 
associated with alkene carboacylation reactions triggered by C−C and C−N bond activation. 
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Introduction 
Intermolecular and intramolecular alkene carbocylation in the presence of a transition-
metal catalyst through the formation of two new C-C bonds is an emerging alkene 
difunctionalization reaction.1-16 Alkene carboacylation reactions initiated by activation of a 
C−C bond of a ketone is the most common and established approach. While much progress 
has been made to demonstrate the utility of these carboacylation reactions, the development of 
these reactions is limited by the requirement for substrates to contain either a quinoline 
directing group1-5 or a strained cyclic ketone (Scheme 1a-c).6-12 The ability to perform alkene 
carboacylation reactions on additional classes of substrates has the potential to expand the 
utility of these reactions.13-16,17-21 
Recently, studies by a number of groups have demonstrated Suzuki-Miyaura coupling 
of benzamides with arylboron compounds to generate a variety of aromatic ketones that occur 
through C−N bond activation.22-33 Similar approaches have recently been reported utilizing 
aryl benzoates as suitable substrates for cross-coupling triggered via C−O bond activation.34-40 
Recently, we have reported formal intramolecular nickel-catalyzed carboacylation of ortho-
allylbenzamides with PhBpin. Our approach demonstrated that the acyl-metal-aryl 
intermediate generated from oxidative addition into a carbon-heteroatom bond of an amide 
followed by transmetalation of an organometallic nucleophile can be intercepted by an alkene 
(Scheme 1d).  The ability to intercept these acylmetal intermediates from C−X bond activation 
of carboxylic acid derivatives with alkenes offers the potential to expand alkene carboacylation 
beyond the current limitations of strained cyclic ketones, directing groups, or twisted amide 
substrates. 
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Scheme 1. Synthesis of Ketones via Transition-Metal Catalyzed Alkene Carboacylation 
The potential to develop a new class of asymmetric, intermolecular alkene 
carboacylation reactions via activation of ester C−O bonds led us to investigate palladium-
catalyzed carboacylations of aryl benzoates. We envisioned a process involving activation of 
the C−O bond of an ester via oxidative addition and transmetalation with an arylboron 
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nucleophile to generate acyl-Pd(II)-aryl intermediate (Scheme 1e). Migratory insertion of an 
alkene and reductive elimination would generate ketones, the product of a formal 
intermolecular alkene carboacylation reaction. The proposed formal carboacylation reactions 
involve difunctionalization of an alkene with the formation of two C−C σ bonds in an 
intermolecular and asymmetric fashion. We now report the first palladium-catalyzed 
asymmetric, intermolecular alkene carboacylations triggered by C−O bond activation of aryl 
benzoates to form phenyl(3-phenylbicyclo[2.2.1]heptan-2-yl)methanones in high yield and 
enantioselectivity. 
Results and Discussion 
To identify reaction conditions for the palladium-catalyzed intermolecular 
carboacylation of aryl benzoates and alkenes, we first evaluated the identity of the aryl and 
alkyl benzoates, norbornene (nbe), and sodium tetraphenylborate (NaBPh4) in the presence of 
a catalyst generated from tris(dibenzylideneacetone)dipalladium(0) and DPEphos (Table 1). 
Alkyl and simple aryl benzoates did not generate any of the desired carboacylation product 
(entries 1-5). When the reaction was run with pentafluorophenyl benzoate (Ph(CO)OC6F5) 1a, 
norbornene, and sodium tetraphenylborate in the presence of the same catalyst the 
carboacylation product phenyl((1R,2S,3R,4S)-3-phenylbicyclo[2.2.1]heptan-2-yl)methanone 
cis-2a and epimerized product phenyl((1R,2R,3R,4S)-3-phenylbicyclo[2.2.1]heptan-2-
yl)methanone trans-2a were formed in 54% yield with a 1.25:1 (cis:trans) diastereomeric ratio 
(entry 6).  
With initial reactivity established using penatafluorophenyl benzoate 1a to generate the 
desired ketone product 2a in moderate yield, we next evaluated a variety of palladium 
precatalysts with DPEphos (Table 2). When the reaction of 1a, nbe, and NaBPh4 was 
conducted in the presence of palladium(II) precatalysts the conversion and yield of the model 
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reaction increased (entries 2-4). The yield of 2a increased to 84% when the reaction was run 
in the presence of a catalyst generated from [Pd(allyl)Cl]2 and DPEphos (entry 2). Similar 
diastereomeric ratios of 2a were generated with each palladium precatalyst. With high yields 
of 2a (84%) generated in the presence of an achiral DPEphos, we shifted our focus to evaluate 
chiral, non-racemic ligands.  
Table 1. Identification of Reaction Conditions for Palladium-Catalyzed Intermolecular 
Carboacylation of 1 with nbe and NaBPh4a  
 
entry R conversion (%) yield 2a (%)b dr (cis:trans)b 
1 Me 0 0 0 
2 Bn 0 0 0 
3 Ph 0 0 0 
4 2-F-C6F5 0 0 0 
5 4-CF3-C6H4 0 0 0 
6 C6F5 55 54 1.25:1 
aReaction conditions: 1 (0.100 mmol), Pd2dba3 (0.005 mmol), DPEphos (0.010 mmol), nbe (10 
equiv), NaBPh4 (0.200 mmol), solvent (0.33 M), 20 h. bDetermined by 1H NMR spectroscopy 
of the crude reaction mixture using dibromomethane as an internal standard.  
 
Table 2. Investigation of Palladium Precatalysts for Carboacylation of 1aa  
 
entry Pd precursor conversion (%) yield 2a (%)b dr (cis:trans)b 
1 Pd2dba3 55 54 1.25:1 
2 [Pd(allyl)Cl]2 91 84 1.27:1 
3 [Pd(cinnamyl)Cl]2 75 53 1.12:1 
4 [Pd(OAc)2]3 75 71 1.37:1 
aReaction conditions: 1 (0.100 mmol), Pd precursor (0.005 mmol), DPEphos (0.010 mmol), 
nbe (10 equiv), NaBPh4 (0.200 mmol), solvent (0.33 M), 20 h. bDetermined by 1H NMR 
spectroscopy of the crude reaction mixture using dibromomethane as an internal standard.  
OR
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aReaction conditions: 1a (0.100 mmol), [Pd(allyl)Cl]2 (0.005 mmol), ligand (0.010 mmol), nbe 
(10 equiv), NaBPh4 (0.200 mmol), solvent (0.33 M), 20 h. Yields and dr determined by 1H 
NMR spectroscopy of the crude reaction mixture using dibromomethane as an internal 
standard. Enantioselectivity determined by chiral HPLC analysis of isolated compounds. 
Scheme 2. Identification of Asymmetric, Intermolecular Alkene Carboacylation of Esters 
Triggered by C-O Bond Activationa 
A wide array of chiral, non-racemic bisphosphine ligands, monophosphine, 
phosphoramidite, and NHC ligands were examined under the carboacylation reaction 
conditions for ester C−O bond activation. Ligands that generated 2a in moderate-to-high yields 
and moderate enantioselectivites are shown in Scheme 2. When the model reaction was run 
with catalysts generated from [Pd(allyl)Cl]2 and (R)-BINAP, (R)-Segphos or (R)-MeO-Biphep, 
2a was generated in 96-99% yield with only 16-24% ee. When the reaction was run with (R)-
DTBM-Segphos as the ligand ketone 2a was formed in 99% yield with 49% ee. Similar yields 
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(96-99%) and enantioselectivities (46-58%) of 2a were observed when (R,R)-MeDuphos, 
Josiphos SL-J004-1, Josiphos SL-J001-2, and (R,R)-QuinoxP were used as the ligand. 
Although these ligands increased the enantiomeric excess of 2a, the diastereoselectivity for 
cis-2a:trans-2a were typically around 1:1 after the reaction was complete.  
Table 3. Investigation of Additives for Carboacylation of 1aa  
 
entry additive conv. (%) yield 2a (%)b ee 2a (%)c dr (cis:trans)b 
1 none 99 99 49 0.98:1 
2 H3BO3 (2 equiv) 77 78 50 1:1 
3 Mg(OTf)2 (0.3 equiv) 64 56 79 0.75:1 
4 DIEA 84 63 47 1.52:1 
aReaction conditions: 1 (0.100 mmol), Pd precursor (0.005 mmol), DPEphos (0.010 
mmol), nbe (10 equiv), NaBPh4 (0.200 mmol), solvent (0.33 M), 20 h. bDetermined by 1H 
NMR spectroscopy of the crude reaction mixture using dibromomethane as an internal 
standard. cEnantioselectivity determined by chiral HPLC analysis of isolated compounds. 
To investigate the impact of additives on the dr of 2a, we evaluated boric acid, 
magnesium(II) triflate, and Hünig's base (diisopropylethyl amine, DIEA) (Table 3). These 
additives were initially investigated due to their prominence in carbon-nitrogen bond activation 
of amides. The yield of 2a decreased by 22-45% when the model reaction was run with an 
additive (entries 2-4). Combinations of each additive and utilizing all three additives at the 
same time did not improve the yield or dr. Interestingly, when Mg(OTf)2 was used as an 
additive in the model reaction the enantiomeric excess of 2a increased to 79%. The large 
improvement in enantioselectivity observed with Mg(OTf)2 led us to evaluate a variety of other 
magnesium salts and metal triflates (Table 4).  When the reaction was run in the presence of 
silver(I), sodium(I), bismuth(III), or samarium(III) triflate, ketone 2a was generated in similar 
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yields and dr to the reaction with magnesium(II) triflate without any improvement of the ee 
(entries 2-5). The reaction of 1a under the model reaction conditions with calcium(II) triflate 
generated 2a in 70% yield with 70% ee (entry 4). When the equivalents of magnesium(II) 
triflate was increased from 0.1 to 2.0 equiv the ee of 2a increased from 60 to 95% ee (entries 
7-13). We observed the highest combination of yield and enantiomeric excess when 1a was 
run with 1 equiv of magnesium(II) triflate, as an additive to generate 2a in 67% yield and 92% 
ee.   
 
Table 4. Investigation of Additives on the Enantioselective Carboacylation of 1aa  
 
entry additive X equiv conv. (%) yield 2a (%)b ee 2a (%)c dr (cis:trans)b 
1 none - 99 99 49 0.98:1 
2 AgOTf 0.3 99 95 50 0.98:1 
3 NaOTf 0.3 97 75 51 0.94:1 
4 Sm(OTf)3 0.3 87 57 47 1.19:1 
5 Bi(OTf)3 0.3 75 71 50 0.78:1 
6 Ca(OTf)2 0.3 69 70 70 0.79:1 
7 Mg(OTf)2 0.1 60 51 60 0.76:1 
8 Mg(OTf)2 0.3 67 56 79 0.75:1 
9 Mg(OTf)2 0.5 79 58 85 0.81:1 
10 Mg(OTf)2 1 78 67 92 0.72:1 
11d Mg(OTf)2 1 99 73 82 0.46:1 
13 Mg(OTf)2 2 72 45 95 0.88:1 
aReaction conditions: 1 (0.100 mmol), Pd precursor (0.005 mmol), DPEphos (0.010 
mmol), nbe (10 equiv), NaBPh4 (0.200 mmol), solvent (0.33 M), 20 h. bDetermined by 1H 
NMR spectroscopy of the crude reaction mixture using dibromomethane as an internal 
standard. cEnantioselectivity determined by chiral HPLC analysis of isolated compounds. 
dReaction run at 120 ºC. 
With a catalyst system identified for the intermolecular, asymmetric alkene 
carboacylation of pentafluorophenyl benzoate, we next investigated the role of each reaction 
OC6F5
O [Pd(allyl)Cl]2 (5 mol %)
(R)-DTBM-Segphos (10 mol %)
nbe (10 equiv)
NaBPh4 (2 equiv)
additive (X equiv)
1,4-dioxane, 110 °C1a
Ph
Ph
O
Ph
Ph
O
+
cis-2a trans-2a
(R)-DTBM-Segphos
Ar = 3,5-tBu-4-MeO-C6H2
O
O
O
O
PAr2
PAr2
134 
component in the generation of the cis-2a and trans-2a diastereomers. We monitored the 
reaction over time and observed the carboacylation product cis-2a being epimerized to trans-
2a throughout the entire reaction (Scheme 3). Interestingly, we observed a steady 10-14% of 
the Heck coupling product 3a during each time period analyzed.  
 
Scheme 3. Alkene Carboacylation Time Studies. 
To identify whether trans-2a is generated primarily through epimerization of cis-2a or 
conjugate addition of NaBPh4 to 3a we conducted a series of control experiments (Scheme 4-
6). When Heck product 3a was run in the presence of [Pd(allyl)Cl]2, (R)-DTBM-Segphos, and 
sodium tetraphenylborate, only 40% was converted into 2a over a 20-hour period (Scheme 4a). 
The reaction of 1a and one equivalent of 3a was run in the presence of [Pd(allyl)Cl]2, (R)-
DTBM-Segphos, nbe, and sodium tetraphenylborate generated the ketone product with 2:1 dr 
(cis:trans), which signifies that conjugate addition to generate trans-2a is not a major 
contributor to the overall yield of 2a (Scheme 4b). These control experiments in addition to 
the studies on reaction progress over time (Scheme 3) demonstrate that even though a small 
amount of 3a is generated in the reaction, trans-2a is predominantly generated from the 
epimerization of cis-2a. When cis-2a was run in the presence of [Pd(allyl)Cl]2, (R)-DTBM-
Segphos, and sodium tetraphenylborate, a large amount of cis-2a was converted to trans-2a 
with a final dr of 0.12:1 (cis:trans) (Scheme 5a). The reaction of 1a and one equivalent of cis-
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2 h, 2a: 7% yield 1:0 dr (cis:trans), 3a: 10% yield 
4 h, 2a: 19% yield 2.17:1 dr, 3a: 11% yield
6 h, 2a: 44% yield 2.38:1 dr, 3a: 14% yield
10 h, 2a: 57% yield 2:1 dr, 3a: 11% yield
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2a run in the presence of [Pd(allyl)Cl]2, (R)-DTBM-Segphos, nbe, and sodium 
tetraphenylborate generated ketone product 2a with 2.20:1 dr (cis:trans) (Scheme 5b). This 
result is consistent with the cis-2a product being generated via carboacylation and 
epimerization over the course of the reaction to generate increasing amounts of trans-2a.   
 
Scheme 4. Control Experiments from 3a.  
 
Scheme 5. Control Experiments from cis-2a. 
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When predominantly trans-2a (0.19:1 dr cis:trans) was run in the presence of 
[Pd(allyl)Cl]2, (R)-DTBM-Segphos, and sodium tetraphenylborate, we observed additional 
epimerization of the cis-2a ketone into trans-2a with a final dr of 0.03:1 cis:trans-2a (Scheme 
6a). The reaction of 1a and one equivalent of trans-2a (0.19:1 dr cis:trans) run in the presence 
of [Pd(allyl)Cl]2, (R)-DTBM-Segphos, nbe, and sodium tetraphenylborate generated 2a with a 
0.43:1 dr (cis:trans) (Scheme 6b). This data also supports that the trans-2a ketone is generated 
through the epimerization of cis-2a under the reaction conditions.  
 
Scheme 6. Control Experiments from trans-2a. 
With a better understanding of the diastereomeric ratios generated from alkene 
carboacylation, we next sought to evaluate which components of the reaction are responsible 
for the epimerization of cis-2a to trans-2a. Control experiments with palladium precatalyst, 
palladium bisphosphine complex, NaBPh4, and NaOC6F5 were conducted in the presence of 
cis-2a (Scheme 7). Based off these control experiments, the active palladium bisphosphine 
complex and palladium precursor are not major contributors to the epimerization of cis-2a 
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(Scheme 7a-c). Additionally, the pentafluorophenoxide byproduct from oxidative addition did 
not rapidly epimerize cis-2a, although over 16 hours more than 50% of the cis-2a diastereomer 
was converted (Scheme 7e). Interestingly, when cis-2a was stirred with NaBPh4 we observed 
almost complete epimerization of cis-2a to trans-2a (Scheme 7d). Therefore, we hypothesize 
that NaBPh4 is the component responsible for the majority of the epimerization under standard 
reaction conditions. This result also demonstrates the potential to convert the high yield, high 
ee, and low dr ketone products from this alkene carboacylation into the trans-diastereomer 
after the reaction is complete.  
 
Scheme 7. Control Experiments from trans-2a. 
[Pd(allyl)Cl]2 (5 mol %)
(R)-DTBM-Segphos (10 mol %)
1,4-dioxane, 110 °C
Ph
Ph
O
3.39:1
dr (cis:trans)
Ph
Ph
O
cis-2a
CpPd(1-phenylallyl) (10 mol %)
(R)-DTBM-Segphos (10 mol %)
1,4-dioxane, 110 °C
Ph
Ph
O
2.48:1
dr (cis:trans)
Ph
Ph
O
cis-2a
[Pd(allyl)Cl]2 (5 mol %)
1,4-dioxane, 110 °C
Ph
Ph
O
49:1
dr (cis:trans)
Ph
Ph
O
cis-2a
NaBPh4 (2.0 equiv)
1,4-dioxane, 110 °C
Ph
Ph
O
1:47
dr (cis:trans)
Ph
Ph
O
cis-2a
NaOC6F5 (2.0 equiv)
1,4-dioxane, 110 °C
Ph
Ph
O
1:1.77
dr (cis:trans)
Ph
Ph
O
cis-2a
(a)
(b)
(c)
(d)
(e)
138 
Conclusion 
In summary, we have developed the first palladium-catalyzed enantioselective, 
intermolecular alkene carboacylation reactions triggered via C−O bond activation of readily 
accessible esters. This reaction enables the three-component coupling of aryl benzoates, 
norbornene, and sodium tetraarylborates to form the corresponding ketone products in high 
yields, enantioselectivities, and diastereoselectivities. The ability to access acyl-metal-aryl 
intermediates via ester C−O bond activation and interception with an alkene demonstrates a 
new approach into carboacylation reactions and bypasses the limitations associated with C−C 
and C−N bond activation. Studies to expand the scope of alkenes and organometallic 
nucleophiles and to gain additional mechanistic understanding of the palladium-catalyzed 
alkene carboacylation reaction are ongoing in our laboratory. 
Experimental 
General synthetic details. All air-sensitive procedures were conducted under inert 
atmosphere in a nitrogen-filled dry box or by standard Schlenk techniques.  All reactions were 
performed under an atmosphere of nitrogen unless otherwise stated.  All glassware for moisture 
sensitive reactions were dried at 140 °C in an oven.  Tetrahydrofuran, methylene chloride, 
benzene, and toluene were degassed by purging with argon for 45 minutes and dried with a 
solvent purification system by passing through a one-meter column of activated alumina.  
Anhydrous 1,4-dioxane was purchased from Sigma Aldrich. Flash column chromatography 
was performed on SiliFlash® P60 silica gel (40-63 µm, 60Å) or using a Teledyne Isco 
Combiflash® Rf system with RediSep Gold™ columns using hexanes/ethyl acetate, 
dichloromethane/methanol, or pentane/ether mixtures as eluents.  Reactions products were 
visualized on TLC by UV light or by staining with KMnO4. 
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Instrumentation. HRMS (ESI) analysis was performed at the Iowa State University 
Chemical Instrumentation Facility on an Agilent 6540 QTOF spectrometer. HPLC analyses 
were carried out on a Waters Alliance HPLC system with an e2695 separations module and a 
2489 dual wavelength detector. NMR spectra were acquired on Varian MR-400 and Bruker 
Avance III 600 spectrometers at the Iowa State University Chemical Instrumentation Facility. 
Chemicals shifts are reported in ppm relative to residual solvent peaks (CDCl3 = 7.26 ppm for 
1H and 77.16 ppm for 13C). Coupling constants are reported in hertz. 19F NMR shifts are 
reported based on indirect reference to CDCl3.41 
Materials. Benzoyl chloride, methyl benzoate, benzyl benzoate, phenyl benzoate, 
norbornene, sodium tetraphenylborate, [Pd(allyl)Cl]2, CpPd(1-phenylallyl), rac-BINAP 
((rac)-2,2'-bis(diphenylphosphino)-1,1'-binaphthalene), (R)-BINAP ((R)-2,2'-
bis(diphenylphosphino)-1,1'-binaphthalene), (R)-Tol-BINAP ((R)-2,2'-bis(di-p-
tolylphosphino)-1,1'-binaphthalene), (R)-Xyl-BINAP ((R)-2,2'-bis(di-3,5-
dimethylphenylphosphino)-1,1'-binaphthalene), (R)-MeO-Biphep ((R)-2,2'-
bis(diphenylphosphino)-1,1'-biphenyl), (R)-Segphos ((R)-2,2'-bis(diphenylphosphino)-4,4'-bi-
1,3-benzodioxole), DPEphos (Oxydi-2,1-phenylene)bis(diphenylphosphine), (R,R)-DIOP (−)-
2,3-O-Isopropylidene-2,3-dihydroxy-1,4-bis(diphenylphosphino)butane, (S,S)-chiraphos 
(2S,3S)-(−)-Bis(diphenylphosphino)butane, (R,R)-QuinoxP (R,R)-(–)-2,3-Bis(tert-
butylmethylphosphino)quinoxaline, CTH-(R)-P-Phos (R)-(+)-2,2',6,6'-Tetramethoxy-4,4'-
bis(diphenylphosphino)-3,3'-bipyridine, dppf 1,1′-bis(diphenylphosphino)ferrocene, dcpb 1,4-
bis(dicyclohexylphosphino)butane, magnesium(II) triflate, silver(I) triflate, sodium(I) triflate, 
magnesium(II) iodide, magnesium(II) carbonate, magnesium(II) perchlorate, magnesium(II) 
triflamide, scandium(III) triflate, zinc(II) triflate, silver nitrate, silver mesylate, silver 
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hexafluoroantimonate, silver tetrafluoroborate, silver hexafluorophosphate, silver perchlorate, 
bismith(III) triflate, yttrium(III) triflate, copper(II) triflate, samarium(III) triflate, N,N-
dimethylaminopyriridine, diisopropylethylamine, sodium hydride, cesium fluoride, copper(I) 
iodide, magnesium, sodium sulfate, magnesium sulfate, were purchased from Sigma-Aldrich 
and used without further purification. Pentraflurophenol was purchased from Oakwood 
Chemical and used without further purification. Triethylamine was purchased from Fisher 
Scientific and used without further purification.  
(R)-DTBM-Segphos (R)-(−)-5,5′-bis[di(3,5-di-tert-butyl-4-
methoxyphenyl)phosphino]-4,4′-bi-1,3-benzodioxole, (R)-DTBM-MeO-Biphep (R)-(-)-2,2'-
bis[di(3,5-di-t-butyl-4-methoxyphenyl)phosphino]-6,6'-dimethoxy-1,1'-biphenyl, (R)-tBu-
MeO-Biphep (R)-(+)-2,2'-bis[di(3,5-di-t-butylphenyl)phosphino]-6,6'-dimethoxy-1,1'-
biphenyl, (S,S)-BDPP  (2S,4S)-2,4-bis(diphenylphosphino)pentane, Josiphos SL-J004-1 (R)-
1-[(SP)-2-(dicyclohexylphosphino)ferrocenylethyl]diphenylphosphine, Josiphos SL-J009-1 
(R)-1-[(SP)-2-(dicyclohexylphosphino)ferrocenyl]ethyldi-tert-butylphosphine, JoSPOphos 
SL-J681-2 (RP)-1-[(S)-tert-butylphosphinoyl]-2-[(S)-1-(diphenylphosphino)ethyl]ferrocene, 
and Josiphos SL-J001-2 (S)-1-[(RP)-2-
(diphenylphosphino)ferrocenyl]ethyldicyclohexylphosphine, were purchased from Strem 
Chemicals and used without further purification.  
Synthesis of Pentafluorophenyl benzoate 1a.  
Pentrafluorophenyl benzoate 1a:  In an oven dried round-bottom-flask, 
pentafluorophenol (1.104 g, 6.00 mmol), triethylamine (1.05 mL, 7.50 mmol), and 4-
dimethylaminopyridine (0.061g, 0.500 mmol), were dissolved in DCM (10 mL, 0.60 M). The 
solution was cooled to 0 °C and then a solution of benzoyl chloride (0.58 mL, 5.00 mmol) in 
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DCM (10 mL, 0.50 M) was added slowly. The reaction was allowed to warm to rt and stirred 
for 12 hours. After completion of the reaction, 1 N HCl was added to quench the reaction, and 
more DCM was added. The solution was washed with aq. NaHCO3 (sat.), brine, and then the 
organic layer was dried with MgSO4. The dried organic layer was concentrated under reduced 
pressure to yield the crude product. The crude product was purified by flash column 
chromatography (90:10 hexanes:EtOAc) to yield 1a (1.124 g, 3.9 mmol, 78% yield) as a white 
solid. 1H NMR (CDCl3, 400 MHz): δ 7.45 - 7.58 (m, 2H), 7.69 - 7.73 (m, 1H), 8.20 - 8.22 (m, 
2H), 9.96 (s, 1H). 13C NMR (CDCl3, 100 MHz): δ 127.1, 129.0, 130.9, 134.9, 136.7 - 137.1 
(m), 138.3 - 138.6 (m), 139.2 - 141.1 (m), 142.7 - 142.9 (m), 162.8. 19F NMR (CDCl3, 376 
MHz) δ -162.5 (m, 2F), -158.1 (t, 1F), -152.6 (m, 2F).  
General Procedure A for Alkene Carboacylation of 1a. 
 
In a nitrogen-filled dry box, the palladium precatalyst (0.005 mmol dimer) and 
corresponding ligand (0.010 mmol) were stirred to precomplex for 30 minutes in 1,4-dioxane 
(0.30 mL). In an oven-dried 1-dram vial, 1a (22.8 mg, 0.100 mmol), nbe (94.1 mg, 1.00 mmol), 
sodium tetraphenylborate (68.4 mg, 0.200 mmol), and additive (0.00 - 2.00 equiv, 0 - 0.200 
mmol) were added with a magnetic stir bar. Then 0.30 mL of the precomplexed ligated-
palladium solution was added to the 1-dram vial. The vial was capped with a teflon-lined screw 
cap and removed from the dry box and stirred at 110 °C for 16-24 hours. The reaction mixture 
was cooled to room temperature and DCM was added. The reaction was filtered through a plug 
of celite and washed 4x with DCM (2 mL). The filtrate was concentrated under reduced 
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pressure. The crude reaction mixtures were purified by flash column chromatography 
(hexanes:EtOAc) to yield 2a (a mixture of cis-2a and trans-2a, and in some cases 3a).  
phenyl((1R,2S,3R,4S)-3-phenylbicyclo[2.2.1]heptan-2-yl)methanone (cis-
2a): Prepared according to general procedure A starting from 
pentafluorophenyl benzoate 1a (28.8 mg, 0.100 mmol), nbe (94.1 mg, 1.00 
mmol), NaBPh4 (68.4 mg, 0.200 mmol), [Pd(allyl)Cl]2 (1.8 mg, 0.005 mmol), and (R)-DTBM-
Segphos (11.8 mg, 0.010 mmol). After completion of the reaction the yield 2a was determined 
to be 49% cis-2a and 50% trans-2a (0.98:1 dr), an overall 99% yield of 2a based off 
dibromomethane internal standard. To isolate cis-2a and trans-2a the crude product was 
purified by flash column chromatography (100% hexanes to 91:9 hexanes:EtOAc) to yield cis-
2a (13.1 mg, 0.047 mmol, 47% yield) as a white solid. The enantiomeric excess was 
determined by HPLC analysis (254 nm, 25 °C) tR 14.3 min (major); tR 16.6 min (minor) 
[Chiracel OJ-H (0.46cm x 25 cm) (from Daicel Chemical Ind., Ltd.) hexane/iPrOH, 95:5, 1 
mL/min] to be 49% ee. 1H NMR (CDCl3, 400 MHz): δ 1.39 -1.78 (m, 4H), 1.67 - 1.78 (m, 
2H), 2.44 - 2.49 (m, 2H), 2.71 (s, 1H), 3.29 (d, J = 10.4 Hz, 1H), 3.84 (d, J = 10.2 Hz, 1H), 
6.88 - 6.96 (m, 5H), 7.21 (t, J = 7.8 Hz, 1H), 7.34 (d, J = 6.9, 1H), 7.55 (d, J = 7.5 Hz, 1H). 
13C NMR (CDCl3, 100 MHz): δ 29.1, 31.3, 37.6, 39.3, 43.7, 54.1, 56.4, 126.0, 127.8, 128.0, 
128.1, 128.5, 132.1, 138.7, 141.9, 201.8.  
phenyl((1R,2R,3R,4S)-3-phenylbicyclo[2.2.1]heptan-2-yl)methanone 
(trans-2a): Prepared according to general procedure A starting from 
pentafluorophenyl benzoate 1a (28.8 mg, 0.100 mmol), nbe (94.1 mg, 1.00 
mmol), NaBPh4 (68.4 mg, 0.200 mmol), [Pd(allyl)Cl]2 (1.8 mg, 0.005 mmol), and (R)-DTBM-
Segphos (11.8 mg, 0.010 mmol). After completion of the reaction the yield 2a was determined 
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to be 49% cis-2a and 50% trans-2a (0.98:1 dr), an overall 99% yield of 2a based off 
dibromomethane internal standard. To isolate cis-2a and trans-2a the crude product was 
purified by flash column chromatography (100% hexanes to 91:9 hexanes:EtOAc) to yield 
trans-2a (13.5 mg, 0.049 mmol, 49% yield) as a white solid. The enantiomeric excess was 
determined by HPLC analysis (254 nm, 25 °C) tR 28.6 min (major); tR 31.9 min (minor) 
[Chiracel OJ-H (0.46cm x 25 cm) (from Daicel Chemical Ind., Ltd.) hexane/iPrOH, 95:5, 1 
mL/min] to be 53% ee. 1H NMR (CDCl3, 400 MHz): δ 1.21 - 1.39 (m, 3H), 1.50 (d, J = 9.9 
Hz, 1H), 1.61 - 1.69 (m, 1H), 2.01 (d, J = 9.6 Hz, 1H), 2.61 (d, J = 3.7 Hz, 1H), 3.62 (d, J = 
5.4 Hz, 1H), 3.72 (dd, J = 4.2, 4.2 Hz, 1H), 6.93 (d, J = 8.6, 2H), 7.14 (t, J = 6.8 Hz, 1H), 7.22 
- 7.28 (m, 5H), 7.98 (d, J = 8.6 Hz, 1H). 13C NMR (CDCl3, 100 MHz): δ 23.8, 30.1, 39.7, 42.5, 
43.1, 55.6, 59.8, 113.8, 125.8, 127.0, 128.6, 130.8, 146.8, 163.4, 198.9.  
phenyl((1R,4S)-3-phenylbicyclo[2.2.1]hept-2-en-2-yl)methanone (4a): 
This compound was generated in varying amounts 0 to 15% yield as a 
byproduct of the general procedure A starting from pentafluorophenyl 
benzoate 1a (28.8 mg, 0.100 mmol), nbe (94.1 mg, 1.00 mmol), NaBPh4 (68.4 mg, 0.200 
mmol), [Pd(allyl)Cl]2 (1.8 mg, 0.005 mmol), and ligand (0.010 mmol). NMR yield of this 
byproduct was determined with dibromomethane internal standard. To isolate 4a the crude 
product was purified by flash column chromatography (100% hexanes to 91:9 hexanes:EtOAc) 
to yield 4a as a white solid. 1H NMR (CDCl3, 400 MHz): δ 1.44 - 1.52 (m, 3H), 1.56 - 1.60 
(m, 1H), 2.48 (d, J = 10.0 Hz, 1H), 2.59 (d, J = 2.4 Hz, 1H), 2.78 (d, J = 3.2 Hz, 1H), 4.12 (d, 
J = 1.7 Hz, 1H), 7.20 - 7.26 (m, 1H), 7.30 - 7.34 (m, 4H), 7.42 (t, J = 7.8 Hz, 2H), 7.52 (t, J = 
7.5 Hz, 1H), 8.24 (d, J = 7.2 Hz, 1H). 13C NMR (CDCl3, 100 MHz): δ 22.4, 30.2, 38.2, 40.7, 
47.6, 53.3, 89.4, 127.2, 128.2, 129.0, 129.2, 130.3, 132.7, 136.3, 138.2, 200.7.  
Ph
Ph
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Table 5. Investigation of Achiral and Chiral Ligands for Carboacylation of 1aa  
 
entry ligand conv. 
(%) 
yield 2a 
(%)b 
ee 2a 
(%)c 
dr 
(cis:trans)b 
yield 4a 
(%) 
1 DPEphos 91 84 - 1.27:1 4 
2 Cy-DPEphos 71 34 - 1.43:1 0 
3 dppf 62 58 - 4.27:1 0 
4 dcpb 46 17 - 0.89:1 0 
5 (R)-Segphos 99 92 39 1.19:1 8 
6 (R)-DTBM-Segphos 99 99 49 0.98:1 <1 
7 (R)-MeO-Biphep 99 92 16 1.56:1 6 
8 (R)-DTBM-MeO-Biphep 93 80 29 1.86:1 8 
9 (R)-tBu-MeO-Biphep 88 70 41 0.84:1 17 
10 (R)-BINAP 96 70 19 1.19:1 16 
11 (R)-tol-BINAP 95 70 10 1.19:1 15 
12 (R)-xyl-BINAP 96 91 16 1.12:1 9 
13 (R)-Monophos 57 3 - 20:1 0 
14 (S,S)-BDPP 96 75 7 1.14:1 13 
15 (R,R)-DIOP 56 44 8 1.20:1 3 
16 (S,S)-Chiraphos 54 52 36 1.48:1 6 
17 (R,R)-MeDuphos 99 83 56 0.93:1 8 
18 (R,R)-QuinoxP 99 85 51 0.98:1 18 
19 CTH-(R)-P-Phos 68 69 9 1.56:1 0 
20 Josiphos SL-J004-1 96 82 46 1.05:1 11 
21 Josiphos SL-J009-1 0 0 - - 0 
22 JoSPOphos SL-J681-2 98 91 13 1.12:1 <1 
23 Josiphos SL-J001-2 97 93 58 1.02:1 <1 
aReaction conditions: 1a (0.100 mmol), [Pd(allyl)Cl]2 (0.005 mmol), ligand (0.010 mmol), nbe 
(10 equiv), NaBPh4 (0.200 mmol), solvent (0.33 M), 20 h. Yields and dr determined by 1H 
NMR spectroscopy of the crude reaction mixture using dibromomethane as an internal 
standard. cEnantioselectivity determined by chiral HPLC analysis of isolated compounds. 
A large amount of the bisphosphine ligands investigated generated 2a in moderate-to-
high yields, albeit in poor enantioselectivities. The ligands that generated high yields and 
moderate enantioselectivities for intermolecular alkene carboacylation were reported and 
discussed in scheme 2. There was an additional byproduct 4a observed in trace to low yields 
in the majority of the reactions which was isolated and characterized (Table 5).  
Ph
Ph
O
4a
OC6F5
O [Pd(allyl)Cl]2 (5 mol %)
ligand (10 mol %)
nbe (10 equiv)
NaBPh4 (2 equiv)
1,4-dioxane, 110 °C
1a
Ph
Ph
O
Ph
Ph
O
+
cis-2a trans-2a
+
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Table 6. Investigation of Additives on the Enantioselective Carboacylation of 1aa  
 
entry additive X equiv conv. (%) yield 2a (%)b ee 2a (%)c dr (cis:trans)b 
1 none - 99 99 49 0.98:1 
2 AgOTf 0.3 99 95 50 0.98:1 
3 NaOTf 0.1 96 74 49 0.95:1 
4 NaOTf 0.3 97 75 51 0.94:1 
5 NaOTf 0.5 93 65 55 1.24:1 
6 NaOTf 1 93 55 54 1.39:1 
7 Sm(OTf)3 0.3 87 57 47 1.19:1 
8 Bi(OTf)3 0.3 75 71 50 0.78:1 
9 Ca(OTf)2 0.3 69 70 70 0.79:1 
10 Sc(OTf)3 0.3 24 26 - 1:1 
11 Zn(OTf)2 0.3 98 47 - 0.24:1 
12 Y(OTf)3 0.3 40 33 - 0.74:1 
13 Mg(OTf)2 0.1 60 51 60 0.76:1 
14 Mg(OTf)2 0.3 67 56 79 0.75:1 
15 Mg(OTf)2 0.5 79 58 85 0.81:1 
16 Mg(OTf)2 1 78 67 92 0.72:1 
17d Mg(OTf)2 1 99 73 82 0.46:1 
18 Mg(OTf)2 2 72 45 95 0.88:1 
19 MgI2 0.3 47 22 - 1:20 
20 MgCO3 0.3 82 79 48 1.19:1 
21 Mg(ClO4)2 0.3 25 14 - 20:1 
22 Mg(NTf)2 0.3 29 15 - 20:1 
23 AgNO3 0.3 76 44 - 0.91:1 
24 AgSO2Me 0.3 63 36 - 0.80:1 
25 AgSbF6 0.3 15 0 - - 
26 AgBF4 0.3 92 59 - 0.84:1 
27 AgPF6 0.3 99 76 54 1.11:1 
28 AgClO4 0.3 99 59 49 1.03:1 
aReaction conditions: 1a (0.100 mmol), [Pd(allyl)Cl]2 (0.005 mmol), (R)-DTBM-Segphos 
(0.010 mmol), nbe (10 equiv), NaBPh4 (0.200 mmol), additive (X equiv), solvent (0.33 M), 20 
h. bDetermined by 1H NMR spectroscopy of the crude reaction mixture using dibromomethane 
as an internal standard. cEnantioselectivity determined by chiral HPLC analysis of isolated 
compounds. dReaction run at 120 ºC. 
 
 
OC6F5
O [Pd(allyl)Cl]2 (5 mol %)
(R)-DTBM-Segphos (10 mol %)
nbe (10 equiv)
NaBPh4 (2 equiv)
additive (X equiv)
1,4-dioxane, 110 °C1a
Ph
Ph
O
Ph
Ph
O
+
cis-2a trans-2a
(R)-DTBM-Segphos
Ar = 3,5-tBu-4-MeO-C6H2
O
O
O
O
PAr2
PAr2
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Table 7. Investigation of Organoboron Nucleophiles for Carboacylation of 1aa  
 
entry Nu-M base conv. (%) yield 2a (%)b yield 3a (%)c 
1 NaBPh4 - 99 99 0 
2c PhB(OH)2 Na2CO3 99 0 48 
3c PhB(OH)2 CsF 99 0 3 
4c,d PhB(OH)2 CsF 84 0 18 
5c PhB(OH)2 K3PO4 99 0 24 
6 PhB(OH)2 Na2CO3 84 4 60 
7 - Na2CO3 31 0 0 
8 PhB(OH)2 CsF 99 0 31 
9d PhB(OH)2 CsF 78 0 27 
10 PhB(OH)2 K3PO4 94 0 19 
11c PhBpin Na2CO3 68 0 6 
12c PhBpin CsF 99 0 0 
13c PhBpin K3PO4 99 0 3 
14 PhBpin Na2CO3 43 0 2 
15 PhBpin CsF 99 0 10 
16 PhBpin K3PO4 78 0 13 
17c NaBPh4 CsF 55 0 8 
18c,d NaBPh4 CsF 71 0 20 
aReaction conditions: 1a (0.100 mmol), [Pd(allyl)Cl]2 (0.005 mmol), (R)-DTBM-Segphos 
(0.010 mmol), nbe (10 equiv), Nu-M (0.200 mmol), base (0.200 mmol), water (0.00 or 0.200 
mmol), solvent (0.33 M), 20 h. bDetermined by 1H NMR spectroscopy of the crude reaction 
mixture using dibromomethane as an internal standard. cRun with 2 equiv of water. dReaction 
run with 10 mol % CuI 
 
Attempts to utilize other organoboron nucleophiles were unsuccessful in the generation 
of the desired carboacylation product 2a. Instead, we observed the formation of 3a, the product 
of Heck coupling in low-to-moderate yields (0-60%) (Table 7).  
 
 
 
 
OC6F5
O [Pd(allyl)Cl]2 (5 mol %)
(R)-DTBM-Segphos (10 mol %)
nbe (10 equiv)
Nu-M (2 equiv)
base (2 equiv), H2O (2 equiv)
1,4-dioxane, 110 °C1a
Ph
Ph
O
Ph
O
+
2a 3a
147 
Table 8. Investigation of Solvents on the Enantioselective Carboacylation of 1aa  
 
entry solvent conv. (%) yield 2a (%)b ee 2a (%)c dr (cis:trans)b 
1 1,4-dioxane 99 99 49 0.98:1 
2 benzene 88 68 57 1.83:1 
3 toluene 87 66 57 1.64:1 
4 CF3C6H5 13 3 - 20:1 
5 cyclopentyl methyl ether 99 71 52 1.29:1 
6 dibutyl ether 87 68 51 3.53:1 
aReaction conditions: 1a (0.100 mmol), [Pd(allyl)Cl]2 (0.005 mmol), (R)-DTBM-Segphos 
(0.010 mmol), nbe (10 equiv), NaBPh4 (0.200 mmol), solvent (0.33 M), 20 h. bDetermined by 
1H NMR spectroscopy of the crude reaction mixture using dibromomethane as an internal 
standard. cEnantioselectivity determined by chiral HPLC analysis of isolated compounds.  
Experimental Procedure for Control Experiments: 
 
A control experiment generating ketone 2a was carried out by the following procedure. A 1-
dram vial was charged with 3a (19.8 mg, 0.100 mmol), [Pd(allyl)Cl]2 (1.8 mg, 0.005 mmol), 
(R)-DTBM-Segphos (11.8 mg, 0.010 mmol), sodium tetraphenylborate (68.4 mg, 0.200 
mmol), and 1,4-dioxane (0.30 mL).   The vial was capped with a teflon-lined screw cap and 
stirred at 110 °C for 16 hours.  The reaction mixture was cooled to room temperature and DCM 
was added. The reaction was filtered through a plug of celite and washed 4x with DCM (2 
mL). The filtrate was concentrated under reduced pressure. The crude mixture was dissolved 
in CDCl3 with CH2Br2 as internal standard. The diastereomeric ratio of cis-2a:trans-2a was 
determined to be 0.12:1 by 1H NMR spectroscopy.  The NMR yields of cis-2a and trans-2a 
were determined to be 3% and 16%, respectively with 40% conversion of 3a. 
OC6F5
O [Pd(allyl)Cl]2 (5 mol %)
(R)-DTBM-Segphos (10 mol %)
nbe (10 equiv)
NaBPh4 (2 equiv)
solvent, 110 °C
1a
Ph
Ph
O
Ph
Ph
O
+
cis-2a trans-2a
[Pd(allyl)Cl]2 (5 mol %)
(R)-DTBM-Segphos (10 mol %)
NaBPh4 (2.0 equiv)
1,4-dioxane, 110 °C
Ph
O
Ph
Ph
O
2a3a
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A control experiment generating ketone 2a was carried out by the following procedure. A 1-
dram vial was charged with 3a (19.8 mg, 0.100 mmol), 1a (28.8 mg, 0.100 mmol) 
[Pd(allyl)Cl]2 (1.8 mg, 0.005 mmol), (R)-DTBM-Segphos (11.8 mg, 0.010 mmol), nbe (94.1 
mg, 1.00 mmol), sodium tetraphenylborate (68.4 mg, 0.200 mmol), and 1,4-dioxane (0.30 mL).   
The vial was capped with a teflon-lined screw cap and stirred at 110 °C for 16 hours.  The 
reaction mixture was cooled to room temperature and DCM was added. The reaction was 
filtered through a plug of celite and washed 4x with DCM (2 mL). The filtrate was concentrated 
under reduced pressure. The crude mixture was dissolved in CDCl3 with CH2Br2 as internal 
standard. The diastereomeric ratio of cis-2a:trans-2a was determined to be 2.0:1 by 1H NMR 
spectroscopy.  The NMR yields of cis-2a and trans-2a were determined to be 40% and 20%, 
respectively with 40% conversion of 3a and 92% conversion of 1a. 
 
A control experiment generating ketone 2a was carried out by the following procedure. A 1-
dram vial was charged with cis-2a (27.6 mg, 0.100 mmol), [Pd(allyl)Cl]2 (1.8 mg, 0.005 
mmol), (R)-DTBM-Segphos (11.8 mg, 0.010 mmol), sodium tetraphenylborate (68.4 mg, 
0.200 mmol), and 1,4-dioxane (0.30 mL).   The vial was capped with a teflon-lined screw cap 
and stirred at 110 °C for 16 hours.  The reaction mixture was cooled to room temperature and 
DCM was added. The reaction was filtered through a plug of celite and washed 4x with DCM 
[Pd(allyl)Cl]2 (5 mol %)
(R)-DTBM-Segphos (10 mol %)
NaBPh4 (2.0 equiv)
nbe (10 equiv)
1,4-dioxane, 110 °C
Ph
O
Ph
Ph
O
2a3a
Ph OC6F5
O
+
1a
+
Ph
O
Ph
18% yield
[Pd(allyl)Cl]2 (5 mol %)
(R)-DTBM-Segphos (10 mol %)
NaBPh4 (2.0 equiv)
1,4-dioxane, 110 °C Ph
Ph
O
2a
Ph
Ph
O
cis-2a
149 
(2 mL). The filtrate was concentrated under reduced pressure. The crude mixture was dissolved 
in CDCl3 with CH2Br2 as internal standard. The diastereomeric ratio of cis-2a:trans-2a was 
determined to be 0.28:1 by 1H NMR spectroscopy.  The NMR yields of cis-2a and trans-2a 
were determined to be 21% and 75%, respectively with 79% conversion of cis-2a. 
 
A control experiment generating ketone 2a was carried out by the following procedure. A 1-
dram vial was charged with cis-2a (27.6 mg, 0.100 mmol), 1a (28.8 mg, 0.100 mmol) 
[Pd(allyl)Cl]2 (1.8 mg, 0.005 mmol), (R)-DTBM-Segphos (11.8 mg, 0.010 mmol), nbe (94.1 
mg, 1.00 mmol), sodium tetraphenylborate (68.4 mg, 0.200 mmol), and 1,4-dioxane (0.30 mL).   
The vial was capped with a teflon-lined screw cap and stirred at 110 °C for 16 hours.  The 
reaction mixture was cooled to room temperature and DCM was added. The reaction was 
filtered through a plug of celite and washed 4x with DCM (2 mL). The filtrate was concentrated 
under reduced pressure. The crude mixture was dissolved in CDCl3 with CH2Br2 as internal 
standard. The diastereomeric ratio of cis-2a:trans-2a was determined to be 2.20:1 by 1H NMR 
spectroscopy.  The NMR yields of cis-2a and trans-2a were determined to be 62% and 28%, 
respectively with 84% conversion of 1a. 
 
 
 
 
[Pd(allyl)Cl]2 (5 mol %)
(R)-DTBM-Segphos (10 mol %)
NaBPh4 (2.0 equiv)
nbe (10 equiv)
1,4-dioxane, 110 °C Ph
Ph
O
2a
Ph OC6F5
O
+
1a 3a
14% yield
Ph
Ph
O
Ph
O
+
cis-2a
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A control experiment generating ketone 2a was carried out by the following procedure. A 1-
dram vial was charged with trans-2a (0.19:1 dr cis:trans, 27.6 mg, 0.100 mmol), [Pd(allyl)Cl]2 
(1.8 mg, 0.005 mmol), (R)-DTBM-Segphos (11.8 mg, 0.010 mmol), sodium tetraphenylborate 
(68.4 mg, 0.200 mmol), and 1,4-dioxane (0.30 mL).   The vial was capped with a teflon-lined 
screw cap and stirred at 110 °C for 16 hours.  The reaction mixture was cooled to room 
temperature and DCM was added. The reaction was filtered through a plug of celite and washed 
4x with DCM (2 mL). The filtrate was concentrated under reduced pressure. The crude mixture 
was dissolved in CDCl3 with CH2Br2 as internal standard. The diastereomeric ratio of cis-
2a:trans-2a was determined to be 0.03:1 by 1H NMR spectroscopy.  The NMR yields of cis-
2a and trans-2a were determined to be 3% and 97%. 
 
A control experiment generating ketone 2a was carried out by the following procedure. A 1-
dram vial was charged with trans-2a (0.19:1 dr cis:trans, 27.6 mg, 0.100 mmol), 1a (28.8 mg, 
0.100 mmol) [Pd(allyl)Cl]2 (1.8 mg, 0.005 mmol), (R)-DTBM-Segphos (11.8 mg, 0.010 
mmol), nbe (94.1 mg, 1.00 mmol), sodium tetraphenylborate (68.4 mg, 0.200 mmol), and 1,4-
dioxane (0.30 mL).   The vial was capped with a teflon-lined screw cap and stirred at 110 °C 
[Pd(allyl)Cl]2 (5 mol %)
(R)-DTBM-Segphos (10 mol %)
NaBPh4 (2.0 equiv)
1,4-dioxane, 110 °C Ph
Ph
O
trans-2a
0.03:1
dr (cis:trans)
Ph
Ph
O
trans-2a
0.19:1
dr (cis:trans)
[Pd(allyl)Cl]2 (5 mol %)
(R)-DTBM-Segphos (10 mol %)
NaBPh4 (2.0 equiv)
nbe (10 equiv)
1,4-dioxane, 110 °C Ph
Ph
O
trans-2a
0.43:1
dr (cis:trans)
Ph OC6F5
O
+
1a
22% yield
Ph
Ph
O
PhPh
O
+
trans-2a
0.19:1
dr (cis:trans)
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for 16 hours.  The reaction mixture was cooled to room temperature and DCM was added. The 
reaction was filtered through a plug of celite and washed 4x with DCM (2 mL). The filtrate 
was concentrated under reduced pressure. The crude mixture was dissolved in CDCl3 with 
CH2Br2 as internal standard. The diastereomeric ratio of cis-2a:trans-2a was determined to be 
0.43:1 by 1H NMR spectroscopy.  The NMR yields of cis-2a and trans-2a were determined to 
be 28% and 66%, respectively with 99% conversion of 1a. 
 
A control experiment generating ketone 2a was carried out by the following procedure. A 1-
dram vial was charged with cis-2a (27.6 mg, 0.100 mmol), [Pd(allyl)Cl]2 (1.8 mg, 0.005 
mmol), (R)-DTBM-Segphos (11.8 mg, 0.010 mmol), and 1,4-dioxane (0.30 mL).   The vial 
was capped with a teflon-lined screw cap and stirred at 110 °C for 16 hours.  The reaction 
mixture was cooled to room temperature and DCM was added. The reaction was filtered 
through a plug of celite and washed 4x with DCM (2 mL). The filtrate was concentrated under 
reduced pressure. The crude mixture was dissolved in CDCl3 with CH2Br2 as internal standard. 
The diastereomeric ratio of cis-2a:trans-2a was determined to be 3.39:1 by 1H NMR 
spectroscopy.  The NMR yields of cis-2a and trans-2a were determined to be 78% and 22%, 
respectively. 
 
 
[Pd(allyl)Cl]2 (5 mol %)
(R)-DTBM-Segphos (10 mol %)
1,4-dioxane, 110 °C
Ph
Ph
O
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O
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A control experiment generating ketone 2a was carried out by the following procedure. A 1-
dram vial was charged with cis-2a (27.6 mg, 0.100 mmol), CpPd(1-phenylallyl) (2.9 mg, 0.005 
mmol), (R)-DTBM-Segphos (11.8 mg, 0.010 mmol), and 1,4-dioxane (0.30 mL).   The vial 
was capped with a teflon-lined screw cap and stirred at 110 °C for 16 hours.  The reaction 
mixture was cooled to room temperature and DCM was added. The reaction was filtered 
through a plug of celite and washed 4x with DCM (2 mL). The filtrate was concentrated under 
reduced pressure. The crude mixture was dissolved in CDCl3 with CH2Br2 as internal standard. 
The diastereomeric ratio of cis-2a:trans-2a was determined to be 2.48:1 by 1H NMR 
spectroscopy.  The NMR yields of cis-2a and trans-2a were determined to be 71% and 29%, 
respectively. 
 
A control experiment generating ketone 2a was carried out by the following procedure. A 1-
dram vial was charged with cis-2a (27.6 mg, 0.100 mmol), [Pd(allyl)Cl]2 (1.8 mg, 0.005 
mmol), and 1,4-dioxane (0.30 mL).   The vial was capped with a teflon-lined screw cap and 
stirred at 110 °C for 16 hours.  The reaction mixture was cooled to room temperature and DCM 
was added. The reaction was filtered through a plug of celite and washed 4x with DCM (2 
mL). The filtrate was concentrated under reduced pressure. The crude mixture was dissolved 
in CDCl3 with CH2Br2 as internal standard. The diastereomeric ratio of cis-2a:trans-2a was 
CpPd(1-phenylallyl) (10 mol %)
(R)-DTBM-Segphos (10 mol %)
1,4-dioxane, 110 °C
Ph
Ph
O
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dr (cis:trans)
Ph
Ph
O
cis-2a
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determined to be 49:1 by 1H NMR spectroscopy.  The NMR yields of cis-2a and trans-2a were 
determined to be 98% and 2%, respectively. 
 
A control experiment generating ketone 2a was carried out by the following procedure. A 1-
dram vial was charged with cis-2a (27.6 mg, 0.100 mmol), sodium tetraphenylborate (68.4 mg, 
0.200 mmol), and 1,4-dioxane (0.30 mL).   The vial was capped with a teflon-lined screw cap 
and stirred at 110 °C for 16 hours.  The reaction mixture was cooled to room temperature and 
DCM was added. The reaction was filtered through a plug of celite and washed 4x with DCM 
(2 mL). The filtrate was concentrated under reduced pressure. The crude mixture was dissolved 
in CDCl3 with CH2Br2 as internal standard. The diastereomeric ratio of cis-2a:trans-2a was 
determined to be 1:47 by 1H NMR spectroscopy.  The NMR yields of cis-2a and trans-2a were 
determined to be 2% and 94%, respectively. 
 
A control experiment generating ketone 2a was carried out by the following procedure. A 1-
dram vial was charged with cis-2a (27.6 mg, 0.100 mmol), sodium tetraphenylborate (68.4 mg, 
0.200 mmol), and 1,4-dioxane (0.30 mL).   The vial was capped with a teflon-lined screw cap 
and stirred at 110 °C for 16 hours.  The reaction mixture was cooled to room temperature and 
DCM was added. The reaction was filtered through a plug of celite and washed 4x with DCM 
(2 mL). The filtrate was concentrated under reduced pressure. The crude mixture was dissolved 
NaBPh4 (2.0 equiv)
1,4-dioxane, 110 °C
Ph
Ph
O
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dr (cis:trans)
Ph
Ph
O
cis-2a
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1,4-dioxane, 110 °C
Ph
Ph
O
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Ph
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in CDCl3 with CH2Br2 as internal standard. The diastereomeric ratio of cis-2a:trans-2a was 
determined to be 1:1.77 by 1H NMR spectroscopy.  The NMR yields of cis-2a and trans-2a 
were determined to be 62% and 36%, respectively. 
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CHAPTER 5.     
 
CONCLUSIONS 
This thesis describes the development of new transition metal-catalyzed asymmetric 
hydroacylation, intramolecular alkene carboacylation, and asymmetric, intermolecular alkene 
carboacylation reactions. The synthesis of a variety of heterocyclic and carbocyclic ketone 
scaffolds is enabled through the methods developed for these alkene difunctionalization 
reactions. Experimental work contributes to fundamental understanding of catalytic principles 
that is the foundation for new alkene difunctionalization reactions. 
The rhodium-catalyzed intramolecular hydroacylation of nitrogen, oxygen, and sulfur 
heterocycles provides a method for the synthesis of complex polycyclic heterocycle scaffolds. 
The rhodium-catalyzed alkene hydroacylation encompasses reactions of a variety of alkyl, 
electron-rich and electron-poor aryl, and heteroaryl substituted alkene units. Varied 
substitution at the nitrogen is also tolerated, and complete selectivity is observed for five-
membered ring generation over six-membered ring generation in the reaction of 1-allyl-3-(1-
phenylvinyl)-1H- indole-2-carboxaldehyde. In addition, the alkene hydroacylation reaction 
encompasses a variety of nitrogen, oxygen, and sulfur heterocycles to generate the 
corresponding polycyclic ketones. 
The nickel-catalyzed alkene carboacylation reactions initiated by amide carbon-
nitrogen bond activation demonstrates novel reactivity. The nickel-catalyzed alkene 
carboacylation encompasses reactions of a variety of ortho-allylbenzamides and arylboronic 
acid pinacol esters to generate indanone products through the formation of two new carbon-
carbon bonds. This process bypasses the typical substrate requirements for alkene 
carboacylation that occur via carbon-carbon bond activation. The ability to bypass the 
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requirement of strained ketones and directing groups demonstrates amides as substrates in the 
new class of alkene difunctionalization reactions and as powerful building blocks in organic 
synthesis.  
The palladium-catalyzed alkene carboacylation reaction initiated by ester carbon-
oxygen bond activation demonstrates the first example of intermolecular, asymmetric alkene 
carboacylation of esters. The palladium-catalyzed alkene carboacylation encompasses 
reactions of norbornene, aryl benzoates, and sodium tetraarylborates to form ketone products 
and two new carbon-carbon bonds. This process bypasses substrate requirements for alkene 
carboacylation processes that proceed through carbon-nitrogen and carbon-carbon bond 
activation. With the foundation of alkene carboacylation of esters established, we aim to 
expand the scope of alkenes and organometallic nucleophiles that can be utilized in this 
three-component reaction. 
Overall, the new alkene difunctionalized methods presented in this thesis occur with 
low catalyst loadings to generate a variety of ketone products with high levels of 
enantioselectivity and/or   diastereoselectivity. Competition and control experiments contribute 
to a deeper understanding of the mechanisms for these processes. The new methods developed 
represents significant advancements for alkene difunctionalization reactions and highlights the 
utility of amides and esters as substrates in transition-metal catalysis.  
